Livent Corp. (Form: 10-K, Received: 02/28/2022 15:56:20)

00017429242021FYFALSEP5DP5D0.1144885250001300000017429242021-01-012021-12-3100017429242021-06-30iso4217:USD00017429242021-12-31xbrli:shares00017429242020-01-012020-12-3100017429242019-01-012019-12-310001742924us-gaap:AccountingStandardsUpdate202006Member2021-01-012021-12-31iso4217:USDxbrli:shares00017429242020-12-310001742924us-gaap:AccountingStandardsUpdate202006Member2021-12-3100017429242019-12-3100017429242018-12-310001742924lthm:StateAndForeignTaxAuthorityMember2021-01-012021-12-310001742924lthm:A2019FederalIncomeTaxReturnMember2020-01-012020-12-310001742924lthm:A2018FederalIncomeTaxReturnMember2020-01-012020-12-310001742924lthm:SeparationStepsMember2020-01-012020-12-310001742924us-gaap:CommonStockMember2018-12-310001742924us-gaap:AdditionalPaidInCapitalMember2018-12-310001742924us-gaap:RetainedEarningsMember2018-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001742924us-gaap:TreasuryStockMember2018-12-310001742924us-gaap:RetainedEarningsMember2019-01-012019-12-310001742924us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001742924us-gaap:TreasuryStockMember2019-01-012019-12-310001742924us-gaap:CommonStockMember2019-12-310001742924us-gaap:AdditionalPaidInCapitalMember2019-12-310001742924us-gaap:RetainedEarningsMember2019-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001742924us-gaap:TreasuryStockMember2019-12-310001742924us-gaap:RetainedEarningsMember2020-01-012020-12-310001742924us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001742924us-gaap:TreasuryStockMember2020-01-012020-12-310001742924us-gaap:CommonStockMember2020-12-310001742924us-gaap:AdditionalPaidInCapitalMember2020-12-310001742924us-gaap:RetainedEarningsMember2020-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001742924us-gaap:TreasuryStockMember2020-12-310001742924us-gaap:RetainedEarningsMember2021-01-012021-12-310001742924us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001742924us-gaap:TreasuryStockMember2021-01-012021-12-310001742924us-gaap:CommonStockMember2021-12-310001742924us-gaap:AdditionalPaidInCapitalMember2021-12-310001742924us-gaap:RetainedEarningsMember2021-12-310001742924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001742924us-gaap:TreasuryStockMember2021-12-310001742924us-gaap:LandImprovementsMember2021-01-012021-12-310001742924srt:MinimumMemberus-gaap:BuildingMember2021-01-012021-12-310001742924srt:MaximumMemberus-gaap:BuildingMember2021-01-012021-12-310001742924us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2021-01-012021-12-310001742924us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2021-01-012021-12-310001742924us-gaap:SoftwareAndSoftwareDevelopmentCostsMembersrt:MinimumMember2021-01-012021-12-310001742924us-gaap:SoftwareAndSoftwareDevelopmentCostsMembersrt:MaximumMember2021-01-012021-12-310001742924lthm:ConvertibleSeniorNotesDue2025Memberus-gaap:ConvertibleDebtMember2021-12-31xbrli:pure0001742924us-gaap:PatentsMember2021-01-012021-12-310001742924srt:MinimumMember2021-01-012021-12-310001742924srt:MaximumMember2021-01-012021-12-31lthm:segment0001742924lthm:LiventCorporationIncentiveCompensationAndStockPlanMember2021-12-31lthm:remediationSite0001742924srt:NorthAmericaMember2021-01-012021-12-310001742924srt:NorthAmericaMember2020-01-012020-12-310001742924srt:NorthAmericaMember2019-01-012019-12-310001742924srt:LatinAmericaMember2021-01-012021-12-310001742924srt:LatinAmericaMember2020-01-012020-12-310001742924srt:LatinAmericaMember2019-01-012019-12-310001742924us-gaap:EMEAMember2021-01-012021-12-310001742924us-gaap:EMEAMember2020-01-012020-12-310001742924us-gaap:EMEAMember2019-01-012019-12-310001742924srt:AsiaPacificMember2021-01-012021-12-310001742924srt:AsiaPacificMember2020-01-012020-12-310001742924srt:AsiaPacificMember2019-01-012019-12-310001742924country:JP2021-01-012021-12-310001742924country:US2021-01-012021-12-310001742924country:KP2021-01-012021-12-310001742924country:CN2021-01-012021-12-310001742924country:JP2020-01-012020-12-310001742924country:US2020-01-012020-12-310001742924country:CN2020-01-012020-12-310001742924country:JP2019-01-012019-12-310001742924country:US2019-01-012019-12-310001742924country:CN2019-01-012019-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:CustomerOneMember2021-01-012021-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:CustomerOneMember2020-01-012020-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:CustomerOneMember2019-01-012019-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:TenLargestCustomersMember2021-01-012021-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:TenLargestCustomersMember2020-01-012020-12-310001742924us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberlthm:TenLargestCustomersMember2019-01-012019-12-310001742924lthm:LithiumHydroxideMember2021-01-012021-12-310001742924lthm:LithiumHydroxideMember2020-01-012020-12-310001742924lthm:LithiumHydroxideMember2019-01-012019-12-310001742924lthm:ButyllithiumMember2021-01-012021-12-310001742924lthm:ButyllithiumMember2020-01-012020-12-310001742924lthm:ButyllithiumMember2019-01-012019-12-310001742924lthm:HighPurityLithiumMetalandOtherSpecialtyCompoundsMember2021-01-012021-12-310001742924lthm:HighPurityLithiumMetalandOtherSpecialtyCompoundsMember2020-01-012020-12-310001742924lthm:HighPurityLithiumMetalandOtherSpecialtyCompoundsMember2019-01-012019-12-310001742924lthm:LithiumCarbonateLithiumChlorideMember2021-01-012021-12-310001742924lthm:LithiumCarbonateLithiumChlorideMember2020-01-012020-12-310001742924lthm:LithiumCarbonateLithiumChlorideMember2019-01-012019-12-3100017429242022-01-012021-12-310001742924lthm:QuebecLithiumPartnersUKMemberlthm:NemaskaProjectMember2021-12-310001742924lthm:QuebecLithiumPartnersUKMember2021-01-012021-12-310001742924lthm:QuebecLithiumPartnersUKMember2021-12-310001742924lthm:QuebecLithiumPartnersUKMember2020-12-310001742924us-gaap:LandAndLandImprovementsMember2021-12-310001742924us-gaap:LandAndLandImprovementsMember2020-12-310001742924us-gaap:BuildingMember2021-12-310001742924us-gaap:BuildingMember2020-12-310001742924us-gaap:MachineryAndEquipmentMember2021-12-310001742924us-gaap:MachineryAndEquipmentMember2020-12-310001742924us-gaap:ConstructionInProgressMember2021-12-310001742924us-gaap:ConstructionInProgressMember2020-12-310001742924us-gaap:FacilityClosingMember2021-01-012021-12-310001742924us-gaap:FacilityClosingMember2020-01-012020-12-310001742924us-gaap:FacilityClosingMember2019-01-012019-12-31lthm:site0001742924lthm:NikolovVLiventCorpMemberus-gaap:PendingLitigationMember2021-12-310001742924lthm:TMAAgreementIndemnificationAssetMember2021-12-31lthm:jurisdiction0001742924srt:MinimumMember2021-12-310001742924srt:MaximumMember2021-12-310001742924us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-12-310001742924us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMember2021-12-310001742924us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001742924us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-12-310001742924us-gaap:ConvertibleDebtMember2021-12-310001742924us-gaap:ConvertibleDebtMember2020-12-310001742924us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001742924us-gaap:RevolvingCreditFacilityMember2021-12-310001742924us-gaap:RevolvingCreditFacilityMember2020-12-310001742924srt:ScenarioPreviouslyReportedMember2021-01-012021-12-310001742924us-gaap:AccountingStandardsUpdate202006Membersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2021-01-012021-12-310001742924srt:ScenarioPreviouslyReportedMember2020-01-012020-12-310001742924us-gaap:AccountingStandardsUpdate202006Member2020-01-012020-12-310001742924us-gaap:AccountingStandardsUpdate202006Membersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2020-01-012020-12-310001742924srt:ScenarioPreviouslyReportedMember2021-12-310001742924us-gaap:AccountingStandardsUpdate202006Membersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2021-12-310001742924srt:ScenarioPreviouslyReportedMember2020-12-310001742924us-gaap:AccountingStandardsUpdate202006Member2020-12-310001742924us-gaap:AccountingStandardsUpdate202006Membersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2020-12-310001742924srt:ScenarioPreviouslyReportedMember2019-12-310001742924us-gaap:AccountingStandardsUpdate202006Membersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2019-12-310001742924lthm:ConvertibleSeniorNotesDue2025Memberus-gaap:ConvertibleDebtMember2020-06-250001742924us-gaap:ConvertibleDebtMemberlthm:ConvertibleSeniorNotesOverAllotmentOptionMember2020-07-072020-07-070001742924us-gaap:ConvertibleDebtMemberlthm:ConvertibleSeniorNotesOverAllotmentOptionMember2020-07-070001742924lthm:ConvertibleSeniorNotesDue2025Memberus-gaap:ConvertibleDebtMember2020-06-252020-06-250001742924lthm:ConversionCircumstanceOneMembersrt:ScenarioForecastMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2022-01-012022-03-31lthm:day0001742924lthm:ConvertibleSeniorNotesDue2025Memberus-gaap:ConvertibleDebtMember2021-01-012021-12-310001742924lthm:ConvertibleSeniorNotesDue2025Memberus-gaap:ConvertibleDebtMember2020-01-012020-12-310001742924us-gaap:RevolvingCreditFacilityMemberlthm:CitibankN.A.Member2018-09-280001742924us-gaap:LetterOfCreditMemberlthm:CitibankN.A.Member2018-09-280001742924us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberlthm:CitibankN.A.Member2018-09-282018-09-280001742924us-gaap:EurodollarMemberus-gaap:RevolvingCreditFacilityMemberlthm:CitibankN.A.Member2018-09-282018-09-280001742924lthm:FirstAmendmentMember2021-12-310001742924us-gaap:RevolvingCreditFacilityMemberlthm:FirstAmendmentMemberlthm:CitibankN.A.Member2021-01-012021-12-310001742924us-gaap:EmployeeStockOptionMemberlthm:LiventCorporationIncentiveCompensationAndStockPlanMember2021-01-012021-12-310001742924us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001742924us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001742924us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001742924us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001742924us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001742924us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310001742924us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001742924us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001742924us-gaap:RestructuringChargesMember2020-01-012020-12-310001742924lthm:BusinessSeparationCostsMember2020-01-012020-12-310001742924us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310001742924us-gaap:RestructuringChargesMember2019-01-012019-12-310001742924lthm:BusinessSeparationCostsMember2019-01-012019-12-310001742924srt:MinimumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-12-310001742924srt:MinimumMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-310001742924srt:MaximumMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-310001742924srt:MinimumMemberus-gaap:EmployeeStockOptionMember2019-01-012019-12-310001742924srt:MaximumMemberus-gaap:EmployeeStockOptionMember2019-01-012019-12-310001742924us-gaap:EmployeeStockOptionMember2021-12-310001742924us-gaap:EmployeeStockOptionMember2020-12-310001742924us-gaap:RestrictedStockUnitsRSUMember2020-12-310001742924us-gaap:RestrictedStockUnitsRSUMember2021-12-310001742924us-gaap:RestrictedStockUnitsRSUMemberlthm:FMCPlanMember2020-01-012020-12-310001742924lthm:LiventPlanMember2020-01-012020-12-310001742924us-gaap:RestrictedStockUnitsRSUMemberlthm:FMCPlanMember2021-01-012021-12-310001742924lthm:LiventPlanMember2021-01-012021-12-310001742924us-gaap:CommonStockMember2021-01-012021-12-3100017429242021-06-152021-06-1500017429242021-06-150001742924us-gaap:OverAllotmentOptionMember2021-06-112021-06-1100017429242021-06-112021-06-110001742924us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001742924us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-12-310001742924us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001742924us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310001742924us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001742924us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001742924us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001742924us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001742924us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001742924us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001742924us-gaap:ConvertibleDebtMember2021-01-012021-12-310001742924us-gaap:ConvertibleDebtMember2020-01-012020-12-310001742924us-gaap:StockCompensationPlanMember2021-01-012021-12-310001742924us-gaap:StockCompensationPlanMember2020-01-012020-12-310001742924us-gaap:StockCompensationPlanMember2019-01-012019-12-310001742924us-gaap:ConvertibleDebtSecuritiesMember2021-01-012021-12-310001742924us-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-12-310001742924us-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-12-310001742924us-gaap:EmployeeStockOptionMember2021-10-012021-12-310001742924us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001742924us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001742924us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001742924us-gaap:ForwardContractsMember2021-12-3100017429242021-01-012021-06-300001742924us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-12-310001742924us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-12-310001742924us-gaap:DesignatedAsHedgingInstrumentMember2021-12-310001742924us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001742924us-gaap:ForeignExchangeContractMemberlthm:CostOfSalesAndServicesMember2021-01-012021-12-310001742924us-gaap:ForeignExchangeContractMemberlthm:CostOfSalesAndServicesMember2020-01-012020-12-310001742924us-gaap:ForeignExchangeContractMemberlthm:CostOfSalesAndServicesMember2019-01-012019-12-310001742924lthm:RestructuringSettlementAndImpairmentProvisionsMemberlthm:IntercompanyLoanHedgesMember2021-01-012021-12-310001742924lthm:RestructuringSettlementAndImpairmentProvisionsMemberlthm:IntercompanyLoanHedgesMember2020-01-012020-12-310001742924lthm:RestructuringSettlementAndImpairmentProvisionsMemberlthm:IntercompanyLoanHedgesMember2019-01-012019-12-310001742924us-gaap:FairValueInputsLevel1Member2021-12-310001742924us-gaap:FairValueInputsLevel2Member2021-12-310001742924us-gaap:FairValueInputsLevel3Member2021-12-310001742924us-gaap:FairValueInputsLevel1Member2020-12-310001742924us-gaap:FairValueInputsLevel2Member2020-12-310001742924us-gaap:FairValueInputsLevel3Member2020-12-310001742924us-gaap:BuildingMember2021-01-012021-12-310001742924us-gaap:BuildingMember2021-03-310001742924us-gaap:BuildingMember2021-04-130001742924us-gaap:BuildingMember2021-06-300001742924lthm:NikolovVLiventCorpMemberus-gaap:PendingLitigationMember2020-10-2800017429242020-05-290001742924lthm:PositiveOutcomeOfLitigationReimbursementOfPaymentMember2020-05-290001742924lthm:PositiveOutcomeOfLitigationTerminationPenaltyRepaymentMember2020-05-29utr:sqft0001742924lthm:ArgentinaGovernmentMember2021-12-310001742924lthm:ArgentinaGovernmentMember2020-12-310001742924lthm:TMAAgreementUncertainTaxPositionsMember2021-12-310001742924lthm:TMAAgreementIndemnificationLiabilityMember2021-12-3100017429242021-01-012021-03-3100017429242021-04-012021-06-3000017429242021-07-012021-09-3000017429242021-10-012021-12-3100017429242020-01-012020-03-3100017429242020-04-012020-06-3000017429242020-07-012020-09-3000017429242020-10-012020-12-31

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________________________________________

FORM 10-K

_______________________________________________________________________


☒			Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2021


☐			Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______ to _______

Commission File Number 001-38694

__________________________________________________________________________

LIVENT CORPORATION

(Exact name of registrant as specified in its charter)

__________________________________________________________________________


Delaware						82-4699376
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1818 Market Street Philadelphia, Pennsylvania						19103
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: 215-299-5900

__________________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol (s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	LTHM	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Table of Contents

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☒ No ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of voting stock held by non-affiliates of the registrant as of June 30, 2021, the last day of the registrant’s second fiscal quarter was $3,112,320,130. The market value of voting stock held by non-affiliates excludes the value of those shares held by executive officers and directors of the registrant.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.


Class						December 31, 2021
Common Stock, par value $0.001 per share						161,689,984

DOCUMENTS INCORPORATED BY REFERENCE


DOCUMENT						FORM 10-K REFERENCE
Portions of Proxy Statement for 2022 Annual Meeting of Stockholders						Part III

Table of Contents

Livent Corporation

2021 Form 10-K

Table of Contents


			Page

Glossary			4

PART I
Item 1. Business			6
Item 1A. Risk Factors			21
Item 1B. Unresolved Staff Comments			37
Item 2. Properties			38
Item 3. Legal Proceedings			38
Item 4. Mine Safety Disclosures			38
Item 4A. Executive Officers of the Registrant			39

PART II

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities			40

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations			41
Item 7A. Quantitative and Qualitative Disclosures about Market Risk			51
Item 8. Financial Statements and Supplementary Data			52
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure			92
Item 9A. Controls and Procedures			92
Item 9B. Other Information			92
Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections			92

PART III

Item 10. Directors, Executive Officers and Corporate Governance			93
Item 11. Executive Compensation			93
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters			93
Item 13. Certain Relationships and Related Transactions, and Director Independence			93
Item 14. Principal Accountant Fees and Services			94

PART IV

Item 15. Exhibits and Financial Statement Schedules			94
Item 16. Form 10-K Summary			95
Signatures			96

Table of Contents

Glossary of Terms

When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:


2025 Notes			$245.75 million principal amount 4.125% Convertible Senior Notes due 2025
AOCL			Accumulated other comprehensive loss
Application			The application filed by Livent with the CCAA Court to obtain remittance of the Escrow Funds
ARO			Asset retirement obligation
ASC			Accounting Standards Codification, under U.S. GAAP
ASC 842			Accounting Standards Codification Topic 842 - Leases
ASU			Accounting Standards Update, under U.S. GAAP
Brexit			The withdrawal of the United Kingdom from the European Union
CCAA			The Companies’ Creditors Arrangement Act
CCAA Court			The Superior Court of Quebec where Nemaska, Nemaska Lithium Inc. and certain affiliates filed for creditor protection in Canada under the CCAA
CERCLA			Comprehensive Environmental Response, Compensation and Liability Act
CSR			Corporate Social Responsibility
Credit Agreement			The Original Credit Agreement, as amended
Distribution			On March 1, 2019, FMC made a tax-free distribution to its stockholders of all its remaining interest in Livent Corporation
ETS			BloombergNEF’s Economic Transition Scenario, primarily driven by techno-economic trends and market forces, and assumes no new policies or regulations are enacted that impact the market. The ETS is in line with previous edition of the Long-Term Electric Vehicle Outlook report.
ESG			Environmental, social and governance
Exchange Act			Securities and Exchange Act of 1934
EV			Electric vehicle
FASB			Financial Accounting Standards Board
FMC			FMC Corporation
GDP			Gross domestic product
HCM			Human Capital Management
IPO			Initial public offering
kMT			Thousand metric tons
LCE			Lithium carbonate equivalent
Livent NQSP			Livent Non-qualified Savings Plan
Livent Plan			Livent Corporation Incentive Compensation and Stock Plan
MdA			Minera del Altiplano SA, our local operating subsidiary in Argentina
MT			Metric ton
Nemaska			Nemaska Lithium Shawinigan Transformation Inc., a subsidiary of Nemaska Lithium Inc. a Canadian lithium company based in Québec, Canada
Nemaska Project			The ownership and operation of the business previously conducted by Nemaska, by a consortium in which Livent indirectly owns a 25% equity interest through its investment in QLP.
Nemaska Transaction			The transaction through which a consortium has purchased and operates the business previously conducted by Nemaska Lithium Inc.


QLP			Québec Lithium Partners, a joint venture owned equally by The Pallinghurst Group and Livent. QLP owns a 50% equity interest in the Nemaska Project.
NQSO			Non-qualified stock option
OM&M			Operation, maintenance and monitoring of site environmental remediation
Original Credit Agreement			On September 18, 2018 Livent Corporation entered into the credit agreement, which provides for a $400 million senior secured revolving credit facility
RCRA			Resource Conservation and Recovery Act
REACH			Registration, Evaluation, Authorization and Restriction of Chemicals
REMSA			Recursos Energeticos y Mineros Salta, S.A., local natural-gas sub-distributor in Argentina

Table of Contents


Revolving Credit Facility			Livent's $400 million senior secured revolving credit facility
ROU			Right-of-use
RSU			Restricted stock unit
SEC			Securities and Exchange Commission
Securities Act			Securities Act of 1933
Separation Date			On October 15, 2018, Livent Corporation completed the IPO and sold 20 million shares of Livent common stock to the public at a price of $17.00 per share
TCA			UK-EU Trade and Cooperation Agreement
TCFD			Task Force for Climate-Related Financial Disclosures
TMA			Tax Matters Agreement
U.S. GAAP			United States Generally Accepted Accounting Principles

Table of Contents

PART I

ITEM 1. BUSINESS

Livent Corporation was formed and incorporated by FMC Corporation as FMC Lithium USA Holding Corp. in the State of Delaware on February 27, 2018, and was subsequently renamed Livent Corporation ("Livent"). Prior to this time, our business was operated through various subsidiaries of FMC and their predecessors. Pursuant to a 2018 restructuring, FMC transferred substantially all of the assets and liabilities of its lithium business to us in exchange for all of our common stock. We conducted our initial public offering of common stock in October 2018, and FMC completed the spin-off distribution of all remaining shares of our common stock that FMC owned in March 2019. We have been operating as an independent company since that time. Livent's principal executive offices are located at 1818 Market Street, Philadelphia, Pennsylvania, 19103.

Throughout this Annual Report on Form 10-K, except where otherwise stated or indicated by the context, “Livent”, the "Company", “we,” “us,” or “our” means Livent Corporation and its consolidated subsidiaries and their predecessors, including FMC's lithium segment. References to “FMC” refer to FMC Corporation and its consolidated subsidiaries. Copies of the annual, quarterly and current reports we file with or furnish to the Securities and Exchange Commission (“SEC”), and any amendments to those reports, are available free of charge on our website at www.livent.com as soon as reasonably practicable after we file such materials with, or furnish them to, the SEC. We also make available, free of charge on our website, the reports filed with the SEC by our officers, directors and 10% stockholders pursuant to Section 16 under the Exchange Act as soon as reasonably practicable after copies of those filings are provided to us by those persons. The SEC also maintains a website, at www.sec.gov, that contains reports, proxy and information statements and other information regarding us and other issuers that file electronically. The information contained on, or that can be accessed through, our website is not a part of or incorporated by reference in this Annual Report on Form 10-K.

General

We are a pure-play, fully integrated lithium company, with a long, proven history of producing performance lithium compounds. Our primary products, namely battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal are critical inputs used in various performance applications. Our strategy is to focus on supplying high performance lithium compounds to the fast-growing electric vehicles ("EV") and broader battery markets, while continuing to maintain our position as a leading global producer of butyllithium and high purity lithium metal. With extensive global capabilities, nearly 80 years of continuous production experience, applications and technical expertise, long standing customer relationships and a favorable sustainability profile, we believe we are well positioned to capitalize on the accelerating trends of vehicle electrification and renewable energy adoption.

We produce lithium compounds for use in applications that have specific and constantly changing performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries. We believe the demand for our compounds will continue to grow as the electrification of transportation accelerates, and as the use of high nickel content cathode materials increases in the next generation of battery technology products. We also supply butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds including high purity lithium metal, which is used in non-rechargeable batteries and in the production of lightweight materials for aerospace

Table of Contents

applications. It is in these applications that we have established a differentiated position in the market through our ability to consistently produce and deliver performance lithium compounds.

Livent Strategy

We believe that growth in EV sales will drive significant growth in demand for performance lithium compounds. We believe that we are well positioned to benefit from this trend thanks to our leading position, long-standing customer relationships and favorable sustainability profile. We view sustainability as central to our mission and a key consideration in all of our investment and operational decisions.

To fully capitalize on our growth opportunities, our strategy will involve investing in our assets, our technology capabilities and our people to ensure we can continue to meet our customers’ growing demands as well as our broader commitments to other key stakeholders, including investors, employees, regulators and our local communities.

Expand our Production Capacities

We are well advanced on a 5,000 metric ton lithium hydroxide addition in Bessemer City, North Carolina, and a 20,000 metric ton expansion of lithium carbonate in Argentina. The new hydroxide unit is expected to come online by the fourth quarter of 2022, and the additional carbonate capacity is expected to come online in two equal phases by the first quarter of 2023 and year-end 2023, respectively.

In the first quarter of 2022, we began engineering work on a second expansion to add an additional 20,000 metric tons of carbonate capacity in Argentina by the end of 2025. Upon completion, we would have total carbonate capacity in Argentina of roughly 60,000 metric tons.

Longer-term, we plan to expand our hydroxide capacity in multiple geographies in order to meet growing customer demand globally. We will also continue to evaluate our butyllithium capacity regionally and add capacity as demand continues to increase. For high purity lithium metal, we are evaluating expansion opportunities, including expansion of lithium chloride as a feedstock, to align with the potential increase in demand for lithium metal as customers develop next generation battery technologies. This includes opportunities for our proprietary LIOVIXTM lithium metal product.

Diversify our Sources of Supply

We continue to pursue additional sources of lithium products, which may include further expansion in Argentina, increasing our ownership stake in the Nemaska Lithium Inc. development project and assets, acquisition and development of new resources, entering into long-term supply agreements with other producers or some combination thereof. We will continually assess new resources that offer the potential to provide alternative sources of lithium products and will look to invest in developing such resources where it makes sense to do so.

Expand our Applications and Process Technology Capabilities

Our market position today depends on our ability to consistently provide our customers with the products they need, in a sustainable and responsible manner. To maintain this position, we are continuously investing to improve our application, process and extraction technologies, on both existing and new potential resources, and to reduce our environmental footprint. As we work with our customers to understand their evolving lithium needs, we will focus on expanding our extraction and processing capabilities and our ability to adapt the properties of our products, whether chemical or physical, to meet those needs. This may require us to invest in and potentially acquire new capabilities, hire people or acquire new technical resources.

Develop Next Generation Lithium Compounds

We believe that the evolution of battery technologies will lead to the adoption of lithium-based applications in the anode and electrolyte within the battery. This evolution will require new forms of lithium to be produced, such as new lithium metal powders or printable lithium products. We will continue to invest in our research and development efforts to help us create new products, such as LIOVIXTM, and we will also invest with and partner with our customers to further their own research and development efforts.

Invest in Our People

Our business requires that we hire, retain and engage research scientists, engineers and a technical sales force. We will continue to invest in our people through training and developing our employees to retain talent. We will look to cultivate an inclusive and positive work environment that (i) creates and supports diversity; (ii) prioritizes equal opportunity and fairness in the company’s management systems and practices; and (iii) fosters a sense of belonging for employees with diverse perspectives, backgrounds and expertise.

Table of Contents

Focus on Sustainability

We believe lithium will continue to play an important role in enabling a cleaner, healthier and more sustainable world, including the transition to a lower carbon future and the fight against climate change. Likewise, we believe that meeting the growing demand for lithium compounds must be balanced with considerations for responsible production across the spectrum of Environmental, Social and Governance (“ESG”) issues and concerns. Our core values reflect this commitment to sustainability. We believe that operating in a safe, ethical, socially conscious and sustainable manner is important for our business.

As such, we intend to continue to integrate ESG and sustainability considerations into our business, operations and investment decisions. In addition, we are determined to help set the standard in the lithium industry for sustainability, performance, transparency and independent validation. We believe that our ESG and sustainability efforts will continue to help us differentiate ourselves from competitors and help us develop and strengthen relationships with customers and other key stakeholders.

We encourage you to review our 2020 Sustainability Report and website (located at www.livent.com/sustainability) for more detailed information regarding our ESG programs and initiatives as well as our 2030 and 2040 sustainability goals. Nothing on our website, including our Sustainability Report or sections thereof, shall be deemed incorporated by reference into this Form 10-K.

Financial Information About Our Business

We operate as one reportable segment based on the commonalities among our products and services, the types of customers we serve and the manner in which we review and evaluate operating performance. As we earn a substantial amount of our revenues through the sale of lithium products, we have concluded that we have one operating segment for reporting purposes.

Business Overview

As a result of our focus on supplying performance lithium compounds for use in the rapidly growing EV and broader energy storage battery markets, we expect our revenue generated from lithium hydroxide and lithium carbonate, energy storage and our Asia operations to increase. We intend to maintain our leadership positions in other high performance markets such as non-rechargeable batteries, greases, pharmaceuticals and polymers.

We believe that we have earned a reputation as a leading supplier in the markets we serve, based on the performance of our products in our customers’ production processes and our ability to provide application know-how and technical support. In the EV market, we are one of a small number of lithium suppliers whose battery-grade lithium hydroxide has been qualified by global customers for use in their cathode material production that is ultimately used in numerous global EV programs at scale. Throughout our history, as end market application technologies have evolved, we have worked closely with our customers to understand their changing performance requirements and have developed products to address their needs.

As a vertically integrated lithium producer, we benefit from operating one of the lowest cost lithium mineral deposits in the world that also has a favorable, industry leading sustainability footprint. We have been extracting lithium brine at our operations at the Salar del Hombre Muerto in Argentina for more than 25 years, and have been producing various lithium compounds for approximately 80 years. Our operational history provides us with a deep understanding of the process of extracting lithium compounds from brine safely and sustainably. We have developed proprietary process knowledge that enables us to produce high quality, low impurity lithium carbonate and lithium chloride, and helps us to produce industry leading quality downstream products. We source the majority of our base lithium compounds for use in the production of performance lithium compounds from these low cost operations in Argentina. Our operations in Argentina are expandable, giving us the ability to increase our lithium carbonate and lithium chloride production to meet increasing demand. We also have the operational flexibility to procure lithium carbonate from third party suppliers as needed. This allows us to manage our production requirements and produce more end-products for customers than we would have the ability to do with lithium carbonate derived solely from our internal sources of supply.

We are one of a few lithium compound producers with global manufacturing capabilities. We use the majority of the lithium carbonate we produce in the production of battery-grade lithium hydroxide in the U.S. and China. We use lithium chloride to produce lithium metal, a key feedstock in the production of butyllithium products in the U.S., the United Kingdom, China and India, as well as in the production of high purity lithium metal in the U.S. We have significant know-how and experience in the lithium hydroxide, butyllithium and high purity lithium metal production processes and product applications, which we believe provide us with a competitive advantage in these markets.

Table of Contents

Capacity and Production

The chart below presents a breakdown of our capacity and production by product type and category presented in product basis metric tons ("MT") for the years ended December 31, 2021, 2020 and 2019:


Product Category	Product	2021		2020		2019
		Capacity	Production	Capacity	Production	Capacity	Production
Performance Lithium	Lithium Hydroxide	25,000	19,671	25,000	14,686	25,000	21,348
	Butyllithium	3,265	2,549	3,265	2,180	3,265	2,437
	High Purity Lithium Metal (1)	250	156	250	160	250	167
Base Lithium	Lithium Carbonate (2)	18,000	15,542	18,000	15,589	18,000	16,785
	Lithium Chloride (2)	9,000	3,723	9,000	4,836	9,000	4,284

____________________

1.Excludes other specialty product capacities and production.

2.Represents theoretical capacity for lithium carbonate and lithium chloride. Actual combined production of both products is lower and limited by the total capacity of lithium brine production. Lithium brine production was approximately 18,500 MT on a lithium carbonate equivalent ("LCE") basis for 2021, approximately 19,500 MT for 2020 and approximately 20,000 MT for 2019, resulting in the total production shown in the chart.

The charts below detail our 2021 revenues by product, application and geography

____________________

1.Company internal estimates

Table of Contents

Products and Markets

Our performance lithium compounds are frequently produced to meet specific customer application and performance requirements. We have developed our capabilities in producing performance lithium compounds through decades of interaction with our customers, and our products are key inputs into their production processes. Our customer relationships provide us with first-hand insight into our customers’ production objectives and future needs in terms of product volume, mix and specifications, which we in turn use to further develop our products.

Other specialties include lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride and specialty organics. In addition to performance lithium compounds, we also produce lithium carbonate and lithium chloride, both of which we largely consume as feedstock in the process of producing our performance lithium compounds.

Competition and Industry Overview

We sell our performance lithium compounds worldwide. Most markets for lithium compounds are global, with significant growth occurring in Asia, eventually expected to follow in Europe, and then the U.S. This is being driven primarily by the development and manufacturing of lithium-ion batteries. The market for lithium compounds faces barriers to entry, including access to an adequate and stable supply of lithium feedstock, the need to produce sufficient quality and quantity, technical expertise and development lead time. According to Wood Mackenzie 2021 estimates, we are one of the five largest producers of lithium compounds, including SQM, Albemarle, Tianqi Lithium and Ganfeng Lithium, which accounted for just over 50% of the global refined lithium production as measured by lithium carbonate equivalent ("LCE"). We expect capacity to be added by new and existing producers over time. We believe our lithium brines in Salar del Hombre Muerto, Argentina, which have a favorable sustainability profile and are considered by the industry to be one of the lowest-cost sources of lithium, provide us with a distinct competitive advantage against current and future entrants. Additionally, as the EV supply chain gradually

Table of Contents

regionalizes to Europe and North America, our lithium resource in Argentina and battery-grade lithium hydroxide capacity in the U.S. positions us well for partnering with leading automakers for their regional electrification roadmaps.

We compete by providing advanced technology, high product quality, reliability, quality customer and technical service, and by operating in a cost-efficient manner and prioritizing safety and sustainability. We also enjoy competitive advantages from our vertically integrated manufacturing approach, low production costs and history of efficient capital deployment. We believe that we are a leading provider of battery-grade lithium hydroxide in EV battery applications and in performance grease applications. We currently have lithium hydroxide capacity in the U.S. and China. We are also the only fully integrated producer of high purity lithium metal in the Western Hemisphere. We believe that we are one of only two global suppliers of butyllithium and, according to Wood Mackenzie, we are one of the two largest producers of downstream lithium chemicals outside of China. Our primary competitors for performance lithium compounds are Albemarle Corporation and Ganfeng Lithium.

Growth

According to BloombergNEF's June 2021 Long-Term Electric Vehicle Outlook, under the Economic Transition Scenario ("ETS"), EV (battery electric and plug-in hybrid electric passenger vehicles) sales are expected to be approximately 32 million units in 2030, rising to approximately 66 million units in 2040, representing a penetration rate of 34% and 68%, respectively, of all passenger vehicles sold. According to EV Volumes’ August 2021 report on global plug-in (battery electric and plug-in hybrid electric) passenger cars and light commercial vehicles forecast, sales are expected to be approximately 37 million units in 2030, rising to approximately 65 million units in 2035, representing a penetration rate of 37% and 61%, respectively, of all passenger cars and light commercial vehicles sold. Both BloombergNEF, and EV Volumes expect battery electric vehicles to comprise a clear majority of the EV sales mix.

The strong EV demand growth in 2021 was in large part driven by national and regional governments' announced incentives, subsidies and more stringent fuel economy/carbon dioxide emissions regulations to stimulate the automotive industry’s recovery from the COVID-19 pandemic’s impact and support electrification efforts. Throughout 2021, numerous automakers announced large investments towards drivetrain electrification and laid out roadmaps for launching a growing number of competitive models across various segments. As countries around the world gradually phase out subsidies for consumers, in order to comply with the fuel economy regulations, automakers will require an increasing share of EVs in their product sales mix.

In 2022 and beyond, fuel economy/carbon dioxide emissions regulations for commercial vehicles coupled with environmental commitments of an increasing number of corporations are likely to propel electric commercial vehicle sales. According to BloombergNEF's June 2021 Long-Term Electric Vehicle Outlook, under the ETS, electric commercial vehicles (battery electric, plug-in hybrid electric, and range extender electric light-, medium-, heavy-duty commercial vehicles) sales are expected to increase from approximately 0.5 million units in 2022 to approximately 6 million units in 2030, and to approximately 15 million units in 2040. By 2040, according to BloombergNEF, electric commercial vehicles will have 52% share of all commercial vehicles sold.

Besides electrification of transportation, electricity generation continued its decarbonization trend with solar and wind installations crossing new milestones; many of these installations are coupled with lithium-ion battery-based energy storage systems. According to BloombergNEF’s November 2021 Long-Term Energy Storage Outlook, lithium-ion technology will be dominant in stationary storage applications through 2030.

In line with varying consumer preferences across regions, automakers are launching an increasing number of EVs across segments and for shorter-ranges and longer-ranges. Automakers have been introducing longer-range, bigger size, premium-performance-luxury EV models using higher energy density batteries and are increasingly doing so by using high (>60%) nickel content cathode materials. Continued strong demand for high nickel content cathode materials for automotive applications will require battery-grade lithium hydroxide in the production of cathode materials. Additionally, since late 2020, automakers have been increasing adoption of lithium iron phosphate cathode material initially for the China passenger vehicles market and subsequently for markets outside China. Lithium iron phosphate is also a more suitable cathode material in stationary storage applications and other forms of electric transportation. Lithium iron phosphate is predominantly synthesized using lithium carbonate, and thereby carbonate demand has been witnessing strong growth.

As an existing, proven global producer of battery-grade lithium hydroxide, and lithium carbonate, we are well positioned to benefit from this expected increase in lithium demand from EV growth. As one of the pioneers in the lithium industry, we have relationships throughout the lithium-ion battery value chain. Across the battery value chain, product performance requirements have continued to evolve since the first lithium-ion batteries and cathode materials were introduced in the early 1990s. We have developed our application and materials knowledge by working with our customers over time to produce performance lithium compounds which meet evolving customer needs.

Table of Contents

Our growth efforts focus on developing environmentally compatible and sustainable lithium products. We are committed to providing unique, differentiated products to our customers by acquiring and further developing technologies as well as investing in innovation to extend product life cycles.

_____________________________

1.Includes capital expenditures and other investing activities, inclusive of capitalized interest. See our consolidated statements of cash flows in Part II, Item 8 of this Form 10-K for further details.

Raw Materials

Lithium

Our primary raw material is lithium, and we obtain the substantial majority of our lithium from our operations in Argentina. We extract lithium from naturally occurring lithium-rich brines located in the Andes Mountains of Argentina, which are believed to be one of the world’s most significant and lowest cost sources of lithium, through a proprietary selective adsorption and solar evaporation process. We process the brine into lithium carbonate at our co-located manufacturing facility in Fénix, Argentina and into lithium chloride at our nearby manufacturing facility in Güemes, Argentina. In 2018 and 2019 we expanded capacity of lithium carbonate at these facilities through debottlenecking projects.

For the years ended December 31, 2021, 2020 and 2019, our Argentine operations extracted and processed approximately 16 kMT, 16 kMT and 17 kMT of lithium carbonate, respectively, and approximately 4 kMT, 5 kMT and 4 kMT of lithium chloride, respectively. For the years ended December 31, 2021, 2020 and 2019, lithium brine production from both lithium carbonate and lithium chloride, on a lithium carbonate equivalent ("LCE") basis, was approximately 18.5 kMT, 19.5 kMT and 20 kMT, respectively.

We have also historically purchased a portion of our lithium carbonate raw materials from other suppliers as needed.

Salar del Hombre Muerto

We conduct our Argentine operations through Minera del Altiplano SA ("MdA"), our local operating subsidiary. We extract lithium from naturally occurring lithium-rich brines in Salar del Hombre Muerto, an area covering approximately 600 square kilometers in a region of the Andes Mountains of northwest Argentina known as the “lithium triangle.” This area of the Central Andes is within an arid plateau with numerous volcanic peaks and salt flats known as “salars” and is the principal lithium-bearing region of South America.

Salar del Hombre Muerto consists of evaporite deposits formed within an isolated basin depression. Fault-bounded bedrock hills occur within and along the margins of the salar basin, subdividing the Salar del Hombre Muerto into two separate sub-basins (eastern and western), each with different evaporite sediment compositions. The eastern sub-basin is dominated by

Table of Contents

borate evaporites, whereas the western sub-basin is relatively free of clastic sediment (such as sand, silts and clays) and is dominated by halite (sodium chloride) evaporite deposits.

We performed initial geological investigations of the Salar del Hombre Muerto in the early 1990s, prior to development of our lithium production facilities. We commenced commercial extraction operations in Salar del Hombre Muerto in 1998. Lithium extract is processed into lithium carbonate at our co-located manufacturing facility in Fénix, Argentina and into lithium chloride at our nearby manufacturing facility in Güemes, Argentina. These facilities were opened in conjunction with the commencement of our extraction operations and are in good working condition. MdA owns these facilities. We use natural gas and diesel to generate electricity, which is the principal source of power at our facilities. From time to time, we experience interruptions in the supply of electricity, but we do not believe these interruptions materially impact our operations.

Brine containing approximately 600 parts per million ("ppm") lithium is pumped from saltwater aquifers using extraction wells. The brine is then diverted to an evaporation pond system. We have also developed a proprietary lithium concentration and purification process for brine operations that significantly reduces the time from pumping brine from the Salar to processing it into lithium carbonate or lithium chloride. This reduction in processing time compares favorably to a conventional solar evaporation process, while effectively removing impurities, providing increased process control and improving lithium yields. During evaporation, other minerals, such as sodium, potassium and magnesium, which are typically contained in brine, are concentrated and removed through processing. The resulting lithium chloride brine from the terminal pond of the system is then routed to our processing plants.

We access our extraction sites and nearby manufacturing facilities by local roadway, which is a suitable transportation alternative. We transport the brine extract from our Fénix facility by truck to our Güemes facility for processing. We then transport the processed lithium carbonate and lithium chloride by truck to ports in Argentina and Chile, where it is shipped by vessel to our manufacturing facilities and customers.

Mineral concession rights

MdA holds title to mineral concession rights for its extraction activities in Salar del Hombre Muerto. These mineral concession rights cover an area of approximately 327 square kilometers and are granted to MdA pursuant to the Argentine Mining Code. See subsection “Argentine Law and Regulation” to this Item 1 for more information. Pursuant to the Argentine Mining Code, MdA’s mineral concession rights are valid until the deposit is depleted of all minerals. The concession rights may be rescinded if we fail to pay fees or do not actively extract minerals for a period lasting more than four years.

In 1991, MdA entered into an ongoing agreement, for so long a time as our mineral concession is valid, with the Argentine federal government and the Catamarca province in connection with the development of the Salar del Hombre Muerto exploration site. Following legislative and constitutional reforms in 1993 and 1994, the Argentine federal government assigned all of its rights and obligations under the agreement to the Catamarca province. The agreement governs limited matters relating to our production activities and grants to the Catamarca province an immaterial minority ownership stake in MdA, which enables the province to receive certain dividends and to appoint two of MdA’s ten-member Board of Directors and one of MdA’s three-member audit committee. The term of the agreement expires when MdA ceases to extract and produce lithium compounds from Salar del Hombre Muerto.

MdA is required to pay the Catamarca province an immaterial semi-annual “canon” fee pursuant to the Argentine Mining Code and royalties equal to 3% of the pithead value of the minerals extracted by MdA pursuant to the Argentine Mining Investment Law and Catamarca provincial law. Separately, under an amendment to its long-term agreement with Catamarca entered into on January 25, 2018, MdA agreed to pay the Catamarca province a monthly royalty payment and to make Corporate Social Responsibility ("CSR") expenditures. The royalty amount is equal to 2% of sales of products in a given month measured at the higher of MdA’s average invoice price or an average international price for similar products, net of tax. MdA is permitted to net the royalty payment paid to the Catamarca province against the royalties to be paid under the Mining Investment Law. Total payments to the Catamarca province, including the "canon" fee and royalties, water trust payments (as described below in the "Water" subsection to this Item 1) and CSR expenditures were approximately $5.5 million, $5.9 million and $7.6 million for the years ended December 31, 2021, 2020 and 2019.

A portion of the territory governed by our concession rights is subject to a longstanding border dispute between Catamarca and the adjacent Salta province. The border dispute has not impacted our operations for the over twenty years we have been operating in Argentina and we do not expect that it will impact our operations going forward. We estimate the total area in dispute represents approximately 7.6% of our concession (approximately 25 square kilometers). We do not view this as material, especially considering that the area in question is largely at the fringe of the salar, where the deposits are not as thick and the grade of lithium concentration is much lower.

Salta province claims that it is entitled to royalties from us for the minerals extracted within the small portion of our concession that falls within the disputed territory, although under Argentine law we cannot be charged duplicate royalties for the same minerals (the "Salta Royalty Claim"). In addition, the Salta province has granted and may grant mineral concessions in the

Table of Contents

disputed territory to other parties, although to date Catamarca authorities have not permitted any others to extract lithium from within the boundaries of our concession.

In December 2019, the provinces of Catamarca and Salta entered into an agreement to create an interprovincial commission to: evaluate projects and programs for mining activity in the area subject to the border dispute; prepare a technical report to set the border between both provinces; and submit a bill to the Argentine Congress on the matter.

We previously engaged in judicial proceedings in Argentina with the Salta province to resolve the Salta Royalty Claim. The outcome of these proceedings was not expected to have a material impact on our financial position or results of operations. In January 2021, MdA and the State Prosecutor of Salta entered into an agreement to suspend the judicial proceedings and for discussions with the competent authorities of the Salta province to evaluate and resolve the Salta Royalty Claim. The agreement may be terminated by either party upon sixty days prior notice. The discussions are ongoing.

Water

Our Argentine operations require fresh water. We have water rights for the supply of fresh water from the Trapiche aquifer, from which water is pumped through a battery of wells to our facilities. We and the Catamarca province regularly monitor the water and salinity levels of the aquifer.

We only had to temporarily suspend water extraction once, in January 2015, due to a dispute with the Catamarca province, and our access to our water source was quickly restored. We also regularly evaluate supplemental supplies of fresh water. The grant of water concessions and other water rights is subject to local governmental approvals, the timing and availability of which are uncertain and may be subject to delay or denial.

In October 2015, MdA entered into a water trust agreement with the Catamarca province that was amended in 2018. Under the amended trust agreement, MdA is obligated to pay into the trust an amount equal to 1.2% of its annual sales (calculated using the methodology used to determine the monthly royalty payments described above in the "Mineral Concession Rights" subsection to this Item 1), in lieu of any water use fees. These payments are fully reflected in our financial statements.

Energy

Our Argentine operations rely on a steady source of energy. In 2015, we completed construction of a 135 kilometer natural gas pipeline from Pocitos, within the Salta province, to our Fénix facilities at Salar del Hombre Muerto, which eliminated our reliance on natural gas shipments by truck. This pipeline is governed by various agreements between MdA and Recursos Energeticos y Mineros Salta, S.A., or REMSA, a local natural gas sub-distributor, including a subdistribution agreement providing for contracted capacity through 2027. We are in discussions to increase our contracted capacity in advance of our needs for all phases of our expansion plans and may need to invest in additional infrastructure to support this expansion. REMSA or Gasnor S.A., another local natural gas distributor that operates in the northeast of Argentina, have no obligation to provide us the additional capacity on a timely basis or at all. If we cannot obtain such additional capacity, we would need to secure alternative arrangements to meet the increased energy needs of the planned expansion and such alternative arrangements may be less cost effective.

MdA also has a natural gas supply contract with Enel Trading Argentina S.R.L. and Gasmarket S.A. providing for the supply of natural gas for our Fénix manufacturing facility. This supply agreement expires in May 2022 and is typically renewed on an annual basis. We also have a purchase agreement with YPF SA for the supply of diesel fuel and gasoline to our Fénix and Güemes manufacturing facilities. This purchase agreement expires on February 28, 2022.

Other raw materials

We purchase raw materials and chemical intermediates for use in our production processes, including materials for use in our production of the proprietary adsorbent used to selectively extract lithium from our brine in Argentina, soda ash, or sodium carbonate, for use in our production of lithium carbonate, and lithium metal for our production of butyllithium. In 2021, 2020 and 2019, costs of major raw materials represented 14%, 13% and 11% of our total revenues, respectively. Major raw materials include soda ash, solvents, butyl chloride, hydrochloric acid, quicklime, metal and caustic soda. We generally satisfy our requirements through spot purchases and medium- or long-term contractual relationships. In general, where we have limited sources of raw materials, we have developed contingency plans to minimize the effect of any interruption or reduction in supply, such as sourcing from other suppliers or maintaining safety stocks. Supply chain constraints arising due to the COVID-19 pandemic continue to remain a challenge in all countries where we operate. See "Management's Discussion and Analysis of Financial Condition and Results of Operations - COVID-19 Impacts."

Temporary shortages of raw materials may occasionally occur and cause temporary price increases. For example, we have had past regional interruptions in raw material supply, notably in China. In recent years, these shortages have not resulted in any material unavailability of raw materials. However, the continuing availability and price of raw materials are affected by many factors, including domestic and world market and political conditions, as well as the direct or indirect effect of governmental regulations. During periods of high demand, our raw materials are subject to significant price fluctuations, and such fluctuations may have an adverse impact on our results of operations. In addition, there could be inflationary pressure on costs of the raw

Table of Contents

materials and/or services that could impact our results of operations. The impact of any future raw material shortages on our business as a whole or in specific geographic regions, including China, or in specific business lines cannot be accurately predicted. In line with recent market developments, we have seen price increases in butyllithium raw materials, especially solvents, butyl chloride and lithium metal. We have also seen significant price increases for certain of our raw materials as a result of recent global inflationary pressures.

Seasonality

Our operations in Argentina are seasonally impacted by weather, including varying evaporation rates and amounts of rainfall during different seasons, which can be heavy at times. These changes impact the concentration in large evaporation ponds and can have an impact on the downstream processes to produce lithium carbonate and lithium chloride. Heavy rainfall can damage pond liners, lead to loss of product, and make the ponds generally difficult to maintain. Our operations team continuously measures pond concentrations and models how they will change based on operating decisions. Our processes use proprietary and traditional technologies to minimize the variation of concentrations at the inlet to our plants. There was an abnormally large rain event in both the first quarter of 2019 and during the last quarter of 2021. These resulted in reductions in lithium carbonate production of approximately 1,000 MT in 2019, and approximately 500 MT in 2021.

Argentine Law and Regulation

We are subject to various regulatory requirements in Argentina under the Argentine Mining Code, the Argentine Mining Investment Law and certain federal and provincial regulations, including with respect to environmental compliance. In addition, the relationship between us, MdA and the Catamarca provincial government is regulated through a contractual framework.

The Argentine Mining Code, which sets forth the rights and obligations of both mining companies and their workers, is the principal regulatory framework under which we conduct our operations in Argentina. The Argentine Mining Code provides for the terms under which the provinces regulate and administer the granting of mining rights to third parties.

The Argentine Mining Code establishes two basic means of granting title to mining property: the exploration permit and the mining concession, both of which convey valid mining title in Argentina.

Exploration permits grant their holders the right to freely explore for minerals within the boundaries of the territory covered by that permit as well as to request the mining concession for any discoveries within the covered territory.

Once a mining concession is granted, the recipient owns all in-place mineral deposits within the boundaries of the territory covered by the concession. Mining concessions are freely tradable by the title holder and can be sold, leased or otherwise transferred to third parties. Two requirements must be met to keep a mining concession in good standing: (i) the concession holder must make regular payments of a semi-annual fee known as a canon; and (ii) the concession holder must file and perform an initial five-year expenditure plan. In addition, prior to commencing mining activities, the concession holder must submit environmental impact studies, which must be renewed at least every two years, for approval by the relevant environmental authorities.

In addition to the Argentine Mining Code, we are also subject to the Argentine Mining Investment Law. The Argentine Mining Investment Law offers specific financial incentives to mining investors, including a 30-year term fiscal stability of national, provincial and municipal tax rates; a deduction from income tax for prospecting, exploration and feasibility study expenditures; a refund of Value Added Tax fiscal credits resulting from exploration works; accelerated depreciation of fixed assets; and a 3% cap on royalties payable out of production to the province where the deposit is located. Our 30-year term fiscal stability certificate expires in 2026.

Our fiscal stability rights under the Argentine Mining Investment Law have been challenged by the imposition of certain export taxes on our lithium chloride and carbonate exports that did not exist at the time we obtained our 30-year term fiscal stability certificate. For instance, in 2018, the Federal Government imposed another export duty on lithium carbonate and chloride through Decree No. 793/2018, which was in effect until December 31, 2020. Furthermore, in December 2019, after the change of Presidential administration, the Argentine Congress passed Law No. 27,541 creating a new legal framework for export duties and establishing a new rate for mining and hydrocarbon exports not to exceed 8% on the taxable amounts or the FOB value. In December 2020, the Executive Power issued Decree No. 1060/2020 establishing a new export duty applicable to all kinds of goods effective from January 1, 2021. In the case of lithium chloride and lithium carbonate, the applicable tax rate amounts to 4.5% and no cap has been set.

Under our 30-year term fiscal stability certificate, we are entitled to reimbursement or set-off (against other federal taxes) of any amount paid in excess of the total federal taxable burden applicable to us under such certificate. Although we are litigating to exercise our fiscal stability rights and are requesting an administrative reimbursement with respect to the imposition of certain of such export taxes, there can be no assurance that we will seek, or be able to obtain, reimbursement or set-off.

Table of Contents

Environmental Laws and Regulations

We are subject to and incur capital and operating costs to comply with, numerous foreign, U.S. federal, state and local environmental, health and safety laws and regulations, including those governing employee health and safety, the composition of our products, the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, the usage and availability of water, the cleanup of contaminated properties and the reclamation of our mines, brine extraction operations and certain other assets at the end of their useful life.

Our business and our customers are subject to significant requirements under the European Community Regulation for the Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”). REACH imposes obligations on European Union manufacturers and importers of chemicals and other products into the European Union to compile and file comprehensive reports, including testing data, on each chemical substance, and perform chemical safety assessments. Currently, certain lithium products are undergoing a risk assessment review under REACH, which may eventually result in restrictions in the handling or use of lithium carbonate and other lithium products that we produce, which may increase our production costs. In addition, REACH regulations impose significant additional responsibilities and costs on chemical producers, importers, downstream users of chemical substances and preparations, and the entire supply chain. South Korea has a similar Act on the Registration and Evaluation of Chemicals which is known as “K-REACH.” Both REACH and K-REACH may lead to increases in the costs of raw materials we purchase and the products we sell in the European Union and South Korea, respectively. Increases in the costs of our products could result in a decrease in their overall demand. In addition, customers may seek products that are not regulated by REACH and/or K-REACH, which could also result in a decrease in the demand of certain products subject to the respective regulations. We continually monitor these laws and the regulations being adopted under them to determine our responsibilities.

In June 2016, modifications to the Toxic Substances Control Act in the U.S. were signed into law, requiring chemicals to be assessed against a risk-based safety standard and for the elimination of unreasonable risks identified during risk evaluation. Other initiatives in Asia and potentially in other regions will require toxicological testing and risk assessments of a wide variety of chemicals, including chemicals used or produced by us. These assessments may result in heightened concerns about the chemicals involved and additional requirements being placed on the production, handling, labeling or use of the subject chemicals. Such concerns and additional requirements could also increase the cost incurred by our customers to use our chemical products and otherwise limit the use of these products, which could lead to a decrease in demand for these products.

Liabilities associated with the investigation and cleanup of hazardous substances and wastes, as well as personal injury, property damages or natural resource damages arising from the release of, or exposure to, such hazardous substances and wastes, may be imposed in many situations without regard to violations of laws or regulations or other fault, and may also be imposed jointly and severally. Such liabilities may be imposed on entities that formerly owned or operated the property affected by the hazardous substances and wastes, entities that arranged for the disposal of the hazardous substances and wastes at the affected property, and entities that currently own or operate such property. Our Bessemer City, North Carolina facility is currently undergoing monitoring and remediation of contamination pursuant to a Resource Conservation and Recovery Act Part B corrective action permit. In addition, we currently have, and may in the future incur, liability as a potentially responsible party with respect to third party locations under CERCLA or state and foreign equivalents, including potential joint and several liabilities requiring us to pay in excess of our pro rata share of remediation costs.

We use and generate hazardous substances and wastes in our operations and may become subject to claims and substantial liability for personal injury, property damage, wrongful death, loss of production, pollution and other environmental damages relating to the release of such substances into the environment. In addition, some of our current properties are, or have been, used for industrial purposes, which could contain currently unknown contamination that could expose us to governmental requirements or claims relating to environmental remediation, personal injury and/or property damage. Depending on the frequency and severity of such incidents, it is possible that the Company’s revenues, operating costs, insurability and relationships with customers, employees and regulators could be impaired.

We record accruals for environmental matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. It is possible that new information or future developments could require us to reassess our potential exposure related to environmental matters. We may incur significant costs and liabilities in order to comply with existing environmental laws and regulations. It is also possible that other developments, such as increasingly strict environmental laws, regulations and orders of regulatory agencies, as well as claims for damages to property and the environment or injuries to employees and other persons resulting from our current or past operations, could result in substantial costs and liabilities in the future.

A discussion of environmental related factors and related reserves can be found in Note 9 “Environmental Obligations” in the notes to our consolidated financial statements included in this Form 10-K.

Table of Contents

Human Capital Management

Human Capital Management ("HCM") General Statement

We continue to build on our heritage as a global leader in the lithium industry. We are investing in the health, well-being, professional and personal development of our employees and are always striving to gain a deeper understanding of the needs of our business, customers, and employees.

In 2021, we experienced a 15% global headcount increase over the previous year. This increase was driven by several factors, including: (i) our ongoing expansion efforts in Argentina and the U.S.; (ii) increasing the depth of our quality program in Asia through key hires; and (iii) expanding our global engineering talent pool. This increase is also, in part, reflective of hiring that was delayed in 2020 as a result of the COVID-19 pandemic. This hiring increase is a reminder of the level of growth and demand our employees will be tasked to support over the next several years. Our focus on the needs of “people” was heightened in 2021 as we worked to provide for the health and safety of our manufacturing workforce who remained onsite. Simultaneously, we sought to balance our return-to-work goals for our non-manufacturing employees while maintaining the flexibility needed by many in response to the ongoing COVID-19 pandemic.

Our Executive Leadership Team ("ELT") and Board of Directors ("Board") have challenged our teams to advance their focus on (i) identifying and developing high-potential talent to advance our business, (ii) global talent retention efforts, (iii) increasing our hiring of diverse talent and females where they are underrepresented and are the most qualified candidates, and (iv) creating an even more inclusive workplace. We are working to meet these challenges while maintaining our commitment to our customers, our employees and the communities in which we operate to be led by our core values:

•Safety First. We put safety at the forefront of everything we do. Simply put: the safety of everyone is everyone's responsibility.

•Be Responsible. We act ethically and honestly and advance responsible and sustainable practices in all aspects of our business.

•Constantly Innovate. We move the world forward and strive to constantly innovate through agile thinking, our industry-leading material science expertise and an intimate understanding of our core element: lithium.

•Celebrate Differences. We celebrate our differences in perspective, background and expertise, empowering our employees to be authentic and transparent. By encouraging employees to bring their own selves to work, we make Livent more dynamic.

•Thrive with Customers. Customers are at the heart of everything we do. By listening to and learning from them, we work together to build better lithium technologies.

Board of Directors’ Oversight of the HCM Process

The Compensation and Organization Committee (the “Compensation Committee”) of our Board of Directors assists the Board in its oversight of the development, implementation and effectiveness of our policies and strategies relating to our human capital management function, including, but not limited to, those policies and strategies regarding corporate culture, talent acquisition and retention, pay equity, career development and employment practices.

The Sustainability Committee of our Board of Directors assists the Board in its oversight of our Corporate Social Responsibility programs, including those relating to community, health and safety, human rights, responsible supply chain, and Diversity, Equity & Inclusion ("DE&I").

In 2021, we engaged the Board and these committees in our HCM process by providing them with updates on relevant HCM topics. This approach has proven to be an effective method of providing continued visibility and transparency, which, in turn, allows our Board to make informed decisions impacting compensation, succession planning, and DE&I priorities.

Employee Safety, Health & Well-being

Safety remains a core value of our business and drives our focus in everything we do. Our weekly publication of a “safety, quality and reliability” message continues to remind employees to prioritize safe behaviors in their personal and professional lives. Globally, we reported only one recordable injury in 2021.

As we continued to deal with the COVID-19 pandemic, we consulted with managers and other senior leaders to identify what meaningful steps could be taken to both assess and contribute to our employees’ health, safety and well-being. Based on feedback, we developed a mental health awareness campaign. In May 2021, we launched a three-month campaign to bring awareness of mental health issues. Throughout this campaign, we published Wellness Wednesday messages focusing on mental health topics relevant to our employees and their families. We also held a global town hall with a panel of mental health professionals from the regions in which we operate. Each regional team also held a local event to address mental health topics

Table of Contents

that were more specific to their communities. We continue to offer access to mental health resources globally to every employee through an employee assistance program.

As in 2020, it was important to maintain safely functioning plant operations as the COVID-19 pandemic continued in 2021. Accordingly, we considered the needs of all employees globally and provided support for them and their families that was appropriate for their circumstances. For most of 2021, non-manufacturing employees in many of our global locations continued to work remotely as we considered how to transition everyone safely back into the office.

Prospective employees have, likewise, challenged us to consider remote working opportunities to protect and support our employees during the COVID-19 pandemic. As we grow the company and increase hiring, we will create opportunities for our people to come together through more regular in-person meetings and social interactions so that we maintain our culture and values while fostering innovation, collaboration, continuous learning, and customer focus. In late 2021, we announced Livent’s official transition to a hybrid workplace for non-manufacturing employees in the U.S. Non-manufacturing employees and their managers will discuss a schedule of in-office and remote work (while maintaining needed flexibility to keep everyone safe and to meet business needs). We expect that transition to begin in early 2022 as we continue monitoring the virus’ impact on our respective communities.

While we have not implemented a vaccine requirement for existing employees, in the U.S. we do require employees whose role requires international travel to be fully vaccinated. We also require that all new U.S. employees be fully vaccinated within 30 days following their start date. We believe such measures will support our efforts to keep our U.S. plant operating safely and allow us to successfully transition U.S. non-manufacturing employees back to their physical offices in Pennsylvania and North Carolina on a hybrid basis. While there have been no government-imposed vaccine mandates at our non-U.S. locations, efforts are taken to understand the vaccination status of all existing and prospective employees and encourage vaccinations subject to legally recognized exemptions. Most of our global employees are vaccinated.

Workforce Diversity, Equity & Inclusion (“DE&I”)

We continue to operate in the U.S., Asia, Europe, and Argentina. As of December 31, 2021, we had a combined workforce of approximately 1,109 full-time, part-time, temporary, and contract employees. Argentina represents our only location with a unionized workforce, with approximately 188 of our 376 employees being union members. The following represents our employee breakdowns by region: North America (35%); Latin America (38%); Europe (7%); and Asia (19%). Our global gender makeup is approximately 70% male, 20% female, and 10% unspecified. Approximately 25% of our employees support our Commercial, Research and Development and Corporate functions, while 75% support our global manufacturing. The gender composition of our senior leadership team was 34% female and 66% male, and our Board composition was 22% female and 78% male.

Currently, racial diversity metrics are only tracked in the U.S. The following table contains aggregate information, as of December 31, 2021, regarding certain self-identified diversity characteristics of our U.S. employees:


US Diversity
	Asian	Black/ African American	Hispanic	Two or More Races	White	Unspecified
2021	6%	20%	3%	<1%	66%	5%

The leadership team members have annual goals focused on our ESG priorities, including DE&I, and those priorities are cascaded to their teams as part of our organizational commitment to building a workforce that is diverse and inclusive. We worked over the course of 2021 to continue to develop and refine our internal talent development practices and external recruitment processes, with a focus on equity and improving the racial and gender profile of our candidates across our regions. In 2021, we continued to monitor our progress in increasing representation among these groups through quarterly reviews of our DE&I talent acquisition metrics. These metrics provide visibility into the diversity of our global candidate pools, for internal and external hires, and offer insights into those roles requiring an adjustment of our recruitment strategy to attract underrepresented talent. Through these insights in 2021, we were able to target our recruiting efforts to specific industry and professional organizations dedicated to the advancement of racially diverse candidates and women. We also tasked our external recruiting partners to support our DE&I efforts by presenting us with diverse candidate slates in each of their engagements. Additionally, we worked closely with hiring managers and others involved in local hiring processes to keep the diversity of their candidate pools and interview selection teams top of mind whenever they initiated a hiring process.

In 2021, we had a significant increase in headcount as a result of the continuation of our capital expansion projects, which had been suspended in 2020 due to the COVID-19 pandemic. As part of our plant expansion in Bessemer City, North Carolina, we filled 17 positions in Operations and Maintenance. Of those hired, 94% were men, 6% were women, and 65% were White and

Table of Contents

35% were Black/African American. Going forward, we will use insights from our 2021 global employee survey to take actions to further improve the diversity of our workforce and overall work experience at Livent.

One of the 2021 priorities of our DE&I Committee was to encourage conversations among our employees that would increase cultural awareness and reinforce a spirit of inclusivity. In partnership with our three Employee Resource Groups (“ERGs”), the Black Employee Network, Global Women’s Network and Lift Up, we delivered a full year of engaging communications and events, both global and local, across a variety of relevant DE&I topics.


ERG	Year Formed	Mission	2021 Highlights
Black Employee Network	2020	To provide a safe space for the Black community and work to ensure Livent is inclusive at all professional levels.	•Joint monthly meetings with Black Employee Network members and allies focused on addressing and raising awareness around relevant topics impacting our work and local communities.
Lift Up	2021	To support employees' shared professional development interests.	•Impactful Communications Workshop •Fireside chats exploring the career paths of Livent’s leaders •Leading Diverse Teams Master Class
Global Women’s Network	2021	To support Livent as an inclusive place to work for women.	•Fireside chat exploring topics relevant to women in the workplace (North America) •‘Listen to Understand’ (U.K./Argentina) •Virtual lunches (Asia Pacific)

We will continue working with our ERGs to review and support their initiatives while also extending the global reach of our programming.

In Argentina, we piloted a DE&I training for our employees aimed at (i) providing a space for reflection, discussion and training for DE&I-related topics; (ii) identifying unconscious biases and stereotypes impacting our behaviors and decisions; (iii) influencing managers to remain committed to and involved with DE&I issues; and (iv) creating a space to promote the development of inclusive leadership. We plan to use this training as a model for similar training at our other global locations in 2022 and beyond.

Our DE&I Committee regularly seeks the input of external experts to ensure that we are remaining current in our efforts to challenge and evolve our DE&I strategy. Continuous learning is also encouraged for our members as well as our ERGs and credits are available for those involved to pursue DE&I-focused trainings to benefit their own growth and development as well as impact the organization’s DE&I culture.

Talent Recruitment, Retention and Development

Over the next decade, the lithium industry is expected to experience increasing demand for product. In response, over the coming years we expect to increase our manufacturing capacity and expand the size of our workforce to ensure that we are identifying, retaining and developing the talent needed to remain competitive. In 2021, we filled 185 jobs across all functions with approximately 60% of such roles representing manufacturing operations (61% were external hires while 39% were filled internally). Our 2021 voluntary turnover rate was 10.2% which represents a decrease of 2.3% from the prior year.

In 2021, we faced significant competition for talent as candidates requested higher compensation packages, PTO allotments and flexible/remote work arrangements. This highlighted for us the importance of identifying the right talent for our needs, retaining our existing talent to preserve historical knowledge and offering career growth and development opportunities. In 2021, we partnered with engineering, technical, legal and veterans’ organizations to specifically target certain talent pools for a variety of roles. Several of these organizations helped us to get more visibility for our roles among more diverse talent pools.

In 2021, driven primarily by our expansion efforts, we expanded our succession planning strategy to include top manufacturing jobs. We recognize that continuous learning and development ("L&D") opportunities will be critical to successfully executing our succession plan. For 2022, our global leaders will continue to execute our L&D strategy and support the succession planning review process that we facilitate with our Board annually, the primary goals of which remain to: (i) identify emerging talent and (ii) prioritize the training and development resources needed to support them.

We continue to foster the development of current and future employees through our development of and participation in an engineering development program for manufacturing and non-plant career opportunities; a university-sponsored employer co-op program; and “emerging talent”-level apprenticeships to increase employability of local and Indigenous resident populations where we operate. In 2021, we hired 34 temporary and full-time employees across all three programs, of which 24% were female and 74% were male.

Table of Contents

Advancing Positive Workplace Culture, Employee Engagement & Recognition

Maintaining an engaged and invested workforce remains a critical priority at Livent. In a follow-up to the COVID-19-related and employee engagement surveys we conducted in 2020 (all of which were developed and administered internally), in 2021 we hired a third-party consulting firm to launch a broader global employee engagement survey to measure employee sentiment around and satisfaction with working at Livent. Of the 828 eligible employees invited to take the survey, we achieved a 64% participation rate, of whom the majority reported high favorability ratings in the areas of Teamwork, Work Environment, Beliefs and Attitudes and Empowerment. From a DE&I perspective, we also sought feedback on how we can further promote a diverse and inclusive culture and environment. We will use the insights gained from the survey to create global and local action plans for improvement. This is part of our commitment to creating a positive work experience for our employees around the world and to continuously improve in all aspects of our operations.

In our 2020 employee engagement survey, our employees shared that they wanted us to focus more on recognizing their achievements. Accordingly, in 2021, we reviewed our Go the Extra Mile ("GEM") award program to determine how we could improve recognizing and rewarding excellence shown by employees who reflect our core values. We launched a new employee recognition portal for the GEM program, the Employee Service Award program as well as other employee recognition tools. Through the portal, managers and colleagues can celebrate everyday wins and successes as well as key milestone anniversaries.

Compensation & Benefits

We recognize the importance of maintaining competitive compensation and benefits programs to be able to attract and retain the talent needed to meet the demands of our evolving business and industry as well as meet the needs of all our employees. In 2021, we updated our global compensation system so that salary levels are reflective of position responsibilities, better aligned with external market data and capable of attracting and retaining strong talent. This was a significant accomplishment that enables us to administer global compensation decisions more effectively while providing the flexibility necessary to fit varying levels of skills and qualifications as compared against similarly situated companies of our size and industry. The updated compensation structure remains comprised of base salaries, short and long-term incentive structures (based on job level), and individual and business performance-based incentives. We also provide a variety of relocation incentives which, in turn, allows us to attract talent from other markets which, from a DE&I perspective, allows us to reach a more diverse talent pool.

We have made no major changes to our benefits programs (which vary by country/region and employment classification). Our benefits include tax-deferred savings programs; medical, prescription drug, vision and dental insurance; health savings and flexible spending accounts; life and accident insurance; short and long-term disability insurance; an employee assistance program; paid time off; family leave; and wellness incentives and challenges. We continue to monitor costs year-over-year and make every effort to negotiate benefits packages that are affordable to all eligible employees. Despite a slight increase in some benefit plans due to increased COVID-19 health care costs, we were able to offer reduced costs to our U.S. based employees based on vaccination status.

Across all our regional locations, we continued to promote a variety of health and wellness programs aimed at heightening awareness around mental health, COVID-19 prevention and maintaining healthy, active lifestyles for our employees and their families.

Supply Chain Human Capital Management Safeguards

We are committed to the objective of ensuring there is no modern slavery in our supply chains or in our business. Through our Supplier Code of Conduct and other internal policies, and our supply chain initiatives and processes, we are committed to sourcing components and materials from companies that share our values regarding respect for human rights, integrity and environmental responsibility. We will continue to act ethically and with integrity in all our business relationships to implement and enforce effective systems and controls to prevent modern slavery in our supply chains.

Table of Contents

ITEM 1A. RISK FACTORS

Summary Risk Factors:

In the course of conducting our business operations, we are exposed to a variety of risks, some of which are inherent in our industry and others of which are more specific to our own businesses. The discussion below addresses the material factors, of which we are currently aware, that could affect our businesses, results of operations and financial condition and make an investment in the Company speculative or risky.

Some of these risks include:

•The scale and scope of the COVID-19 pandemic is having and is likely to continue to have an adverse impact on our business.

•Our growth depends upon the continued growth in demand for electric vehicles with high performance lithium compounds.

•Lithium prices can be volatile, especially due to changes in supply.

•Adverse conditions in the economy and volatility and disruption of financial markets can negatively impact our customers, and downturns in our customers’ end-markets could adversely affect our sales and profitability.

•We face competition in our business.

•Our operating results are subject to substantial quarterly and annual fluctuations.

•Production expansion efforts are complex projects that will require significant capital expenditures and are subject to significant risks and uncertainties.

•The development and adoption of new battery technologies that rely on inputs other than lithium compounds could significantly impact our prospects and future revenues.

•We may have difficulty accessing global capital and credit markets.

•The conditional conversion feature of the 2025 Notes may adversely impact our liquidity or dilute our stockholders, depending on the method of settlement.

•We may not have sufficient cash flow from our business to pay our debt.

•Our research and development efforts may not succeed, and our competitors may develop more effective or successful products.

•We may make future acquisitions which may be difficult to integrate, divert management and financial resources and result in unanticipated costs.

•We have substantial international operations and sales, and the risks of doing business in foreign countries could adversely affect our business, financial condition and results of operations.

•Our lithium extraction and production operations in Argentina expose us to specific political, financial and operational risks.

•Our operations and suppliers may be subject to physical and other risks, including natural disasters, epidemics, pandemics, and other catastrophic events beyond our control, which could disrupt production and have a material adverse effect on our business, financial condition, results of operations and cash flows.

•Severe weather events, including the effects of climate change, are inherently unpredictable and may have a material adverse effect on our operations, financial results and financial condition.

•We derive a substantial portion of our revenue from a limited number of customers, and the loss of, or a significant reduction in orders from a large customer could have a material adverse effect on our business and operating results.

•We may not satisfy customer qualification processes, customers’ or governments’ quality standards, and could be subject to damages based on claims brought against us or lose customers as a result of the failure of our products to meet certain quality standards.

•Global inflation, fluctuations in the price of energy and certain raw materials, and our inability to obtain raw materials and products under contract sourcing arrangements, could have an adverse effect on the margins of our products, our business, financial condition and our results of operations.

Table of Contents

•Our success depends upon our ability to attract and retain key employees and the identification and development of talent to succeed senior management.

•Some of our employees are unionized or are employed subject to local laws that are less favorable to employers than the laws of the U.S.

•Our business and operations could suffer in the event of cybersecurity breaches or disruptions to our information technology environment.

•Our inability to protect our intellectual property rights could have a material adverse effect on our business, financial condition and results of operations.

•We have not established “proven” or “probable” reserves, as defined by the SEC under Industry Guide 7, through the completion of a feasibility study for the minerals that we produce.

•Our business could be negatively impacted by sustainability and ESG matters and/or our reporting of such matters.

•Our business and financial results may be adversely affected by various legal and regulatory proceedings.

•We, our operations, facilities, products and raw materials are subject to environmental, health and safety laws and regulations, and costs to comply with, and liabilities related to, these laws and regulations could adversely affect our business.

•Unanticipated changes in our tax provisions, variability of our effective tax rate, the adoption of new tax legislation or exposure to additional tax liabilities could impact our financial performance.

•If there is a determination that the Separation and the Distribution is taxable for U.S. federal income tax purposes, then FMC and its stockholders could incur significant U.S. federal income tax liabilities, and we could incur significant liabilities.

•Our stock price may fluctuate significantly.

•Some provisions of Delaware law and our certificate of incorporation and bylaws may deter third parties from acquiring us.

•We are not declaring or paying cash dividends at this time, and this may deter certain investors from purchasing our stock.

Additional factors that could affect our businesses, results of operations and financial condition are discussed in Forward-Looking Statements at the end of this section. However, other factors not discussed below or elsewhere in this Annual Report on Form 10-K could also adversely affect our businesses, results of operations and financial condition. Therefore, the risk factors below should not be considered a complete list of potential risks that we may face.

Any risk factor described in this Annual Report on Form 10-K or in any of our other SEC filings could by itself, or together with other factors, materially adversely affect our liquidity, competitive position, business, reputation, results of operations, capital position or financial condition, including by materially increasing our expenses or decreasing our revenues, which could result in material losses.

Among the factors that could have an impact on our ability to achieve operating results and meet our other goals are:

COVID-19 Risks:

The scale and scope of the COVID-19 pandemic is having and is likely to continue to have an adverse impact on our business.

We face various risks related to health epidemics like the continuing global COVID-19 pandemic. Changes in consumer behavior, pandemic fears, market demand downturns, and restrictions intended to slow the spread of COVID-19 have led and may continue to cause business disruption, volatility in global capital and financial markets, and a global slowdown of economic activity. The emergency measures imposed by governments on businesses and individuals, including quarantines, travel restrictions, social distancing, workforce retention rules and restrictions on the movement of workers, among other measures, have impacted and may further impact our workforce and operations, and those of our customers and suppliers. The severity of the disruptions caused by the COVID-19 pandemic, and their impact on our results, will be determined by how long the COVID-19 pandemic continues, which is currently unknown. The disruptions and duration may be impacted by the actions that governments, businesses and individuals may take in relation to the COVID-19 pandemic, more contagious variants of the virus, vaccine resistance and delays in vaccine distribution. Future disruptions could have an adverse impact on our operations and expansion activities, results, financial position and liquidity, or on our ability to successfully execute our business strategies and initiatives.

Table of Contents

We have manufacturing operations in the U.S., Argentina, China, the United Kingdom, and India, general operations in Singapore, and sales offices in the U.S., China, the United Kingdom, India, South Korea and Japan. Each of these countries has been affected by the outbreak and has adopted measures to contain it, and each may adopt even stricter measures in the future. The government of Argentina previously imposed workforce retention rules prohibiting the dismissal of workers without just cause, which were replaced by rules requiring the payment of enhanced severance benefits upon termination of employment. In the UK, lockdown measures may be re-imposed to contain new variants of the coronavirus. Government measures and restrictions globally have had a negative impact on demand for our products and a negative impact on the efficient operation of our facilities, supply chains and logistics. We have experienced disruptions and delays within our supply chain and logistics operations in the U.S., China, Southeast Asia, Argentina and Europe. This includes challenges at ports due to national quarantines, difficulties with scheduling cargo ships, additional warehouse costs due to shipment delays, and the restriction of movements by trucks within and between countries. While in certain cases the Company has availed itself of certain exemptions from government restrictions, there can be no assurance that these exemptions will not be modified or revoked. Any new or continuing government restrictions, and any failure to obtain or retain an exemption, may lead to a further negative impact on our business, including increased costs, higher payroll taxes, and/or an inability to meet supply obligations to customers.

The rapid and global spread of COVID-19 has resulted in the disruption and temporary shutdown of the businesses of certain of our customers, end users, contract manufacturers and suppliers, and limits on access to the production facilities of our contract manufacturers and suppliers. Some contract manufacturers and suppliers may be unable to perform under a contract, file for bankruptcy protection, go out of business, or suffer disruptions in their business due to the COVID-19 pandemic. All of the foregoing could adversely impact our ability to meet our production schedules and otherwise operate our business and will increase our costs and expenses (which will not be covered by insurance).

We may experience impacts from changes in industry trends and customer orders, a recession, IT failures, including remote connectivity or limitations due to internal or external causes, as well as impacts on our workforce in any of the countries or regions where we operate. If the virus were to affect a significant number of the workforce employed or operating at any one of our facilities, or they refrain from working due to pandemic fears or illness, or they are restricted from doing so by government order or request, we may experience delays or the inability to produce and deliver products to our customers on a timely basis; and/or successfully execute upon our expansion plans in a timely and cost effective manner.

The COVID-19 pandemic has also caused disruption and volatility in the global capital and financial markets, which may increase our cost of capital. Our stock price may also fluctuate greatly.

To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of exacerbating many of the other risks described in the risk factors discussed in Part I, Item 1A of this Annual Report on Form 10-K, in our other filings with the SEC, or in reports to our stockholders.

Growth Strategy and Market Risks:

Our growth depends upon the continued growth in demand for electric vehicles with high performance lithium compounds.

We are one of a few producers of performance lithium compounds that are a critical input in current and next generation high energy density batteries used in electric vehicle applications. Our growth is dependent upon the continued adoption by consumers of electric vehicles, the rate of development and adoption of next generation high nickel battery technologies in some electric vehicle segments, and the rate of adoption of high performance lithium compounds. If the market for electric vehicles does not develop as we expect, or develops more slowly than we expect, our business, prospects, financial condition and results of operations will be affected. The market for electric vehicles is relatively new, rapidly evolving, and could be affected by numerous external factors, such as:




			•						government regulations and automakers' responses (including fleet electrification roadmaps and battery technology choices) to those regulations;




			•						tax and economic incentives;




			•						rates of consumer adoption, which is driven in part by perceptions about electric vehicle features (including range per charge), quality, safety, performance, cost and charging infrastructure;




			•						competition, including from other types of alternative fuel vehicles, hybrid vehicles, plug-in hybrid electric vehicles, and high fuel-economy internal combustion engine vehicles; and




			•						volatility in the cost of battery materials, oil and gasoline.

Table of Contents

Lithium prices can be volatile, especially due to changes in supply.

The prices of lithium have been, and may continue to be, volatile. Some of our contracts for the sale of performance lithium compounds have index-based pricing, which could provide a benefit if lithium pricing rises, or could have a material adverse effect on our business, financial condition and results of operations if lithium pricing declines. We expect that prices for the performance lithium compounds we manufacture will continue to be influenced by various factors, including regional and global demand-supply balance as well as the business strategies of major producers and users. Certain market analysts predict a significant increase in global lithium capacity over the short and medium term. However, there is a high degree of uncertainty about the time period involved to achieve targeted output volumes, operating costs, and product quality at a level that will be qualified by customers. Further declines in lithium prices could have a material adverse effect on our business, financial condition and results of operations.

Adverse conditions in the economy and volatility and disruption of financial markets can negatively impact our customers, and downturns in our customers’ end-markets could adversely affect our sales and profitability.

We produce performance lithium compounds for application in a diverse range of end-products, including for batteries in electric vehicles and energy storage applications and for a wide variety of industrial, pharmaceutical, aerospace, electronics, agricultural and polymer applications. Deterioration in the global economy or in the specific industries in which our customers compete could adversely affect the demand for our customers’ products, which, in turn, could negatively affect our sales and profitability. Many of our customers’ end-markets are cyclical in nature or are subject to secular downturns. Historically, cyclical or secular end-market downturns have periodically resulted in diminished demand for our performance lithium compounds and have caused a decline in average selling prices, and we may experience similar problems in the future.

We face competition in our business.

We compete globally against a number of other lithium producers. Competition is based on several key criteria, including economies of scale, technological capabilities, service, product performance, quality, cost and price. Some of our competitors are larger than we are and may have greater financial resources for growth, acquisitions, expansions (including in the geographic areas where we operate), research and development and other matters. These competitors may also be able to maintain greater operating and financial flexibility. If we fail to compete effectively, we may be unable to retain or expand our market share, which could have a material adverse effect on our business, results of operations and financial condition. We may also face potential competition from substitute materials or technologies and through backward integration, alliances, partnerships within the electric vehicle supply chain, and from other mining or resource extraction and battery materials recycling companies that enter the lithium production or recycling business. This may influence our future expansion decisions or limit our ability to expand.

Our operating results are subject to substantial quarterly and annual fluctuations.

Our revenue and operating results have fluctuated in the past and are likely to fluctuate in the future. These fluctuations may occur on a quarterly or annual basis and are due to a number of factors, many of which are beyond our control. These factors include, among others:

• changes in our product mix or customer mix;

• changes in product quality requirements and increased qualification time periods;

• changes in product regulatory classifications;

• changes by electric vehicle and battery manufacturers in supply chain locations and raw material suppliers’ participation for those locations;

• the oversupply and inventory levels of lithium compounds in the global lithium industry;

• the timing of receipt, reduction or cancellation of significant product orders by customers, or the use of substitute products for lithium by customers;

• the timing, duration and pricing terms of new customer contracts and renewals;

• our ability to adapt to changes in technology trends affecting the lithium industry, including new manufacturing processes;

•fluctuations in currency exchange and interest rates, and inflation;

• the effects of competitors’ actions and competitive pricing pressures, including decreases in average selling prices of our products;

•changes in manufacturing costs, including energy, raw material price increases; and

Table of Contents

•the extent to which we are required and able to purchase third-party lithium carbonate meeting necessary specifications to supplement internally produced lithium carbonate from our company-owned mineral deposits in Argentina, as purchasing from third parties (if available) leads to higher production costs and reduced margins.

If our operating results in one or more future quarters fail to meet the expectations of securities analysts or investors, a significant decline in the trading price of our common stock may occur, which may happen immediately or over time.

Production expansion efforts are complex projects that will require significant capital expenditures and are subject to significant risks and uncertainties.

In order to meet growing and forecasted demands for our performance lithium compounds, particularly lithium hydroxide, we intend to expand our lithium carbonate and hydroxide capacities when warranted by market conditions or long-term customer commitments. We are undergoing expansion of annual lithium carbonate production at our existing operations in Argentina in addition to seeking alternative lithium resources. Expansion projects are complex undertakings, and there can be no assurance that we will be able to complete these projects within our projected budget and schedule or that we will be able to achieve the anticipated benefits from them. Unforeseen technical or construction difficulties, lack of adequate water or energy, regulatory requirements (including permits), labor or civil/political unrest, community relations or logistical issues, or local hiring and procurement policies and requirements (discussed further under the below risk factor “Our lithium extraction and production operations in Argentina expose us to specific political, financial and operational risks”) could increase the cost of these projects, delay the projects or render them infeasible. Any significant delay in the completion of the projects or increased costs could have an adverse effect on our business, financial condition and results of operations.

The development and adoption of new battery technologies that rely on inputs other than lithium compounds could significantly impact our prospects and future revenues.

Current and next generation high energy density batteries for use in electric vehicles rely on lithium compounds as a critical input. The pace of advances in current battery technologies, the development and adoption of new battery technologies that rely on inputs other than lithium compounds, or a delay in the development and adoption of next generation high nickel battery technologies that utilize lithium hydroxide could significantly impact our prospects and future revenues. Many materials and technologies are being researched and developed with the goal of making batteries lighter, more efficient, faster charging and less expensive. Some of these could be less reliant on lithium hydroxide or other lithium compounds, especially if the demand for batteries for use in electric vehicles outstrips the available supply of lithium hydroxide or other lithium compounds. We cannot predict which new technologies may ultimately prove to be commercially viable and their share in the overall mix over any time horizon. Commercialized battery technologies that use less lithium compounds could materially and adversely impact our prospects and future revenues.

We may have difficulty accessing global capital and credit markets.

We expect to rely on cash generated from operations and external financing to fund our growth and ongoing capital needs. The expansion of our business or other business opportunities may require significant amounts of capital. While we believe that our cash from operations, together with borrowing availability under our Revolving Credit Facility and other potential financing strategies that may be available to us, will be sufficient to meet these needs in the foreseeable future, if we need additional external financing, our access to credit markets and the pricing of our capital will be dependent upon maintaining sufficiently strong credit metrics and the state of the capital markets generally. There can be no assurances that we would be able to obtain equity or debt financing on terms we deem acceptable, and it is possible that the cost of any financings could increase significantly, thereby increasing our expenses and decreasing our net income. If we are unable to generate sufficient cash flow or raise adequate external financing, including as a result of significant disruptions in the global credit markets, we could be forced to restrict our operations and growth opportunities, which could adversely affect our operating results.

Our net leverage ratio under our Revolving Credit Facility covenants may increase during the next 12 months from the date of this filing. Compliance with our debt covenants will continue to be determined, in large part, by our ability to manage the timing and amount of our capital expenditures, which is within our control, as well as by our ability to achieve forecasted operating results and to pursue other working capital financing strategies that may be available to us, which is less certain and outside of our control.

The conditional conversion feature of the 2025 Notes may adversely impact our liquidity or dilute our stockholders, depending on the method of settlement.

Pursuant to the conditional conversion feature of the 2025 Notes, holders of 2025 Notes are entitled to convert the 2025 Notes at any time during specified periods at their option. The conditional conversion feature was triggered during each of the first,

Table of Contents

second, third and fourth quarters of 2021, and thus holders had the option to convert all or any portion of their 2025 Notes at any time through December 31, 2021. If one or more holders elect to convert their 2025 Notes (if the conditional conversion feature is triggered again), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share). In addition, even if holders do not elect to convert their 2025 Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 2025 Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.

We may not have sufficient cash flow from our business to pay our debt.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the 2025 Notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be unfavorable or dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.

Our research and development efforts may not succeed, and our competitors may develop more effective or successful products.

The industries and the end markets into which we sell our products experience regular technological change and product improvement. Our ability to compete successfully depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize new and innovative performance lithium compounds for use in our customers’ products. There is no assurance that our research and development efforts will be successful or that any newly developed products will pass our customers’ qualification processes or achieve market-wide acceptance. If we fail to keep pace with evolving technological innovations in our customers’ end markets, our business, financial condition and results of operations could be adversely affected. In addition, existing or potential competitors may develop products which are similar or superior to our products or are more competitively priced. If our product launching efforts are unsuccessful, our financial condition and results of operations may be adversely affected.

We may make future acquisitions which may be difficult to integrate, divert management and financial resources and result in unanticipated costs.

As part of our continuing business strategy, we may make additional acquisitions of, or investments in, companies or technologies that complement our current products, enhance our market coverage, technical capabilities or production capacity, expand our access to lithium deposits in other geographic locations, or offer growth opportunities. We do not have specific timetables for any future plans and we cannot be certain that we will be able to identify suitable acquisition or investment candidates for sale at reasonable prices.

Recent and future investments or acquisitions could pose numerous risks to our operations, including difficulty integrating the acquired operations, products, technologies or personnel; substantial unanticipated integration costs; diversion of significant management attention and financial resources from our existing operations; a failure to realize the potential cost savings or other financial benefits and/or the strategic benefits of the acquisitions; and the incurrence of liabilities from the acquired businesses for environmental matters, infringement of intellectual property rights or other claims (for which we may not be successful in seeking indemnification). These and other risks relating to acquiring, integrating and operating acquired assets or companies could cause us not to realize the anticipated benefits from such activity and could have a material adverse effect on our business, financial condition and results of operations.

Operational Risks:

We have substantial international operations and sales, and the risks of doing business in foreign countries could adversely affect our business, financial condition and results of operations.

We conduct a substantial portion of our business outside the U.S. (see Note 4: Revenue Recognition, in Part II, Item 8, Financial Statements and Supplementary Data, Notes to Consolidated Financial Statements, of this Annual Report on Form 10-K). Accordingly, our business is subject to risks related to foreign exchange as well as risks related to the differing legal, political, social and regulatory requirements and economic conditions (including inflation) of the many jurisdictions where we conduct business.

Table of Contents

Changes in exchange rates between foreign currencies and the U.S. Dollar will affect the recorded levels of our assets, liabilities, net sales, cost of goods sold and operating margins and could result in exchange losses. Our results of operations may be adversely affected by any volatility in currency exchange rates and our ability to manage effectively our currency transaction and translation risks. Foreign currency debt and foreign exchange forward contracts may be used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows. The Argentine peso has recently declined significantly in value, and we currently do not hedge foreign currency risks associated with the Argentine peso due to the limited availability and high cost of suitable derivative instruments.

In addition, it may be more difficult for us to enforce agreements or collect receivables through foreign legal systems. There is a risk that foreign governments may nationalize private enterprises in certain countries where we operate. In certain countries or regions, terrorist activities and the response to such activities may threaten our operations more than in the U.S. Social and cultural norms in certain countries may not support compliance with our corporate policies including those that require compliance with substantive laws and regulations. Also, changes in general economic and political conditions in countries where we operate are a risk to our financial performance and future growth. Our sales depend on international trade and moves to impose tariffs and other trade barriers, as is happening in various countries including the U.S., could negatively affect our sales and have a material adverse effect on our business, financial condition and results of operations.

We and our subsidiaries are also subject to rules and regulations related to anti-bribery, anti-corruption (such as the U.S. Foreign Corrupt Practices Act), anti-money laundering, trade sanctions, export controls, and customs matters, including duties and tariffs. Compliance with such laws may be costly and violations of such laws may carry substantial penalties. We may also be subject to complex and time-consuming investigations or audits by governmental authorities and regulatory agencies, which can occur in the ordinary course of business or which can result from increased scrutiny from a particular agency towards an industry, country or practice. Such investigations or audits may subject us to increased government scrutiny, investigation and civil and criminal penalties, and may limit our ability to import or export our products.

As we continue to operate our business globally, our success will depend, in part, on our ability to anticipate and effectively manage these and other related risks. There can be no assurance that the consequences of these and other factors relating to our international operations will not have an adverse effect on our business, financial condition or results of operations.

In particular, one of our key manufacturing facilities is located in the United Kingdom. Following a referendum in 2016, votes in the United Kingdom approved that country's exit from the European Union ("Brexit"). The United Kingdom formally left the European Union on January 31, 2020, subject to a 11-month transition period. Following completion of the transition period, the United Kingdom's withdrawal from the European Union was completed on December 31, 2020. In connection with Brexit, the United Kingdom and the European Union entered into the UK-EU Trade and Cooperation Agreement (the "TCA"), which is an agreement on the future trading relationship between the parties. Because the agreement merely sets forth a framework in many respects and will require complex additional bilateral negotiations between the United Kingdom and the European Union as both parties continue to work on the rules for implementation, significant uncertainty remains about how the precise terms of the relationship between the parties will differ from the terms before withdrawal. We derive a significant portion of our revenues from sales outside of the U.S., including from the European Union. Brexit has and may continue to introduce significant uncertainties into global financial markets, including volatility in foreign currencies, and adversely impact the markets in which we and our customers operate. Adverse consequences such as deterioration in economic conditions, volatility in currency exchange rates or adverse changes in regulation could have a negative impact on our business, financial condition or results of operations. All of these potential consequences could be further magnified if additional countries were to exit the European Union. While we actively monitor for developments in the discussion between the United Kingdom and the European Union and update our contingency plans, any new rules and regulation could adversely affect our business, financial condition or results of operations.

Our lithium extraction and production operations in Argentina expose us to specific political, financial and operational risks.

We obtain the substantial majority of our lithium from our operations in Argentina. Our operations in Argentina expose us to the following risks, and the occurrence of any of these risks could have a material adverse effect on our business, financial condition or results of operations:

Table of Contents




			•						Political and financial risks that are typical of developing countries. Such risks include: high rates of inflation; risk of expropriation and nationalization or changes in or nullification of concession rights; changes in taxation policies; restrictions on foreign exchange and repatriation; labor unrest; changing political norms and currency controls; and governmental policies and regulations that favor or require us or our contractors and subcontractors to award contracts in, employ citizens of, or purchase supplies from, Argentina and the local provinces where we operate. In addition, changes in mining or investment policies or shifts in political attitude in Argentina concerning mining may adversely affect our operations or profitability. There can be no assurance that the new or future governments of Argentina will not impose greater state control of lithium resources, or take other actions that are adverse to us.




			•						Risks associated with changes in tax laws. On December 20, 2019 the Argentine Congress declared an economic emergency and introduced new export duties on hydrocarbon and mining goods (including lithium), a special tax on foreign exchange transactions, changes to taxes on bank accounts, the Argentine income tax, internal taxes and a delay in the reduction of the corporate tax rate (which was subsequently increased to 35% in 2021). Under the tax stability certificate we have with the Argentine federal government, we are entitled to reimbursement or set-off (against other federal taxes) of any amount paid in excess of the total federal taxable burden applicable to us under such certificate. However, there can be no assurance that we will seek, or be able to obtain, such reimbursement or set-off, or that there will be no other changes in tax laws.




			•						Operational risks stemming from our dependence upon mining concessions granted to us under the Argentine Mining Code. We hold title to these mining concessions in perpetuity until the deposit is exhausted of all minerals, provided that we pay annual mining fees and keep the mining concessions active in accordance with the Argentine Mining Code. Failure to pay the annual fees or to keep the mining concessions active may result in revocation of our mining concessions. In addition, Argentinian federal and provincial mining authorities retain broad discretion in the enforcement of mining and environmental regulations, including through imposition of fines or suspension of mining extraction or related water rights.




			•						Risks associated with the loss or depletion of our mineral deposit. Our primary source for lithium is our current brine site at Salar del Hombre Muerto. In order to maintain our production capabilities, we will need to replace or supplement our lithium resources there in the event our access is disrupted or lost, whether due to a natural disaster, depletion or otherwise. Although we seek to reduce dependence on this primary source of supply for lithium, there is no assurance we will be able to do so in a timely manner or on commercially favorable terms. In addition, due to the current trend of growth in the lithium industry, there is no assurance that we will be able to discover or acquire new and valuable lithium resources, or that the actual production results will match the expected results.




			•						Risks of certain natural disasters. Our lithium brines and related production facilities are located in a seismically active region in northwest Argentina. A major earthquake could have adverse consequences for our operations and for general infrastructure, such as roads, rail, and access to goods in Argentina. Our production operations in Argentina could also be subject to significant rain events, as our production processes rely on natural evaporation and a significant rain event could impact our production. In the first quarter of 2019 and the last quarter of 2021, we experienced a significant rain event in Argentina, which disrupted our production operations. We may not recover the expected volume that was lost in the last quarter of 2021 in 2022. If our brine site in Argentina were to suffer continuing, significant rain events, or if any of our operating facilities in Argentina were to suffer an earthquake or other natural disaster, this could have a material adverse effect on our business, financial condition and results of operations.

Table of Contents




			•						Risks associated with water rights and our access to water. Access to fresh water is essential to our production operations in Argentina; we hold water use rights granted to us by provincial Argentine authorities and will need to secure additional water rights for our planned production expansion. (See Part I, Item 1 Business-Raw Materials-Water section of this Annual Report on Form 10-K). Our operations take place in a dry, mountainous region that has limited access to fresh water. The governmental authority may seek to suspend or alter our rights or the applicable water rights code may change, each of which may limit our access to fresh water. In addition, our access to water may be impacted by third-party claims (including local competitors who are expanding their own operations), over-permitting by the government, changes in geology, climate change (including the potential effects of climate change such as drought, changes in precipitation patterns, and severe weather events) or other natural factors, such as wells drying up or reductions in the amount of water available in the wells or sources from which we obtain water, that we cannot control. There can be no assurance that we will have access to sufficient quantities of water to support our production operations, either at current capacities or our planned production expansion, in the future. There is currently no specific regulation of wetlands at the Argentine national or provincial level. However, during 2020, a number of bills to regulate wetlands were introduced to the Argentine Congress and were reviewed by different committees within the Argentine House of Representatives and Senate. One was approved by the Committee of Natural Resources of the House of Representatives, but was not reviewed by the Senate. If any bill is passed, our access to water in the Los Patos and Trapiche rivers may be affected, as it could prohibit any activity in the wetlands, including the installation of any infrastructure that could modify the hydrologic regimen, the construction of dams, and mining activity.




			•						Risks associated with foreign exchange controls and restrictions. On September 1, 2019, the Argentine Government reinstated certain foreign exchange restrictions. The restrictions that may impact our Argentina operations relate to: (i) a requirement that Argentinian exporters repatriate proceeds allocated or earned abroad and convert them into Argentinian pesos within a specified time-frame; (ii) limitations on the payment of dividends and payment for services performed by related parties, which would now generally require prior written authorization from the Argentinian Central Bank; (iii) a prohibition on the purchase of foreign exchange as an investment to hedge foreign exchange fluctuations; and (iv) restrictions on payments for imported goods. These restrictions have been extended until June 30, 2022.




			•						Risks associated with local labor matters. Argentina has experienced labor unrest over wages and benefits paid to workers. In the past, the Argentine government has passed laws, regulations and decrees requiring companies in the private sector to increase salaries or maintain minimum wage levels and provide specified benefits to employees and may do so again in the future. For instance, the national government declared a public labor emergency that took effect on December 13, 2019 and that remained in place until December 31, 2021. During this period, severance compensation for dismissal without justified cause, lack of work and force majeure was to be doubled (this decree did not apply to any employees hired after December 13, 2019). While the decree has now expired, the Argentine Executive Power has implemented a similar measure providing for enhanced severance benefits until June 30, 2022. Employers have also experienced significant pressure from their employees and labor organizations to increase wages and to provide additional employee benefits. Any disruptions, labor unrest, unionization efforts or increased personnel-related expenses in Argentina could have a material and adverse effect on our business and operating expenses.




			•						Risks associated with inflation. Inflation is another risk associated with our Argentina operations. Effective July 1, 2018, Argentina was designated as a highly inflationary economy, as it has experienced cumulative inflation of approximately 100 percent or more over a three-year period. As a result of this determination and in accordance with U.S. GAAP, the functional currency of our operations in Argentina was changed from the Argentine peso to the U.S. dollar. Gains and losses resulting from the remeasurement of non-U.S. dollar monetary assets and liabilities of Argentina are recorded in net earnings. We anticipate high rates of inflation to continue in Argentina.

Table of Contents




			•						Risks associated with Argentina’s economy. Argentina has been facing economic difficulty for the past several years. Since 2015, the Argentine economy has experienced a recession, a political and social crisis, and a significant depreciation of the Argentine peso against major international currencies. Depending on the relative impact of other variables affecting our operations, including technological changes, inflation, gross domestic product (“GDP”) growth, and regulatory changes, the continued depreciation of the Argentine peso could have a material and adverse effect on our business and operating expenses.




			•						Risks associated with civil or political unrest in our areas of operations. Civil and political unrest is common in Argentina and we have experienced protests and claims at our facilities in Argentina. Significant civil or political unrest in the areas of our operations could lead to a delay or suspension in operations or our planned expansion project, delay or loss of production, damage to our facilities, or loss of license, and could negatively impact our reputation. A delay or suspension in operations or our expansion, delay or loss of production, damage to our facilities, or negative impact to our reputation could have a material and adverse effect on our business and operating expenses. In addition, we must comply with requirements for prior consultation of communities and ethnic groups who are affected by our planned expansion project in Argentina (including for future expansion efforts). Notwithstanding our compliance with these requirements, such communities and groups may be successful in lawsuits brought against us or civil unrest may occur, potentially leading to increased costs, operational delays and other impacts that could have a material and adverse effect on our business and operating expenses.

Our operations and suppliers may be subject to physical and other risks, including natural disasters, epidemics, pandemics, and other catastrophic events beyond our control, which could disrupt production and have a material adverse effect on our business, financial condition, results of operations and cash flows.

We conduct large-scale lithium production operations in Argentina and own, operate and/or contract with large-scale manufacturing facilities in China, India, the United Kingdom and the U.S. Our operating results will be dependent in part on the continued operation of the various production facilities and the ability to manufacture products on schedule. Interruptions at these facilities may materially reduce the productivity and profitability of a particular manufacturing facility, or our business as a whole, during and after the period of such operational difficulties.

Our operations and those of our contract manufacturers are subject to hazards inherent in lithium production and manufacturing and the related storage and transportation of raw materials, products such as butyllithium, and wastes. These potential hazards include explosions, fires, severe weather and natural disasters, including earthquakes, mechanical failure of equipment, unscheduled downtimes, supplier disruptions, labor shortages or other labor difficulties (including widespread labor unrest in Argentina and Chile), information technology systems outages, disruption in our supply chain or manufacturing and distribution operations, transportation interruptions, chemical spills, discharges or releases of toxic or hazardous substances or gases, shipment of contaminated or off-specification product to customers, storage tank leaks, changing regulatory requirements, other environmental risks, or other sudden disruption in business operations beyond our control as a result of events such as acts of sabotage, unilateral government actions, terrorism or war, civil or political unrest, natural disasters, power outages and energy shortages, and public health epidemics. Outbreaks of pandemic diseases, such as coronavirus, or the fear of such events, have provoked responses, including government-imposed travel restrictions and limits on access to the production facilities of our contract manufacturers. Some of these hazards may cause severe damage to, or destruction of, property and equipment or personal injury and loss of life and may result in suspension of operations or the shutdown of affected facilities, which could have a material adverse effect on our business, financial condition and results of operations.

There have been a number of industrial plant explosions in China during recent years that have resulted in fatalities. China is the largest producer and consumer of chemicals in the world, but regulation of, and safety standards within the industry has historically been weak and inconsistent. In light of the historical blasts, fatalities and property damage, the Chinese government has expanded inspections, implemented a computerized monitoring system to alert the government of potential accidents, shut down facilities and toughened punishments for companies that violate safety standards. Manufacturers in China have also experienced sporadic power outages as a result of electricity shortages. If any explosion, power outage or similar event were to occur at or near any of our facilities or contract manufacturers in China, or if the Chinese government were to impose new regulations limiting or suspending (temporarily or permanently) the operations of our facilities or contract manufacturers in China, this could have a material adverse effect on our business, financial condition and results of operations.

Furthermore, the hazards described above could cause temporary or long-term disruption in the supply of component products from some local and international suppliers, disruption in the transport of our products and significant delays in the shipment of

Table of Contents

products and the provision of services, or negatively affect customer demand, which could in turn cause the loss of sales and customers, or could otherwise result in significant damages, threats, interruptions, or delays to our business and initiatives. Existing insurance arrangements may not provide protection for all of the costs that may arise from such events. Accordingly, disruption of our operations or the operations of a significant supplier or customer could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

Severe weather events, including the effects of climate change, are inherently unpredictable and may have a material adverse effect on our operations, financial results and financial condition.

Our business, including our customers and suppliers, may be exposed to severe weather events and natural disasters, such as heat waves, tornadoes, tsunamis, tropical storms (including hurricanes, typhoons and cyclones), earthquakes, windstorms, hailstorms, severe thunderstorms and heavy downpours, wildfires, and other fires, which could cause operating results to vary significantly from one period to the next. We may incur losses in our business in excess of: (i) those experienced in prior years, (ii) the average expected level considered in pricing decisions, or (iii) current insurance coverage limits. The incidence and severity of severe weather conditions and other natural disasters are inherently unpredictable. Climate change may affect the occurrence of certain natural events, such as an increase in the frequency or severity of wind and thunderstorm events, and tornado or hailstorm events due to increased convection in the atmosphere; extreme heat; water shortages; more frequent wildfires and subsequent landslides in certain geographies; higher incidence of deluge flooding and accelerated soil erosion; and the potential for an increase in severity of the hurricane, typhoon and cyclone events due to higher sea surface temperatures. Additionally, climate change may adversely impact the demand, price, and availability of insurance. Due to significant variability associated with future changing climate conditions, including potential impacts on air, water and land quality, as well as impacts to ecosystems and human health and safety, we are unable to predict the impact climate change will have on our business.

We derive a substantial portion of our revenue from a limited number of customers, and the loss of, or a significant reduction in orders from, a large customer could have a material adverse effect on our business and operating results.

In any particular period, a substantial amount of our total revenue could come from a relatively small number of customers (see Note 4: Revenue Recognition, in Part II, Item 8, Financial Statements and Supplementary Data, Notes to Consolidated Financial Statements, of this Annual Report on Form 10-K). It is likely that we will continue to derive a significant portion of our revenue from a relatively small number of customers in the future. If we were to lose any material customer or if any such customer significantly reduced or delayed its orders, such loss, reduction or delay could have a material adverse effect on our business, financial condition and results of operations.

We may not satisfy customer qualification processes, customers’ or governments’ quality standards, and could be subject to damages based on claims brought against us or lose customers as a result of the failure of our products to meet certain quality standards.

Since our products are derived from natural resources, they may contain impurities that may not meet certain customer or government quality standards. As a result, we may not be able to sell our products if we cannot meet such requirements. In addition, customers may impose stricter or lengthier qualification processes for our manufacturing operations (or delay any approval, which could in turn delay our plant improvement or expansion plans), stricter quality standards on our products, or governments may enact stricter regulations for the distribution or use of our products. Some of our products also have a limited shelf life, which can affect the ability of a customer to use our product and/or lead to returns and warranty claims. Failure to meet such customer and government standards could materially adversely affect our business, financial condition and results of operations if we are unable to sell our products in one or more markets or to important customers in such markets. In addition, our cost of production may increase to meet any newly imposed or enacted standards.

We warrant to our customers that our products conform to mutually agreed product specifications. If a product fails to meet warranted quality specifications, a customer could seek a replacement, the refund of the purchase price or damages for costs incurred as a result of the product failing to meet the specification. In addition, because many of our products are integrated into our customers’ products, such as lithium-ion batteries in EVs and energy storage applications, we may be requested to participate in or fund, in whole or in part, the costs of a product recall conducted by a customer.

In addition, we utilize third parties to produce or further process a portion of our performance lithium compounds. We endeavor to contract with third-party manufacturers that we believe are able to meet our delivery schedule and other requirements. Nevertheless, we may not be able to monitor the performance of these third parties as directly and efficiently as we do our own production facilities. As a result, we are exposed to the risk that our third-party providers may fail to perform their contractual obligations or may fail to meet the quality or other requirements of our customers, which may in turn adversely affect our business, financial condition and results of operations.

Table of Contents

As with all quality control systems, any failure or deterioration of our quality control systems or that of our third-party contract manufacturers could result in defects in our projects or products, which in turn may subject us to contractual, product liability and other claims. Any such claims, regardless of whether they are ultimately successful, could cause us to incur significant costs, harm our business reputation and result in significant disruption to our operations. Furthermore, if any such claims were ultimately successful, we could be required to pay substantial monetary damages or penalties, which could have a material adverse effect on our reputation, business, financial condition and results of operations.

Global inflation, fluctuations in the price of energy and certain raw materials, and our inability to obtain raw materials and products under contract sourcing arrangements, could have an adverse effect on the margins of our products, our business, financial condition and our results of operations.

The long-term profitability of our operations will be, in part, related to our ability to continue to economically and reliably obtain resources, including energy, raw materials, and finished products. Our raw material and energy costs can be volatile and may increase significantly, as they are doing so now as a result of global inflation and supply chain disruptions. In contrast, we enter into contracts for our products that are often at fixed or formula-based prices or otherwise do not permit us to pass on increased costs in sale prices immediately or at all. To the extent we are unable to obtain such resources or to pass on increases in the prices of energy and raw materials to our customers, our financial condition and results of operations could be materially adversely affected. In addition, we source a significant portion of our intermediate and finished products through contract manufacturing arrangements. An inability to obtain these products or execute under these arrangements would adversely impact our ability to sell products and could have an adverse effect on our business, financial condition and results of operations.

Our success depends upon our ability to attract and retain key employees and the identification and development of talent to succeed senior management.

Our success depends on our ability to attract and retain key personnel, and we rely heavily on critical executive and senior management level individuals, as well as those with niche technical skills. The inability to recruit and retain key personnel, including personnel with technical skills, or the unexpected loss of such personnel may adversely affect our operations. In addition, because of our reliance on these individuals, our future success depends, in part, on our ability to identify and develop or recruit talent to succeed our senior management and other technical positions throughout the organization. If we fail to identify and develop or recruit successors, we are at risk of being harmed by the departures of these key employees.

Some of our employees are unionized or are employed subject to local laws that are less favorable to employers than the laws of the U.S.

As of December 31, 2021, we had approximately 1,109 full time, part time and temporary and contract employees. A large number of our employees are employed in countries in which employment laws provide greater bargaining or other rights to employees than the laws of the U.S. Such employment rights require us to work collaboratively with the legal representatives of the employees to effect any changes to labor arrangements. For example, our operational and production employees in Argentina, approximately 188, are represented by a union that must approve any changes in conditions of employment, including salaries and benefits and staff changes, and may impede efforts to restructure our workforce. In prior years, we have had to negotiate wage increases for our employees with the union because of inflation in Argentina and will be expected to do so in the future. The current four-year collective bargaining agreement in place is set to expire in 2023 and includes annual salary negotiation. A strike, work stoppage, slowdown or significant dispute with our employees could result in a significant disruption of our operations or higher ongoing labor costs.

Our business and operations could suffer in the event of cybersecurity breaches or disruptions to our information technology environment.

As with all enterprise information systems, our information technology systems could be penetrated by outside parties intent on extracting information, corrupting information, or disrupting business processes. Our systems, which contain critical information about our business (including intellectual property and confidential information of our customers, vendors and employees), have in the past been, and likely will in the future be, subject to unauthorized access attempts. Unauthorized access could disrupt our business operations and could result in failures or interruptions in our computer systems and in the loss of assets (including our intellectual property and confidential business information), which could harm our competitive position, reduce the value of our investment in research and development and other strategic initiatives or otherwise have a material adverse effect on our business, financial condition or results of operations. In addition, breaches of our security measures or the accidental loss, inadvertent disclosure, or unapproved dissemination of proprietary information or sensitive or confidential information about the company, our employees, our vendors, or our customers, could result in litigation, violations of various data privacy regulations in some jurisdictions, and also potentially result in liability to us. This could damage our reputation, or otherwise harm our business, financial condition, or results of operations, and the devotion of additional resources to the security of our information technology systems in the future could significantly increase the cost of doing business.

Table of Contents

Our inability to protect our intellectual property rights could have a material adverse effect on our business, financial condition and results of operations.

Protection of our patents, trade secrets, trademarks and copyrights, proprietary processes, methods, formulations, and compounds, the incorporation of such formulations and compounds into various products and other technology is important to our business. Although our existing processes and products may not be protected or protectable by patents, we generally rely on the intellectual property laws of the U.S. and certain other countries in which our products are produced or sold, as well as licenses and nondisclosure and confidentiality agreements, to protect our intellectual property rights. Notwithstanding the measures we take to ensure our intellectual property assets are adequately protected, there are circumstances out of our control that make result in the loss of valuable proprietary technologies. These circumstances include, the patent, trade secret and trademark laws of some countries, or their enforcement, which may not protect our intellectual property rights to the same extent as the laws of the U.S.. If patents are issued to us, those patents may not provide meaningful protection against competitors or against competitive technologies. There can be no assurance that our intellectual property rights will not be challenged, invalidated, circumvented or rendered unenforceable.

From time to time, we may license or otherwise obtain certain intellectual property rights from third parties and we endeavor to do so on terms favorable to us. However, we may not be able to license or otherwise obtain intellectual property rights on such terms or at all, which could have a material adverse effect on our ability to create a competitive advantage and create innovative solutions for our customers, which will adversely affect our net sales and our relationships with our customers.

With respect to unpatented proprietary manufacturing expertise, continuing technological innovation and other trade secrets necessary to develop and maintain our competitive position, while we generally enter into confidentiality agreements with our employees and third parties to protect our intellectual property, there can be no assurance that our confidentiality agreements will not be breached, that they will provide meaningful protection for our trade secrets and proprietary manufacturing expertise or that adequate remedies will be available in the event of an unauthorized use or disclosure of our trade secrets or manufacturing expertise. In addition, our trade secrets and know-how may be improperly obtained by other means, such as a breach of our information technology security systems or direct theft.

If we fail to successfully enforce our intellectual property rights, our competitive position could suffer. We may also be required to spend significant resources to monitor and police our intellectual property rights. Similarly, if we were to infringe on the intellectual property rights of others, our competitive position could suffer. Furthermore, other companies may duplicate or reverse engineer our technologies or design around our patents.

In some instances, litigation may be necessary to enforce our intellectual property rights and protect our proprietary information, or to defend against claims by third parties that our products infringe their intellectual property rights. Any litigation or claims brought by or against us, whether with or without merit, could result in substantial costs to us and divert the attention of our management, which could harm our business and results of operations. In addition, any intellectual property litigation or claims against us could result in the loss or compromise of our intellectual property and proprietary rights, subject us to significant liabilities, require us to seek licenses on unfavorable terms, prevent us from manufacturing or selling certain products or require us to redesign certain products, any of which could harm our business and results of operations.

We have not established “proven” or “probable” reserves, as defined by the SEC under Industry Guide 7, through the completion of a feasibility study for the minerals that we produce.

We have not established proven or probable reserves, as defined by the SEC under Industry Guide 7, through the completion of a “final” or “bankable” feasibility study for any of the minerals that we currently produce. Since we conduct operations without having established proven or probable reserves, there may be greater inherent uncertainty as to whether or not mineralized material can be economically obtained as originally planned and anticipated. In addition, we do not at present plan to conduct exploration activities or other activities to establish reserves in Argentina. Because we do not have any proven or probable reserves, there can be no assurance that a commercially viable deposit exists to support production at existing levels or to expand our production capacity in the future, which could have a material adverse effect on our business, financial condition and results of operations.

Our business could be negatively impacted by sustainability and ESG matters and/or our reporting of such matters.

There is an increasing focus from certain investors, customers, consumers, regulators, government officials, community groups, employees, proxy advisory firms, the press, NGOs and other stakeholders concerning sustainability and ESG matters. From time to time, we communicate certain goals and initiatives regarding environmental matters, responsible sourcing, human rights, corporate governance and social responsibility, including those described in our Company’s Sustainability Report as well as other disclosures. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in fully and accurately reporting our progress on such initiatives and goals. In addition, we could be criticized, including

Table of Contents

through social media, for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Our business and our reputation could be negatively impacted by such shortcomings, failings or perceptions, and this could impact employee recruitment and retention, and the willingness of customers and our partners to do business with us or our customers. Any such sustainability and ESG issues, could have a material adverse effect on our business.

In addition, organizations that provide information to investors on corporate governance and related matters have developed ratings methodologies for evaluating companies on their approach to ESG matters, and unfavorable ratings of our company or our industries may lead to negative investor sentiment and the diversion of investment to other companies or industries.

The Company’s business and reputation could also be negatively impacted by shortcomings, failings or adverse perceptions in ESG matters of the industries and customers we serve, as well as that of the suppliers, contractors and business partners we work with.

Regulatory and Governmental Risks:

Our business and financial results may be adversely affected by various legal and regulatory proceedings.

We are involved from time to time in legal and regulatory proceedings, which may be material. The outcome of proceedings, lawsuits and claims may differ from our expectations, leading us to change estimates of liabilities and related insurance receivables.

Legal and regulatory proceedings, whether with or without merit, and associated internal investigations, may be time-consuming and expensive to prosecute, defend or conduct, divert management’s attention and other resources, inhibit our ability to sell our products, result in adverse judgments for damages, injunctive relief, penalties and fines, and otherwise negatively affect our business.

We, our operations, facilities, products and raw materials are subject to environmental, health and safety laws and regulations, and costs to comply with, and liabilities related to, these laws and regulations could adversely affect our business.

We are subject to extensive federal, state, local, and foreign environmental and safety laws, regulations, directives, rules and ordinances concerning, among other things, employee health and safety, the composition of our products, the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, the usage and availability of water, the cleanup of contaminated properties (including the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund, in the U.S., and similar foreign and state laws) and the reclamation of our brine extraction operations and certain other assets at the end of their useful life. In addition, our production facilities require numerous operating permits. Due to the nature of these requirements and changes in our operations, we may incur substantial capital and operating costs, which may have a material adverse effect on our results of operations.

We may also incur substantial costs, including fines, damages, criminal or civil sanctions and remediation costs, or experience interruptions in our operations, for violations arising under these laws and regulations or permit requirements. In addition, we may be required to either modify existing or obtain new permits to meet our capacity expansion plans. We may be unable to modify or obtain such permits or if we can, it may be costly to do so. Furthermore, environmental, health and safety laws and regulations are subject to change and have become increasingly stringent in recent years. Future environmental, health and safety laws and regulations, or changes to existing laws or regulations, could require us to alter our production processes, acquire pollution abatement or remediation equipment, modify our products or incur other expenses, which could harm our business and results of operations.

If we violate environmental, health and safety laws or regulations, in addition to being required to correct such violations, we can be held liable in administrative, civil or criminal proceedings for substantial fines and other sanctions could be imposed that could disrupt or limit our operations. Liabilities associated with the investigation and cleanup of hazardous substances, as well as personal injury, property damages or natural resource damages arising from the release of, or exposure to, such hazardous substances, may be imposed without regard to violations of laws or regulations or other fault, and may also be imposed jointly and severally. Such liabilities may also be imposed on many different entities, including, for example, current and prior property owners or operators, as well as entities that arranged for the disposal of the hazardous substances.

We have in the past, and may in the future, be subject to claims by third parties or employees relating to exposure to hazardous materials and the associated liabilities may be material. We also have generated, and continue to generate, hazardous wastes at a number of our facilities, including our Bessemer City, North Carolina facility. Additional information may arise in the future concerning the nature or extent of our liability with respect to Bessemer City, North Carolina, and additional sites may be identified for which we are alleged to be liable, that could cause us to materially increase our environmental accrual or the upper range of the costs we believe we could reasonably incur for such matters.

Table of Contents

Scientists periodically conduct studies on the potential human health and environmental impacts of chemicals, including products we manufacture and sell. Also, nongovernmental advocacy organizations and individuals periodically issue public statements alleging human health and environmental impacts of chemicals, including products we manufacture and sell. Based upon such studies or public statements, our customers may elect to discontinue the purchase and use of our products, even in the absence of any reliable scientific basis for such public statements or any controlling government regulation. Such actions could significantly decrease the demand for our products and, accordingly, have a material adverse effect on our business, financial condition, cash flows and profitability.

We manufacture or market a number of products that are or have been the subject of attention by the European Union and United Kingdom regulatory authorities. Concern about the impact of some of our products on human health or the environment may lead to regulation, or reaction in our markets independent of regulation, that could reduce or eliminate markets for such products. Our business and our customers are subject to significant requirements under REACH, which imposes obligation on European Union manufacturers and importers of chemicals and other products into the European Union to compile and file comprehensive reports, including testing data, on each chemical substance, and perform chemical safety assessments. Currently, certain lithium products are undergoing a risk assessment review under REACH, which may eventually result in restrictions in the handling or use of lithium carbonate and other lithium products that we produce, which may increase our production costs. In addition, REACH regulations impose significant additional burdens on chemical producers, importers, downstream users of chemical substances and preparations, and the entire supply chain. South Korea has a similar Act on the Registration and Evaluation of Chemicals which is known as "K-REACH." Both REACH and K-REACH may lead to significant compliance costs and result in increases in the costs of raw materials we purchase and the products we sell. Increases in the costs of our products could result in a decrease in their overall demand; additionally, customers may seek products that are not regulated, which could also result in a decrease in the demand of certain products subject to the REACH and K-REACH regulations, respectively. If we fail to comply with REACH, K-REACH or other similar laws and regulations, we may be subject to penalties or other enforcement actions, including fines, injunctions, recalls or seizures, which would have a material adverse effect on our financial condition, cash flows and profitability.

Unanticipated changes in our tax provisions, variability of our effective tax rate, the adoption of new tax legislation or exposure to additional tax liabilities could impact our financial performance.

We operate in multiple jurisdictions, which contributes to the volatility of our effective tax rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions; accounting for uncertain tax positions; business combinations; expiration of statutes of limitations or settlement of tax audits; changes in valuation allowances; expiration or termination of favorable tax abatement or concession arrangements with foreign tax jurisdictions; and changes in tax law (including, without limitation, in the event of the enactment of the Build Back Better Act or similar legislation in the U.S.).

We have favorable tax concession arrangements with certain foreign tax jurisdictions, which provide for reduced tax rates of income tax, and in certain cases various other taxes. These arrangements are generally valid for a fixed term, subject to renewal at the option of the tax authority. In certain cases, the arrangement is subject to specified conditions which, if not satisfied, may result in the reduction or elimination of the associated beneficial tax arrangement. There can be no assurance that we will be able to renew any favorable tax concession arrangements upon their expiration, or that we will successfully satisfy the conditions required in order to retain any such arrangements. If we are unable to renew any such arrangements or if we do not satisfy the associated conditions, we may lose the benefits of such arrangements, which may have a material adverse effect on our business, financial condition, cash flows and profitability.

We are also subject to ongoing tax audits in various jurisdictions. Tax authorities may disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters, and may assess additional taxes as a result. There can be no assurance that we will accurately predict the outcomes of these audits, and the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in our income tax expense and therefore could have a material impact on our tax provision, net income and cash flows. If these audits result in assessments different from amounts reserved, future financial results may include unfavorable adjustments to our tax liabilities.

Risks Related to the Separation:

If there is a determination that the Separation and the Distribution is taxable for U.S. federal income tax purposes, then FMC and its stockholders could incur significant U.S. federal income tax liabilities, and we could incur significant liabilities.

In connection with the Distribution, FMC received a tax opinion from counsel that the Distribution, together with certain related transactions, qualifies as a tax-free “reorganization” within the meaning of Section 368(a)(1)(D) of the Internal Revenue Code (the “Code”) and a tax-free distribution within the meaning of Section 355 of the Code. The opinion relied on certain facts,

Table of Contents

assumptions, representations and undertakings from FMC and us regarding the past and future conduct of the companies’ respective businesses and other matters. If any of these facts, assumptions, representations or undertakings are incorrect or not otherwise satisfied, FMC and its stockholders may not be able to rely on the opinion of counsel and could be subject to significant tax liabilities. Notwithstanding the opinion of counsel, the Internal Revenue Service (“IRS”) could determine on audit that the Separation and the Distribution is taxable if it determines that any of these facts, assumptions, representations or undertakings is not correct or has been violated or if it disagrees with the conclusions in the opinion, or for other reasons, including as a result of certain significant changes in the stock ownership of FMC or us after the Distribution. If the Separation and the Distribution is determined to be taxable for U.S. federal income tax purposes, FMC and/or its stockholders could incur significant U.S. federal income tax liabilities, and we could incur significant liabilities under applicable law or as a result of the Tax Matters Agreement with FMC.

Risks Related to Ownership of Our Common Stock:

Our stock price may fluctuate significantly.

The trading price of our common stock is likely to be volatile and subject to wide price fluctuations in response to various factors, including:




			•						the severity and duration of the COVID-19 pandemic, including the impact of the COVID-19 pandemic on our business and industry;
			•						market conditions or investor sentiment in the broader stock market, the end markets into which we sell our products, or our industry in particular;




			•						actual or anticipated fluctuations in our quarterly financial and operating results;

			•						our capital financing decisions and debt levels;
			•						mergers, acquisitions, divestitures, corporate reorganizations, and other strategic activity;




			•						introduction of new products and services by us, our competitors or customers;




			•						issuance of new or changed securities analysts’ reports or recommendations;




			•						sales or purchases of large blocks of our stock;




			•						additions or departures of key personnel;




			•						regulatory developments;




			•						litigation and governmental investigations;




			•						economic and political conditions or events; and




			•						changes in investor perception of our market positions based on third-party information.

These and other factors may cause the market price and demand for our common stock to fluctuate substantially, which may limit or prevent investors from readily selling their shares of common stock and may otherwise negatively affect the liquidity of our common stock. In addition, when the market price of a stock is volatile, certain holders of that stock may institute securities class action litigation against the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit or any future securities class litigation that may be brought against the company. We have been sued by several plaintiffs in connection with our IPO. See Part I, Item 3 Legal Proceedings, and Note 15 of Notes to Consolidated Financial Statements, in this Form 10-K. The existing lawsuit and any future lawsuits could also divert the time and attention of our management from our business.

The trading market for our common stock will also be influenced by the research and reports that industry or securities analysts publish about us or our business. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. Moreover, if one or more of the analysts who cover us downgrade our stock, or if our results of operations do not meet their expectations, our stock price could decline.

Some provisions of Delaware law and our certificate of incorporation and bylaws may deter third parties from acquiring us.

Our certificate of incorporation and bylaws provide for, among other things:

Table of Contents




			•						a staggered board and restrictions on the ability of our stockholders to fill a vacancy on the Board of Directors;




			•						the authorization of undesignated preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval;




			•						a requirement that certain business combinations with interested stockholders arising after the date on which no person or group owns a majority of the voting power of our common stock must be approved by the holders of at least 80% of the voting power of our common stock;




			•						advance notice requirements for stockholder proposals; and




			•						a requirement that, after such time as no person or group holds a majority of the voting power of our common stock, our stockholders may not take action by written consent without a duly called annual or special meeting.

These anti-takeover defenses could discourage, delay or prevent a transaction involving a change in control of our company. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and cause us to take other corporate actions than they desire. Our Board of Directors has approved the elimination of the staggered board and the supermajority voting provisions from our certificate of incorporation and bylaws and recommended that our stockholders approve these changes, but to date, we have not received sufficient stockholder support to remove these provisions.

We are not declaring or paying cash dividends at this time, and this may deter certain investors from purchasing our stock.

Any future determination to pay dividends will be at the discretion of our Board of Directors in accordance with applicable law and will be dependent upon our financial condition and results of operations, capital requirements, contractual restrictions, business prospects and other factors that our Board of Directors considers relevant. At this time, no declaration or payment of cash dividends has been made or planned.

SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: We and our representatives may from time to time make written or oral statements that are “forward-looking” and provide other than historical information, including statements contained in Item 1. Business and Management’s Discussion and Analysis of Financial Condition and Results of Operations within this Form 10-K, in our other filings with the SEC, or in reports to our stockholders.

In some cases, we have identified forward-looking statements by such words or phrases as “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These forward-looking statements may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These factors include, among other things, the risk factors listed in Item 1A "Risk Factors" of this Form 10-K. You should specifically consider the numerous risks outlined under "Risk Factors." We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this Form 10-K to conform our prior statements to actual results or revised expectations.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

Table of Contents

ITEM 2. PROPERTIES

We operate six manufacturing facilities in five countries in addition to our lithium extraction operations in Salar del Hombre Muerto, Argentina. We have ten facilities in eight countries to support our sales, marketing, research and development and other administrative needs, including our leased executive offices in Philadelphia, Pennsylvania. Our research, development and innovation facilities are located in Bessemer City, North Carolina.

We have long-term mineral rights to the Salar del Hombre Muerto lithium reserves in Argentina. We require the lithium brine that is mined from these reserves, without which other sources of raw materials would have to be obtained. See Item 1 "Business" included in this Form 10-K for further discussion of our raw materials.

We believe our facilities are in good operating condition. The function and location of our owned or leased production properties is presented in the table below:

Location

Function

Leased/Owned

United States

Philadelphia, Pennsylvania

Corporate Headquarters

Leased

Bessemer City, North Carolina

Manufacturing and Research

Owned

Charlotte, North Carolina

Sales and Administrative

Leased

South America

Fénix, Argentina

Lithium Extraction and Manufacturing

Owned

Guemes, Argentina

Manufacturing

Owned

Catamarca, Argentina

Administrative

Leased

Salta, Argentina

Administrative

Owned

Pocitos, Salta, Argentina

Transfer Station

Land use right so long as we have our mining concession

Europe

Bromborough, United Kingdom

Manufacturing and Sales

Leased

Asia Pacific

Zhangjiagang, China

Manufacturing

Land use right, building owned

Shanghai, China

Sales and Administrative

Leased

Tokyo, Japan

Sales

Leased

Seoul, South Korea

Sales

Leased

Patancheru, India

Manufacturing

Leased

Singapore

Operations and Administrative

Leased

ITEM 3. LEGAL PROCEEDINGS

See Note 2 “Principal Accounting Policies and Related Financial Information" - Environmental obligations, Note 9 “Environmental Obligations” and Note 16 “Commitments and Contingencies” in the notes to our consolidated financial statements included in this Form 10-K, the content of which are incorporated by reference to this Item 3.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

Table of Contents

ITEM 4A. EXECUTIVE OFFICERS OF THE REGISTRANT

The executive officers of Livent Corporation, the offices they currently hold, their business experience and their ages as of December 31, 2021, are as follows:

Name

Age on
12/31/2021

Office, year of election and other

information

Paul W. Graves

President, Chief Executive Officer and Director (May 2018-Present); Executive Vice President and Chief Financial Officer, FMC (12-18); Managing Director, Goldman Sachs Group (06-12)

Gilberto Antoniazzi

Vice President and Chief Financial Officer (May 2018-Present); Chief Financial Officer, FMC's Agricultural Solutions business segment (13-18); Chief Financial Officer, FMC's Latin America Region (04-13)

Sara Ponessa

Vice President, General Counsel and Secretary (May 2018-Present); Senior Business Counsel, FMC's Lithium business segment (14-18); Business Counsel, FMC's Alkali Chemicals division (12-14); Vice President and Risk Management and Compliance Section Manager, Wilmington Trust Company (06-12)

All officers are elected to hold office for one year or until their successors are elected and qualified. No family relationships exist among any of the above-listed officers, and there are no arrangements or understandings between any of the above-listed officers and any other person pursuant to which they serve as an officer. The above-listed officers have not been involved in any legal proceedings during the past ten years of a nature for which the SEC requires disclosure that are material to an evaluation of the ability or integrity of any such officer.

The Table below provides certain highlights of the diversity characteristics of the executive officers:


Executive Officer Diversity (1)
Gender	Male	Female
Number of executive officers based on gender identity	2	1
Number of executive officers who identify in any of the categories below:



Hispanic or Latinx	1	1

White	1	—

National Origin:
United Kingdom	1	—
Brazil	1	—
U.S. (Puerto Rico)	—	1

________________________________

1.The Company has no executive officers who identify in any of the following categories: (i) African American or Black, (ii) Alaskan Native or American Indian, (iii) Asian, (iv) Native Hawaiian or Pacific Islander, (v) two or more races or ethnicities. The Company has no executive officers based on gender identity of the following categories: (i) Non-Binary and (ii) Gender Undisclosed; nor do any of the Company's executive officers identify as LGBTQ+.

Table of Contents

PART II

ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Livent common stock of $0.001 par value is traded on the New York Stock Exchange (Symbol: LTHM). As of February 25, 2022, we had 2,283 holders of record of our common stock and approximately 117,293 beneficial holders of our common stock.

Our Board of Directors has not declared any quarterly dividends as of December 31, 2021 and does not expect to pay any dividends in the foreseeable future. Any future payment of dividends will depend on our financial condition, results of operations, conditions in the financial markets and such other factors as are deemed relevant by our Board of Directors.

Stockholder Return Performance Presentation

The graph that follows shall not be deemed to be incorporated by reference into any filing made by Livent under the Securities Act or the Exchange Act.

The following Stockholder Performance Graph compares the cumulative total return on Livent’s common stock with the S&P 500 Index and the S&P 500 Chemicals Index for the period following the IPO through December 31, 2021. The comparison assumes $100 was invested on October 12, 2018, in Livent’s common stock and in both of the indices, and the reinvestment of all dividends.

Repurchases of Common Shares

A summary of our repurchases of Livent's common stock for the three months ended December 31, 2021 is as follows:


ISSUER PURCHASES OF EQUITY SECURITIES

Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)		Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs (2)
October 1 through October 31, 2021	166	$	25.68	$	—	$	—
November 1 through November 30, 2021	148	$	30.17	—		—
December 1 through December 31, 2021	173	$	25.78	—		—
Total Q4 2021	487	$	27.08	$	—	$	—

1.The trustee of the Livent NQSP deferred compensation plan reacquires Livent common stock shares from time to time through open-market purchases relating to investments by employees in our common stock, one of the investment options available under the Livent NQSP. Such shares are held in a trust fund and recorded to Treasury stock in our consolidated balance sheets.

2.We have no publicly announced repurchase programs.

ITEM 6. [RESERVED]

Table of Contents

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis in conjunction with our financial statements and the related notes included elsewhere in this Form 10-K. This discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth under “Risk Factors” and elsewhere in this Form 10-K.

OVERVIEW

We are a pure-play, fully integrated lithium company, with a long, proven history of producing performance lithium compounds. Our primary products, namely battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal are critical inputs used in various performance applications. Our strategy is to focus on supplying high performance lithium compounds to the rapidly growing EV and broader energy storage battery markets, while continuing to maintain our position as a leading global producer of butyllithium and high purity lithium metal. With extensive global capabilities, approximately 80 years of continuous production experience, applications and technical expertise and deep customer relationships, we believe we are well positioned to capitalize on the accelerating trend of electrification.

We produce lithium compounds for use in applications that have specific and constantly changing performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries. We believe the demand for our compounds will continue to grow as the electrification of transportation accelerates, and as the use of high nickel content cathode materials increases in the next generation of battery technology products. We also supply butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. It is in these applications that we have established a differentiated position in the market through our ability to consistently produce and deliver performance lithium compounds.

2021 Highlights

The following are the more significant developments in our business during the year ended December 31, 2021:

•Revenue of $420.4 million in 2021 increased $132.2 million versus 2020 primarily due to higher sales volumes driven by an increase in customer demand and higher pricing.

•Gross margin of $88.4 million in 2021 increased $51.6 million versus 2020 primarily due to higher sales volumes and higher pricing, partially offset by COVID-19 costs to implement safety protocols and higher logistics, raw material and other operating costs.

•Net income of $0.6 million in 2021 compared to net loss of $16.3 million for 2020 was primarily due to higher sales volumes, higher pricing and lower Restructuring and other charges, offset by an increase in the Argentina tax expense from inflationary tax adjustments, incremental COVID-19 costs to implement safety protocols, higher logistics, raw material and other operating costs and $5.5 million Equity in net loss of unconsolidated affiliates.

•Adjusted EBITDA of $69.5 million for 2021 increased $47.2 million compared to the 2020 amount of $22.3 million primarily due to higher sales volumes and higher pricing, partially offset by higher logistics, raw material and other operating costs.

Completion of Public Offering of Our Common Stock

On June 15, 2021, the Company closed on the issuance of 14,950,000 shares of its common stock, par value $0.001 per share, at a public offering price of $17.50 per share, in an underwritten public offering (the "Offering"). Total net proceeds from the Offering, were $252.2 million after deducting the underwriters’ fees and offering expenses payable by the Company of $9.4 million. We intend to use the net proceeds of the Offering primarily for growth capital expenditures, including lithium capacity expansion, and for general corporate purposes. In June 2021, we used a portion of the proceeds to repay all amounts outstanding under our Revolving Credit Facility.

COVID-19 Impacts

Business and Operations

During the year ended December 31, 2021, the COVID-19 pandemic continued to negatively impact our business, operations and financial performance. We still face operational challenges and uncertainties. The disruptions and duration may be impacted by the actions that governments, businesses and individuals take in relation to the COVID-19 pandemic, new variants

Table of Contents

of the virus, vaccine safety concerns, vaccine resistance, vaccine availability, delays in vaccine distribution and the willingness of individuals to be vaccinated.

Each country where we operate has adopted measures to contain COVID-19, and each may adopt different and/or stricter measures in the future. The government of Argentina, where the Company’s primary lithium brine resource is located, has enacted numerous emergency measures to stem the spread of COVID-19 and may enact new ones. We expect government measures and restrictions globally to continue to have a negative impact on demand for certain of our products and a negative impact on the efficient operation of our facilities, supply chains and logistics. Disruptions and delays within our supply chain and logistics operations included problems and congestion at ports, difficulties with scheduling cargo ships, higher shipment and freight costs, additional warehouse costs due to shipment delays, lack of driver availability and fewer transportation options, and the restriction of movements by trucks within and between countries. The severity of these problems and issues has varied in different geographic locations over the course of the COVID-19 pandemic and continues to remain a challenge in all of the countries where we operate.

Customer demand for certain types of our products improved during 2021. However, customers continue to protect their interests by diversifying among multiple suppliers. They continue to actively manage their own inventory levels in the current uncertain market environment. In addition, customers in the fast-growing EV manufacturing industry are currently experiencing their own supply chain challenges, including semiconductors shortages, congestion at ports, and rolling electricity blackouts in China. The semiconductor chip shortage is expected to continue. This, and similar supply chain disruptions experienced by our customers, could cause delays in their demand for our high performance lithium compounds, further adversely impacting our business and growth plans.

The continuing spread and effects of COVID-19, including health and safety protocols and supply and logistics disruptions in China and elsewhere, are impacting our expansion work in Argentina and the U.S. There can be no assurance that such impacts will not turn into long-term or continuing delays, cause us to decide to suspend our capital expansion work, or otherwise negatively impact our capital expansion. Any significant delay in our capital expansion work in Argentina or the U.S. could have a material adverse effect on our business, financial condition and results of operations. In addition to delays, there have been increased costs due to less availability of materials for construction.

We have not faced any material issues with employee morale or attrition. Likewise, we have not faced any material issues with our ability to recruit new employees or in talent management of existing employees. However, certain of our employees may resign, and we may be unable to attract certain talent, if we were to impose any vaccine mandate. Broadly, we are observing tightness in the local labor markets where we operate in both the U.S. and Argentina (e.g., fewer applicants and higher wages). This may impact us and our expansion efforts, our customers and suppliers in the future.

The material operational challenges that management and our Board of Directors are monitoring are the health and safety of our employees, vaccine availability and distribution, travel restrictions, COVID-19 mitigation measures, the relaxation of work from home requirements, the restriction of movements within and between countries, and supply chain and logistics issues. Furthermore, our Board of Directors is monitoring the additional expected and unexpected impacts that COVID-19 is having on the economies in the countries where we operate, such as Argentina where inflation remains high and economic instability persists, and China where economic growth has led to shortages of electricity and temporary shutdowns of third party providers to the Company.

Liquidity and Financial Resources

Our uses of cash were impacted by the effects of COVID-19 in 2021. We continue to face logistical supply disruptions, such as higher truck, freight and sea shipping costs, along with the need to use air freight from time to time. We expect this to continue. We also continue to use cash to purchase additional COVID-19 testing, personal protective equipment for our employees, such as masks and gloves, and for increased cleaning and disinfectant costs, additional medical personnel at our facilities, and increased personnel transportation costs due to social distancing guidelines.

Corporate Efforts

We continue to maintain a Global Pandemic Response Team, regional COVID-19 Response Teams, and a Vaccine subcommittee. The Vaccine subcommittee is tasked with monitoring vaccine developments and encouraging our employees to be vaccinated. Our regional COVID-19 Response Teams continue to keep Executive Leadership informed of local matters such as government policies and regulations. Our Enterprise Risk Management processes have worked as designed.

We continue to identify potential new suppliers and logistics providers for our operations as supply chain challenges continue. This includes potential new suppliers of chemicals and packaging, and air freight companies when required. We have altered global production schedules to meet changes in customer demand, supply and logistics challenges. Future efforts will continue along these lines and be dictated by the particulars of the COVID-19 pandemic. We continue to plan for a relaxation of

Table of Contents

COVID-19 protocols, more business travel and in-person customer contacts and hybrid work arrangements if and when COVID-19 becomes endemic.

Health & Safety

We continue to protect the health and well-being of our employees, customers and other key stakeholders in accordance with changing circumstances and local conditions. Our plant personnel continue to remain on the job at their respective facilities. We instituted safety procedures to protect the health of these plant personnel based upon local guidance. This can include pre-entry screening, the use of masks and gloves, social distancing measures, and quarantine of close contacts with suspected or confirmed COVID-19 cases. Our non-plant personnel are returning to their offices where permitted by circumstances. Business travel is slowly resuming when permitted, but is still substantially lower than pre-pandemic levels. Communications relating to all of these policies and COVID-19 preventative measures are regularly distributed to our employees, as there can be significant variation with respect to the COVID-19 pandemic situation in different geographic regions at any one time.

We base our health and safety protocols on the advice provided by the White House, the Centers for Disease Control and Prevention, the World Health Organization, and the local government authorities in the countries and regions where we operate.

In the U.S., we are providing paid sick leave for qualified absences due to COVID-19. In other geographic locations, we are providing our customary local sick leave benefits and any other leave and benefits that may be required by local governmental authorities. We have not experienced any material employee absences as a result of COVID-19. However, social distancing measures and other health and safety protocols have led to reduced workforce numbers in certain locations, such as with our expansion project in Argentina. If a significant number of our employees at any one location were to require leave as a result of COVID-19, this could pose a risk to the continued operation of the particular facility and could potentially disrupt our broader operations.

Government Programs.

We continue to evaluate government support and tax relief programs in the countries where we operate. This includes support grants, loans, tax deferrals, and tax credits.

Overall, the impact of the COVID-19 pandemic is fluid and continues to evolve, and therefore, we cannot predict the extent to which our business, results of operations, financial condition or liquidity will ultimately be impacted.

2022 Outlook

We expect flat volumes and significantly higher average pricing across our lithium products in 2022, resulting in higher profitability versus the prior year. We also expect higher costs versus the prior year, primarily related to logistics, raw materials and general inflationary pressures.

Table of Contents

In this section, we discuss the results of our operations for the year ended December 31, 2021 compared to the year ended December 31, 2020. For a discussion of the year ended December 31, 2020 compared to the year ended December 31, 2019, please refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2020.

Results of Operations — Years Ended December 31, 2021 and 2020


(in Millions)	Year Ended December 31,
	2021		2020
Revenue	$	420.4	$	288.2
Costs and expenses:
Costs of sales	332.0		251.4
Gross margin	88.4		36.8
Selling, general and administrative expenses	49.9		44.6
Research and development expenses	3.0		3.7
Restructuring and other charges	3.8		10.7
Separation-related costs/(income)	2.0		(1.1)
Total costs and expenses	390.7		309.3
Income/(loss) from operations before loss on debt extinguishment, equity in net loss of unconsolidated affiliates and interest expense, net	29.7		(21.1)
Loss on debt extinguishment	—		0.1
Equity in net loss of unconsolidated affiliates	5.5		0.5



Interest expense, net	0.3		0.3
Income/(loss) from operations before income taxes	23.9		(22.0)
Income tax expense/(benefit)	23.3		(5.7)


Net income/(loss)	$	0.6	$	(16.3)

In addition to net income/(loss), as determined in accordance with U.S. GAAP, we evaluate operating performance using certain Non-GAAP measures such as EBITDA, which we define as net income plus interest expense, net, income tax expense/(benefit), and depreciation and amortization, and Adjusted EBITDA, which we define as EBITDA adjusted for Argentina remeasurement losses, restructuring and other charges, separation-related costs/(income), COVID-19 related costs and other loss/(gain). Management believes the use of these Non-GAAP measures allows management and investors to compare more easily the financial performance of its underlying business from period to period. The Non-GAAP information provided may not be comparable to similar measures disclosed by other companies because of differing methods used by other companies in calculating EBITDA and Adjusted EBITDA. These measures should not be considered as a substitute for net income/(loss) or other measures of performance or liquidity reported in accordance with U.S. GAAP. The following table reconciles EBITDA and Adjusted EBITDA from net income/(loss).

Table of Contents


(in Millions)	Year Ended December 31,
	2021		2020
Net income/(loss)	$	0.6	$	(16.3)
Add back:
Income tax expense/(benefit)	23.3		(5.7)
Interest expense, net	0.3		0.3
Depreciation and amortization	25.1		25.0
EBITDA (Non-GAAP)	49.3		3.3
Add back:
Argentina remeasurement losses (a)	5.3		6.6
Restructuring and other charges (b)	3.8		10.7
Separation-related costs/(income) (c)	2.0		(1.1)
COVID-19 related costs (d)	5.2		3.2
Loss on debt extinguishment (e)	—		0.1
Other loss/(gain) (f)	3.9		(0.5)
Adjusted EBITDA (Non-GAAP)	$	69.5	$	22.3

____________________

a.Represents impact of currency fluctuations on tax assets and liabilities and on long-term monetary assets associated with our capital expansion as well as significant currency devaluations. The remeasurement losses are included within "Cost of sales" in our consolidated statement of operations but are excluded from our calculation of Adjusted EBITDA because of: i.) their nature as income tax related; ii.) their association with long-term capital projects which will not be operational until future periods; or iii.) the severity of the devaluations and their immediate impact on our operations in the country.

b.We continually perform strategic reviews and assess the return on our business. This sometimes results in management changes or in a plan to restructure the operations of our business. As part of these restructuring plans, demolition costs and write-downs of long-lived assets may occur. 2021 Restructuring and other charges consisted primarily of environmental remediation, transaction related legal fees and miscellaneous nonrecurring costs. 2020 consists of severance-related costs related to management changes, exit costs, and legal fees related to IPO securities litigation, including a settlement accrual, net of insurance reimbursement, of $2.0 million as of December 31, 2020. The IPO litigation settlement was finalized in the second quarter of 2021.

c.Represents legal and professional fees and other separation-related activity.

d.Represents incremental costs associated with the COVID-19 pandemic recorded in "Cost of sales" in the consolidated statement of operations, including but not limited to, incremental quarantine related absenteeism, incremental facility cleaning costs, COVID-19 testing, pandemic related supplies and personal protective equipment for employees, among other costs; offset by economic relief provided by foreign governments.

e.Represents the partial write off of deferred financing costs for the temporary reduction in borrowing capacity of the Revolving Credit Facility excluded from our calculation of Adjusted EBITDA because the loss is nonrecurring.

f.2021 represents our 25% interest in transaction costs incurred for the Nemaska Transaction, certain project-related costs and interest expense, all included in Equity in net loss of unconsolidated affiliates in our consolidated statement of operations. 2020 represents a portion of our nonrefundable prepaid research and development costs advanced to our unconsolidated affiliate in the fourth quarter 2019 and excluded from our calculation of Adjusted EBITDA in the same period because the costs represent research and development activities of the affiliate that had not occurred as of December 31, 2019. These costs were included with our calculation of Adjusted EBITDA in 2020 when the costs were incurred at our unconsolidated affiliate.

Year Ended December 31, 2021 compared with Year Ended December 31, 2020

Revenue

Revenue of $420.4 million for 2021 increased by approximately 46%, or $132.2 million, versus $288.2 million for 2020 primarily due to higher volumes, driven by an increase in customer demand and higher pricing.

Gross Margin

Gross margin of $88.4 million for 2021 increased by $51.6 million, or approximately 140%, versus $36.8 million for 2020. The increase in gross margin was primarily due to sales volumes and higher pricing, partially offset by COVID-19 costs to implement safety protocols and higher logistics, raw material and other operating costs.

Table of Contents

Selling, general and administrative expenses

Selling, general and administrative expenses of $49.9 million for 2021 increased by $5.3 million, or approximately 12% versus $44.6 million in 2020. The increase in selling, general and administrative expenses was primarily due to an increase in employee compensation.

Restructuring and other charges

Restructuring and other charges of $3.8 million for 2021 decreased by $6.9 million or approximately 64% versus $10.7 million for 2020. Restructuring and other charges for 2020 consisted of severance-related costs for management changes at certain operating and administrative facilities, exit costs of $1.6 million for the closing of leased office space and legal fees related to IPO securities litigation, including a settlement accrual, net of insurance reimbursement, of $2.0 million as of December 31, 2020. The IPO litigation settlement was finalized in the second quarter of 2021. 2021 Restructuring and other charges consisted primarily of environmental remediation, transaction related legal fees and miscellaneous nonrecurring costs. See Note 8 to our consolidated financial statements of this Form 10-K for details.

Equity in net loss of unconsolidated affiliates

Equity in net loss of unconsolidated affiliates of $5.5 million for 2021 arises out of our 25% interest in the Nemaska Project and includes $1.6 million of nonrecurring transaction costs incurred for the Nemaska Transaction by an unconsolidated affiliate.

Interest expense

Interest expense of $0.3 million for 2021 and 2020 is noncash amortization of transaction costs related to the 2025 Notes which represents the excess interest over the amount of interest capitalized in accordance with U.S. GAAP for 2021. Interest expense of $15.4 million and $12.0 million was capitalized in 2021 and 2020, respectively.

Income tax expense/(benefit)

The increase in income tax expense to $23.3 million for 2021 compared to the income tax benefit of $(5.7) million for 2020 was primarily due to the fluctuations in foreign currency impacts in Argentina of $15.5 million and $(10.0) million for 2021 and 2020, respectively. Within foreign currency impacts, Argentina tax law annually requires an increase to taxable income for inflationary adjustments in the period when the consumer price index fluctuates over a specific threshold, which for 2021 was met in the third quarter of 2021. Additionally, the increase in tax expense was due to income/(loss) from operations of $23.9 million and $(22.0) million for 2021 and 2020, respectively. The increase in income tax expense was partially offset by an Argentina income tax law, which was amended on June 16, 2021 to introduce new progressive corporate income tax rates from 25% to 35%. This change resulted in a tax benefit of $(2.2) million for the revaluation of Argentina net deferred tax assets for the twelve months ended December 31, 2021.

Net income/(loss)

Net income of $0.6 million for 2021 compared to net loss of $16.3 million for 2020 was primarily due to higher sales volumes, higher pricing and lower Restructuring and other charges, offset by an increase in income tax expense, COVID-19 costs to implement safety protocols, higher logistics, raw material and other operating costs and $5.5 million Equity in net loss of unconsolidated affiliate.

Table of Contents

Liquidity and Capital Resources

Our prospective success in funding our cash needs will depend on the strength of the lithium market and our continued ability to generate cash from operations and raise capital from other sources. Our primary sources of cash are currently generated from operations and borrowings under our revolving credit facility.

Cash and cash equivalents as of December 31, 2021 and 2020, were $113.0 million and $11.6 million, respectively. Of the cash and cash equivalents balance as of December 31, 2021 and 2020, $26.9 million and $10.6 million was held by our foreign subsidiaries, respectively. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries’ operating activities and future foreign investments. We have not provided additional income taxes for any additional outside basis differences inherent in our investments in subsidiaries because the investments are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal. See Note 11 to the consolidated financial statements included within this Form 10-K for more information.

2025 Notes

In 2020, we issued $245.8 million in aggregate principal amount of 4.125% Convertible Senior Notes due 2025. Total net proceeds received were $238.2 million. The Company used the net proceeds received to repay amounts outstanding under its Revolving Credit Facility. The 2025 Notes were issued under the International Capital Market Association's Green Bond framework and followed the Green Bond Principles. See Note 11 to the consolidated financial statements included within this Form 10-K for more details on the 2025 Notes.

Revolving Credit Facility

The Credit Agreement provides for a $400 million senior secured revolving credit facility, $50 million of which is available for the issuance of letters of credit, with an option, subject to certain conditions and limitations, to increase the aggregate amount of the revolving credit commitments to $600 million (the “Revolving Credit Facility”). The issuance of letters of credit and the proceeds of revolving credit loans made pursuant to the Revolving Credit Facility are available, and will be used, for general corporate purposes, including capital expenditures and permitted acquisitions. See Note 11 to the consolidated financial statements included within this Form 10-K for more information.

We had $245.8 million and $281.4 million debt outstanding as of December 31, 2021 and 2020, respectively. Our December 31, 2021 debt outstanding was comprised solely of our 2025 Notes because in June 2021 we used a portion of the net proceeds from the Offering to repay all amounts outstanding under our Revolving Credit Facility. The Credit Agreement contains certain affirmative and negative covenants that are binding on the Borrowers and their subsidiaries, including, among others, restrictions (subject to exceptions and qualifications) on the ability of the Borrowers and their subsidiaries to create liens, to undertake fundamental changes, to incur debt, to sell or dispose of assets, to make investments, to make restricted payments such as dividends, distributions or equity repurchases, to change the nature of their businesses, to enter into transactions with affiliates and to enter into certain burdensome agreements. Among other restrictions, our Revolving Credit Facility contains financial covenants applicable to Livent and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our maximum allowable first lien leverage ratio is 3.5 as of December 31, 2021. Our minimum allowable interest coverage ratio is 3.5. We were in compliance with all covenants at December 31, 2021.

Statement of Cash Flows

Cash provided by operating activities was $26.4 million and $6.3 million for the years ended December 31, 2021 and 2020, respectively.

The increase in cash provided by operating activities for 2021 compared to 2020 was primarily driven by higher net income and a decrease in payments of accounts payables in 2021 compared to 2020, partially offset by an increase in trade receivables and inventories in 2021 compared to 2020.

Cash used in investing activities was $143.3 million and $131.1 million for the years ended December 31, 2021 and 2020, respectively.

The increase in cash used in investing activities for 2021 compared to 2020 is primarily due to the Company's election to suspend all capital expansion work globally in March 2020 to the second quarter of 2021. The time lag of slowing down and subsequently ramping back up capital spending ended in the third quarter of 2021 and resulted in a significant increase in capital expenditures for capacity expansion of lithium carbonate and hydroxide during the fourth quarter of 2021.

Cash provided by financing activities was $218.0 million and $119.1 million for the years ended December 31, 2021 and 2020, respectively.

Table of Contents

The increase in cash provided by financing activities for 2021 compared to 2020 is primarily due to the net proceeds received from the Offering of $252.2 million in the second quarter of 2021, partially offset by the repayment of the Revolving Credit Facility in the same period.

Other potential liquidity needs

We plan to meet our liquidity needs through available cash, cash generated from operations, borrowings under the committed Revolving Credit Facility, and other potential working capital financing strategies that may be available to us. As of December 31, 2021, our remaining borrowing capacity under our Revolving Credit Facility, subject to meeting our debt covenants, was $385.5 million, including letters of credit utilization.

We expect the COVID-19 pandemic uncertainties, and the resulting lithium market challenges to continue in 2022. Our net leverage ratio is determined, in large part, by our ability to manage the timing and amount of our capital expenditures, which is within our control. It is also determined by our ability to achieve forecasted operating results and to pursue other working capital financing strategies that may be available to us, which is less certain and outside our control. In the first quarter of 2020, because of the significant practical constraints resulting from actions being taken by authorities around the word in response to the COVID-19 pandemic, the Company elected to suspend all capital expansion work globally. As of the second quarter of 2021, Livent resumed its capital expansion work in Argentina and the U.S. Based on this resumption, the Company estimates 2022 total capital spending to be in the range of $280 million to $320 million.

The company remains focused on maintaining its financial flexibility and will continue to manage its cash flow and capital allocation decisions to navigate through this challenging environment.

We believe that our available cash and cash from operations, together with our borrowing availability under the Revolving Credit Facility and other potential financing strategies that may be available to us, will provide adequate liquidity for the next 12 months. Access to capital and the availability of financing on acceptable terms in the future will be affected by many factors, including our credit rating, economic conditions, the COVID-19 pandemic and the overall liquidity of capital markets and cannot be guaranteed.

Contractual Obligations and Commercial Commitments

As of December 31, 2021, we have significant committed contracts that we believe will affect cash over the next three years. These contracts represent certain of our raw material commercial contract purchase obligations that are enforceable and legally binding requirements contracts with specified quantities, pricing and timing of transactions. Expected cash payments for such purchase obligations are $3.5 million in 2022, $4.9 million in 2023 and $2.8 million for 2024.

Climate Change

The potential physical impacts of climate change on our operations are highly uncertain, and are specific to the geographic circumstances of areas in which we operate. These may include changes in rainfall and storm patterns and intensities, droughts and water shortages, changing sea levels and changing temperatures, and an increase in the number and severity of weather events and natural disasters. These changes may have a material adverse effect on our operations, including lithium extraction and production processes, as well as transportation of raw materials and delivery of products to customers. We may also face more stringent customer and regulatory requirements to accelerate the pace of our GHG and water use reduction initiatives, including achievement of our 2040 net zero target, more reliance on renewable energy sources and more water re-use and re-cycling. Climate change may also exacerbate socio-economic and political issues around the world and have other direct impacts to ecosystems, human health and quality of life, ranging from destruction of habitats to air, water and land quality to growing incidences of famines, pandemics and population shifts.

In addition, a number of governmental bodies have introduced or are contemplating legislative and regulatory change in response to the potential impacts of climate change. Such legislation or regulation, if enacted, potentially could include provisions for a “cap and trade” system of allowances and credits or a carbon tax, among other provisions. There is also a potential for climate change legislation and regulation to adversely impact the cost of purchased energy and electricity.

The growing concerns about climate change and related increasingly stringent regulations may provide Livent with new or expanded business opportunities. Livent’s technologies and applications contribute to the efforts of our customers to revolutionize their product lines and markets. As a key part of the EV and battery supply chain, we provide lithium products that help enable the growth of electric transportation and the shift away from fossil fuels. As demand for, and legislation mandating or incentivizing the use of, alternative fuel technologies that limit or eliminate greenhouse gas emissions increases, we will continue to monitor the market and offer solutions where we have appropriate technology.

In 2020, Livent began the voluntary process of implementing the framework established by the Task Force for Climate-Related Financial Disclosures ("TCFD") to assess, disclose and plan for the company’s risks and opportunities related to climate change. As part of this process, we will evaluate various climate-related scenarios and business models in a net zero economy.

Table of Contents

More information on TCFD will be provided in our future Sustainability Reports and other disclosures. Nothing in any of our Sustainability Reports, or sections thereof, shall be deemed incorporated by reference into this Form 10-K.

Recently Issued and Adopted Accounting Pronouncements and Regulatory Items

See Note 3 "Recently Issued and Adopted Accounting Pronouncements and Regulatory Items" to our consolidated financial statements included in this Form 10-K.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Critical Accounting Estimates

Our consolidated financial statements are prepared in conformity with U.S. GAAP. The preparation of these financial statements requires management to make judgments, assumptions and estimates that affect the reported amounts of assets, liabilities, revenues and expenses and that have or could have a material impact on our financial condition and results of operations. We have described our accounting policies in Note 2 "Principal Accounting Policies and Related Financial Information" to our consolidated financial statements included in this Form 10-K. The SEC has defined critical accounting estimates as those estimates made in accordance with U.S. GAAP that involve a significant level of measurement uncertainty and have had or are reasonably likely to have a material impact on the financial condition or operating performance of a company. We have reviewed these accounting estimates, identifying those that we believe contain matters that are inherently uncertain, have significant levels of subjectivity and complex judgments and are critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting estimates with the Audit Committee of the Board of Directors. Critical accounting estimates are central to our presentation of results of operations and financial condition in accordance with U.S. GAAP and require management to make judgments, assumptions and estimates on certain matters. We base our estimates, assumptions and judgments on historical experience, current conditions and other reasonable factors.

Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. The estimates used for, but not limited to, revenue recognition and the collectability of trade receivables, impairment and valuation of long-lived assets, and income taxes could be impacted. We have assessed the impact and are not aware of any specific events or circumstances that required an update to our estimates and assumptions or materially affected the carrying value of our assets or liabilities as of the date of issuance of this Form 10-K. These estimates may change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.

Revenue recognition

Sale of Goods

Revenue from product sales is recognized when we transfer control of the promised goods to a customer. We determine when the control of goods is transferred typically by assessing, among other things, the transfer of title and risk and the shipping terms of the contract. Judgment is sometimes required when assessing specific customer facts and circumstances surrounding transfer of control.

Variable Consideration

As a part of our customary business practice, we may offer sales incentives to our customers, such as volume discounts or rebates. Variable consideration given can differ by product. For all such contracts that include any variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Although determining the transaction price requires significant judgment, we have significant historical experience with incentives provided to customers and estimating the expected consideration considering historical patterns of incentive payouts. These estimates are re-assessed each reporting period as required.

In addition to the variable consideration described above, in certain instances, we may require our customers to meet certain volume thresholds within their contract term. We estimate what amount of variable consideration should be included in the transaction price at contract inception and continually reassess this estimation each reporting period to determine situations when the minimum volume thresholds will not be met. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. In those circumstances, we apply the guidance on breakage and estimate the amount of the shortfall and recognize it over the remaining performance obligations in the contract.

Table of Contents

Right of Return

We warrant to our customers that our products conform to mutually agreed product specifications. This offering is accounted for as a right of return and the transaction price is adjusted for an estimate of expected returns.

Trade and other receivables

The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we consider general factors such as historical experience, current collection trends and external economic and political factors as well as specific customer circumstances where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions. One of our subsidiaries that conducts business within Argentina has outstanding receivables due from the Argentina government, which primarily represent export tax and export rebate receivables. As with all outstanding receivable balances, we continually review recoverability by analyzing historical experience, current collection trends and regional business and political factors among other factors.

Impairments and valuation of long-lived assets

Our long-lived assets primarily include property, plant and equipment and intangible assets. The Company has no goodwill or indefinite-lived intangible assets as of December 31, 2021. We periodically evaluate whether events or circumstances indicate that the net book value of our property, plant and equipment may not be recoverable (“triggering events”). We exercise significant judgment in performing this evaluation, considering factors such as general market outlooks, company-specific historical results as well as future forecasts for production, operating income and cash flows. No triggering events occurred during 2021.

Income taxes

Our annual tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgements and assumptions regarding the recoverability of certain deferred tax balances, primarily net operating loss and other carryforwards, and our ability to uphold certain tax positions. We have recorded a valuation allowance to reduce deferred tax assets in certain jurisdictions to the amount that we believe is more likely than not to be realized. In assessing the need for this allowance, we have considered a number of factors including future taxable income, the jurisdictions in which such income is earned and our ongoing tax planning strategies. In the event that we determine that we would not be able to realize all or part of our net deferred tax assets in the future, an adjustment to the deferred tax assets would be charged to income in the period such determination was made. Similarly, should we conclude that we would be able to realize certain deferred tax assets in the future in excess of the net recorded amount, an adjustment to the deferred tax assets would increase income in the period such determination was made.

Additionally, we filed income tax returns in the U.S. and various state and foreign jurisdictions, as part of a FMC legal entity for the period ended February 28, 2019. Certain income tax returns for FMC entities taxable in the U.S. and significant foreign jurisdictions are open for examination and adjustment. We assess our income tax positions and record a liability for all years open to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where it is more likely than not that a tax benefit will be sustained, we have recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. The evaluation of the Company's uncertain tax positions involves significant judgment in the interpretation and application of U.S. GAAP and complex domestic and international tax laws. Although management believes the Company's uncertain tax positions are reasonable, no assurance can be given that these matters will not be subject to successful challenge by the applicable taxing authority and the final tax outcome will not be different from that which is reflected in the Company's reserves.

Because there are a number of estimates and assumptions inherent in calculating the various components of our tax provision, certain changes or future events such as changes in tax legislation, geographic mix of earnings and completion of tax audits could have an impact on those estimates, our effective tax rate and financial results.

See Note 10 to our consolidated financial statements included in this Form 10-K for additional discussion surrounding income taxes.

Table of Contents

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our earnings, cash flows and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

As of December 31, 2021, our net financial instrument position was a net asset of $0.2 million. As of December 31, 2020, we had no open derivative cash flow hedge contracts. Livent's 2022 hedge plan will be executed in the first quarter of 2022 when management's projections are approved.

Foreign Currency Exchange Rate Risk

Our worldwide operations expose us to currency risk from sales, purchases, expenses and intercompany loans denominated in currencies other than the U.S. dollar, our functional currency. The primary currencies for which we have exchange rate exposure are the Euro, the British pound, the Chinese yuan, the Argentine peso and the Japanese yen. Foreign currency debt and foreign exchange forward contracts are used where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows. We currently do not hedge foreign currency risks associated with the Argentine peso due to the limited availability and the high cost of suitable derivative instruments.

To analyze the effects of changing foreign currency rates, we perform a sensitivity analysis in which we assume an instantaneous 10% change in the foreign currency exchange rates from their levels at December 31, 2021 with all other variables (including interest rates) held constant. As of December 31, 2020, we had no open derivative cash flow hedge contracts.


			Hedged Currency vs. Functional Currency
(in Millions)	Net asset position on consolidated balance sheets		Net liability position with 10% strengthening		Net asset position with 10% weakening
Net asset/(liability) position as of December 31, 2021	$	0.2	$	(2.0)	$	1.6

Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of December 31, 2021 and 2020, we had no interest rate swap agreements.

Our debt portfolio at December 31, 2021 is composed of fixed-rate and variable-rate debt; consisting of borrowings under our 2025 Notes and Revolving Credit Facility. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways. As of December 31, 2021, we had no outstanding balances under the Revolving Credit Facility.

Based on the variable-rate debt in our debt portfolio at December 31, 2021, a one percentage point increase or decrease in interest rates would have increased or decreased, respectively, gross interest expense by $0.2 million for the year ended December 31, 2021.

Table of Contents

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


			Page
Item 8 Financial Statements and Supplemental Data			52
Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019			53
Consolidated Statements of Comprehensive Income /(Loss) for the years ended December 31, 202 1 , 20 20 and 20 1 9			54
Consolidated Balance Sheets as of December 31, 202 1 and 20 20			55
Consolidated Statements of Cash Flows for the years ended December 31, 202 1 , 20 20 and 2 0 1 9			56
Consolidated Statements of Equity for the years ended December 31, 202 1 , 20 20 and 2 0 19			58
Notes to Consolidated Financial Statements			59
Report of Independent Registered Public Accounting Firm			88

Table of Contents

LIVENT CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS


(in Millions, Except Per Share Data)	Year Ended December 31,
	2021		2020 (1)		2019
Revenue	$	420.4	$	288.2	$	388.4
Costs and expenses:
Costs of sales	332.0		251.4		273.5
Gross margin	88.4		36.8		114.9
Selling, general and administrative expenses	49.9		44.6		40.5
Research and development expenses	3.0		3.7		3.3
Restructuring and other charges	3.8		10.7		6.2
Separation-related costs/(income)	2.0		(1.1)		6.3
Total costs and expenses	390.7		309.3		329.8
Income/(loss) from operations before loss on debt extinguishment, equity in net loss of unconsolidated affiliates, and interest expense, net	29.7		(21.1)		58.6
Loss on debt extinguishment	—		0.1		—
Equity in net loss of unconsolidated affiliates	5.5		0.5		0.8

Interest expense, net	0.3		0.3		—

Income/(loss) from operations before income taxes	23.9		(22.0)		57.8
Income tax expense/(benefit)	23.3		(5.7)		7.6


Net income/(loss)	$	0.6	$	(16.3)	$	50.2






Net income/(loss) per weighted average share - basic	$	—	$	(0.11)	$	0.34
Net income/(loss) per weighted average share - diluted	$	—	$	(0.11)	$	0.34
Weighted average common shares outstanding - basic	154.7		146.2		146.0
Weighted average common shares outstanding - diluted	184.3		146.2		146.4

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

LIVENT CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)


(in Millions)	Year Ended December 31,
	2021		2020 (1)		2019
Net income/(loss)	$	0.6	$	(16.3)	$	50.2
Other comprehensive income, net of tax:
Foreign currency adjustments:
Foreign currency translation gain/(loss) arising during the period	1.3		3.9		(0.3)

Total foreign currency translation adjustments	1.3		3.9		(0.3)
Derivative instruments:
Unrealized hedging gains, net of tax of zero	0.3		—		—
Reclassification of deferred hedging (gains)/losses included in net income, net of tax of $(0.1) (2)	(0.1)		—		1.2
Total derivative instruments, net of tax of zero, zero and $(0.1)	0.2		—		1.2




Other comprehensive income, net of tax	1.5		3.9		0.9
Comprehensive income/(loss)	$	2.1	$	(12.4)	$	51.1

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

2.For more detail on the components of these reclassifications and the affected line item in the consolidated statements of operations, see Note 13 within these consolidated financial statements.

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

LIVENT CORPORATION

CONSOLIDATED BALANCE SHEETS


	December 31,
(in Millions, Except Share and Par Value Data)	2021		2020 (1)
ASSETS
Current assets
Cash and cash equivalents	$	113.0	$	11.6
Trade receivables, net of allowance of approximately $0.3 in 2021 and $0.4 in 2020	96.4		76.3
Inventories, net	134.6		105.6
Prepaid and other current assets	55.3		56.3


Total current assets	399.3		249.8
Investments	27.2		23.8
Property, plant and equipment, net of accumulated depreciation of $243.0 in 2021 and $222.4 in 2020	677.9		545.3


Deferred income taxes	0.9		13.4
Right of use assets - operating leases, net	6.3		16.1
Other assets	90.9		88.4

Total assets	$	1,202.5	$	936.8
LIABILITIES AND EQUITY
Current liabilities

Accounts payable, trade and other	$	65.4	$	43.9

Accrued customer rebates	—		0.3
Accrued and other liabilities	61.8		36.7
Operating lease liabilities - current	1.1		1.4


Income taxes	3.0		—

Total current liabilities	131.3		82.3
Long-term debt	240.4		274.6

Operating lease liabilities - long-term	5.4		14.8
Environmental liabilities	5.6		6.1
Deferred income taxes	12.7		5.6

Other long-term liabilities	11.7		17.2
Commitments and contingent liabilities (Note 16)	—		—
Total current and long-term liabilities	407.1		400.6
Equity

Common stock; $0.001 par value; 2 billion shares authorized; 161,791,602 and 146,461,249 shares issued; 161,689,984 and 146,361,981 outstanding at December 31, 2021 and 2020, respectively	0.1		0.1

Capital in excess of par value of common stock	778.1		520.9
Retained earnings	60.9		60.3
Accumulated other comprehensive loss	(42.9)		(44.4)
Treasury stock, common, at cost; 101,618 and 99,268 shares at December 31, 2021 and 2020, respectively	(0.8)		(0.7)


Total equity	795.4		536.2
Total liabilities and equity	$	1,202.5	$	936.8

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

LIVENT CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS


(in Millions)	Year Ended December 31,
	2021		2020 (1)		2019
Cash provided by operating activities:


Net income/(loss)	$	0.6	$	(16.3)	$	50.2
Adjustments to reconcile net income/(loss) to cash provided by operating activities:
Depreciation and amortization	25.1		25.0		20.9

Restructuring and other (income)/charges	(1.5)		3.3		2.1
Separation-related (income)/charges	—		(0.3)		0.9
Deferred income taxes	12.5		(6.3)		(0.9)

Share-based compensation	5.3		4.1		4.3
Change in investments in trust fund securities	0.6		1.0		0.1
Equity in net loss of unconsolidated affiliates	5.5		0.5		—
Loss on debt extinguishment	—		0.1		—
Deferred financing fee amortization	0.3		0.7		—
Loss on asset disposal	0.5		0.6		—
Changes in operating assets and liabilities:
Trade receivables, net	(19.0)		15.3		51.4
Changes in deferred compensation	1.4		0.7		0.6
Inventories	(28.2)		10.1		(40.6)
Accounts payable, trade and other	20.9		(39.8)		10.8


Income taxes	3.0		(0.9)		(0.7)




Change in due to related party	—		—		(23.7)
Change in prepaid and other current assets and other assets	(3.7)		(9.9)		(2.7)
Change in accrued and other current and long-term liabilities	3.1		18.4		(14.6)
Cash provided by operating activities	$	26.4	$	6.3	$	58.1





Cash used in investing activities:
Capital expenditures (2)	(131.9)		(124.0)		(184.3)

Investments in Livent NQSP securities	(1.4)		(0.6)		(0.4)
Proceeds from settlement of long-term supply agreement	—		10.0		—
Investments in unconsolidated affiliate	(8.0)		(15.0)		(0.8)
Other investing activities	(2.0)		(1.5)		(4.5)
Cash used in investing activities	$	(143.3)	$	(131.1)	$	(190.0)




Cash provided by financing activities:


Proceeds from Revolving Credit Facility	39.5		175.5		232.0
Repayments of Revolving Credit Facility	(75.1)		(294.6)		(111.4)
Proceeds from 2025 Notes	—		245.8		—
Payments of financing fees	—		(8.4)		(0.1)
Proceeds from issuance of common stock - incentive plans	1.5		0.8		—
Payments of underwriting fees and expenses - Offering	(9.4)		—		—
Proceeds from Offering	261.6		—		—

Net purchases of treasury stock - Livent NQSP	(0.1)		—		—

Cash provided by financing activities	$	218.0	$	119.1	$	120.5
Effect of exchange rate changes on cash and cash equivalents	0.3		0.5		(0.1)
Increase/(decrease) in cash and cash equivalents	101.4		(5.2)		(11.5)
Cash and cash equivalents, beginning of period	11.6		16.8		28.3
Cash and cash equivalents, end of period	$	113.0	$	11.6	$	16.8

Table of Contents


	Year Ended December 31,
Supplemental disclosure for cash flow:	2021		2020		2019
Cash payments for income taxes, net of refunds (3)	$	4.1	$	2.6	$	38.5
Cash payments for interest (2)	$	13.3	$	5.6	$	4.3
Cash payments for Restructuring and other charges	$	5.3	$	7.4	$	4.1
Cash payments/(receipts) for Separation-related charges (4)	$	2.0	$	(0.8)	$	9.9
Accrued capital expenditures	$	32.5	$	15.1	$	34.0
Operating lease right-of-use assets and lease liabilities recorded for ASC 842	$	2.1	$	0.8	$	16.1
Accrued investment in unconsolidated affiliate	$	—	$	6.3	$	—

__________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

2.For the year ended December 31, 2021 and December 31, 2020 $15.4 million and $12.0 million of interest was capitalized, respectively. All of the interest related to our Revolving Credit Facility was capitalized for the year ended December 31, 2019.

3.The year ended December 31, 2021 includes $1.7 million of refunds relating to U.S. state taxes and foreign taxes. The year ended December 31, 2020 includes refunds of $1.6 million and $1.9 million from FMC related to the Company's 2019 and 2018 federal income tax returns, respectively.

4.The year ended December 31, 2020 includes $2.0 million gain on settlement of long-term supply agreement. The year ended December 31, 2019 includes $4.6 million paid to FMC related to the Separation steps.

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

LIVENT CORPORATION

CONSOLIDATED STATEMENTS OF EQUITY


(in Millions, Except Per Share Data)	Common Stock, 0.001 Per Share Par Value		Capital In Excess of Par		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total
Balance December 31, 2018	$	0.1	$	512.3	$	26.4	$	(49.2)	$	—	$	489.6
Net income	—		—		50.2		—		—		50.2
Stock compensation plans	—		5.7		—		—		—		5.7

Reclassification of deferred hedging losses, net of $0.1 income tax	—		—		—		1.2		—		1.2
Foreign currency translation adjustments	—		—		—		(0.3)		—		(0.3)
Separation related adjustments	—		(1.6)		—		—		—		(1.6)



Transfer in of treasury stock - Livent NQSP	—		—		—		—		(0.8)		(0.8)
Balance December 31, 2019	$	0.1	$	516.4	$	76.6	$	(48.3)	$	(0.8)	$	544.0
Net loss	—		—		(16.3)		—		—		(16.3)



Stock compensation plans	—		4.4		—		—		—		4.4
Shares withheld for taxes - common stock issuances	—		(0.7)		—		—		—		(0.7)
Foreign currency translation adjustments	—		—		—		3.9		—		3.9
Exercise of stock options	—		0.8		—		—		—		0.8
Net sales of treasury stock - Livent NQSP	—		—		—		—		0.1		0.1
Balance December 31, 2020 (1)	$	0.1	$	520.9	$	60.3	$	(44.4)	$	(0.7)	$	536.2
Net income	—		—		0.6		—		—		0.6
Stock compensation plans	—		5.3		—		—		—		5.3
Shares withheld for taxes - common stock issuances	—		(1.8)		—		—		—		(1.8)
Issuance of common stock - Offering	—		252.2		—		—		—		252.2
Net hedging gains, net of income tax expense	—		—		—		0.2		—		0.2
Foreign currency translation adjustments	—		—		—		1.3		—		1.3
Exercise of stock options	—		1.5		—		—		—		1.5
Net purchases of treasury stock - Livent NQSP	—		—		—		—		(0.1)		(0.1)
Balance December 31, 2021	$	0.1	$	778.1	$	60.9	$	(42.9)	$	(0.8)	$	795.4

__________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1: Description of the Business

Background and Nature of Operations

Livent Corporation ("Livent", "we", "us", "Company" or "our"), manufactures lithium for use in a wide range of lithium products, which are used primarily in lithium-based batteries, specialty polymers, and chemical synthesis applications. We serve a diverse group of markets. Our product offerings are primarily inorganic and generally have few cost-effective substitutes. A major growth driver for lithium in the future will be the rate of adoption of electric vehicles.

Most markets for lithium chemicals are global with significant growth occurring both in Asia and North America, primarily driven by the development and manufacture of lithium-ion batteries. We are one of the primary producers of performance lithium compounds.

Note 2: Principal Accounting Policies and Related Financial Information

Basis of presentation and principles of consolidation. The accompanying consolidated financial statements are presented on a consolidated basis and include all of the accounts and operations of Livent and its majority-owned subsidiaries. The financial statements reflect the financial position, results of operations and cash flows of Livent in accordance with U.S. GAAP. All significant intercompany accounts and transactions are eliminated in consolidation.

Earnings per share. The weighted average common shares outstanding for both basic and diluted earnings per share for all periods presented was calculated, in accordance with ASC 260, Earnings Per Share.

Estimates and assumptions. In preparing the financial statements in conformity with U.S. GAAP we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position, results of operations or cash flows.

Due to the current coronavirus ("COVID-19") pandemic, there has been uncertainty and disruption in the global economy and financial markets. The estimates used for, but not limited to, the collectability of trade receivables, fair value of long-lived assets, income taxes, inventory valuation and fair value of financial instruments could be impacted. We have assessed the impact and are not aware of any specific events or circumstances that required an update to our estimates and assumptions or materially affected the carrying value of our assets or liabilities as of the date of issuance of this Annual Report on Form 10-K. These estimates may change as new events occur and additional information is obtained.

Cash equivalents. We consider investments in all liquid debt instruments with original maturities of three months or less to be cash equivalents.

Trade receivables, net of allowance. Trade receivables consist of amounts owed to us from customer sales and are recorded when revenue is recognized. The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we use a two stage process which includes calculating a formula to develop an allowance to appropriately address the uncertainty surrounding collection risk of our entire portfolio and specific allowances for customers where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions.

Our method of calculating the formula consists of estimating the recoverability of trade receivables based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. Our analysis of trade receivable collection risk is performed quarterly, and the allowance is adjusted accordingly.

Inventories. Inventories are stated at the lower of cost or net realizable value. Inventory costs include those costs directly attributable to products before sale, including all manufacturing overhead but excluding distribution costs. All inventories are determined on a first-in, first-out (“FIFO”) basis.

Property, plant and equipment. We record property, plant and equipment, including capitalized interest, at cost. We

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

recognize acquired property, plant and equipment, from acquisitions at its estimated fair value. Depreciation is calculated principally on a straight-line basis over the estimated useful lives of the assets. The major classifications of property, equipment and software, including their respective expected useful lives, consisted of the following:


Asset type						Useful Life
Land						—
Land improvements						20 years
Buildings						20-40 years
Machinery and Equipment						3-18 years
Software						3-10 years

Gains and losses are reflected in income upon sale or retirement of assets. Expenditures that extend the useful lives of property, plant and equipment or increase productivity are capitalized. Ordinary repairs and maintenance are expensed as incurred through operating expense. We periodically evaluate whether events or circumstances indicate that the net book value of our property, plant and equipment may not be recoverable.

Capitalized interest. For the years ended December 31, 2021, 2020 and 2019 we capitalized interest expense of $15.4 million, $12.0 million and $5.7 million, respectively. These costs were associated with the construction of certain long-lived assets and have been capitalized as part of the cost of those assets. We amortize capitalized interest over the estimated useful lives of the assets.

Impairments of long-lived assets. We review the recoverability of the net book value of long-lived assets whenever events and circumstances indicate that the net book value of an asset may not be recoverable from the estimated undiscounted future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the net book value, we recognize an impairment loss equal to an amount by which the net book value exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. There were no significant impairments during the three years ended December 31, 2021.

Asset retirement obligations. We record asset retirement obligations (“AROs”) at present value at the time the liability is incurred if we can reasonably estimate the settlement date. The associated AROs are capitalized as part of the carrying amount of related long-lived assets. In future periods, the liability is accreted to its estimated fair value and the capitalized cost is depreciated over the useful life of the related asset. We also adjust the liability for changes resulting from the passage of time and/or revisions to the timing or the amount of the original estimate. Upon retirement of the long-lived asset, we either settle the obligation for its recorded amount or incur a gain or loss.

We have mining operations and legal reclamation obligations related to our facilities upon closure of the mines. The AROs primarily relate to post-closure reclamation of brine wells and sites involved in the surface mining and manufacturing of lithium in Argentina. Also, we have obligations at certain of our manufacturing facilities and offices in the event of permanent plant shutdown.

The carrying amounts for the AROs for the years ended December 31, 2021 and 2020 are $0.3 million and $0.3 million, respectively. These amounts are included in "Other long-term liabilities" on the consolidated balance sheets.

Deferred compensation plan. We have established a trust fund administered by a third party to provide funding for benefits payable under the Livent Non-qualified Saving Plan ("Livent NQSP") to which highly compensated Livent employees can elect to defer part of their compensation. The assets held in the trust consist of money market investments, a managed portfolio of equity securities and Livent common stock. For each reporting period, the Company records a net mark-to-market adjustment to Selling, general and administrative expense in our consolidated statements of operations for the investments in the trust fund and the corresponding obligation to participants in the Livent NQSP. The money market investments and equity securities assets are included in Other assets in the accompanying consolidated balance sheets. The investments in Livent common stock under the Livent NQSP are included in Treasury stock on our consolidated balance sheets. The deferred compensation obligation to participants is included in Other long-term liabilities on our consolidated balance sheets. See Note 15 and Note 17 for additional details on the Livent NQSP deferred compensation plan.

4.125% Convertible Senior Notes due 2025 (the “2025 Notes”). We account for our 2025 Notes under Accounting Standards Update ("ASU") No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06"), which we early adopted January 1, 2021 under the full retrospective method. See Note 11 and Note 14 for details.

Financial instruments. Our financial instruments include cash and cash equivalents, trade receivables, other current assets, investments held in trust fund, trade payables, derivatives and amounts included in accruals meeting the definition of financial instruments. Trade receivables and trade payables are recorded at cost, which approximates fair value due to the short-term nature of the instruments. Investments held in trust are for the Livent NQSP as discussed in "Deferred compensation plan" subsection above. Livent enters into derivative contracts to hedge exposures and the associated assets or liabilities are recorded in our consolidated balance sheets and the gains or losses associated with these transactions are included in the consolidated statements of operations.

Equity method investments. Livent has entered into agreements with The Pallinghurst Group relating to Quebec Lithium Partners ("QLP"), a joint venture owned equally by The Pallinghurst Group and Livent, and the conduct of certain business operations and oversight previously conducted by Nemaska Lithium Inc. The Company accounts for the investment in QLP as an equity method investment included in Investments in our consolidated balance sheets. See Note 16 for details.

Leases. The Company determines if an arrangement is a lease at the inception of the contract. Our operating leases are included in Operating lease right-of-use ("ROU") assets, Operating lease liabilities - current, and Operating lease liabilities - long term in the consolidated balance sheets. The operating lease ROU assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit interest rate, we utilize an estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. In determining the discount rate used in the present value calculation, the Company has elected to apply the portfolio approach for leases provided the leases commenced at or around the same time. This election allows the Company to account for leases at a portfolio level provided that the resulting accounting at this level would not differ materially from the accounting at the individual lease level. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

The Company has elected not to separate lease and non-lease components and accounts for each separate lease component and non-lease component associated with that lease component as a single lease component. Operating lease ROU assets include all contractual lease payments and initial direct costs incurred less any lease incentives. Facility leases generally only contain lease expense and non-component items such as taxes and pass through charges. Additionally, we have elected not to apply the recognition requirements of ASC 842 to leases which have a lease term of less than one year at the commencement date.

Most of the Company's leases for corporate facilities contain terms for renewal and extension of the lease agreement. The exercise of lease renewal options is generally at the Company’s sole discretion. The Company includes the lease extensions when it is reasonably certain we will exercise the extension. The Company’s lease agreements do not contain any material variable lease payments, material residual value guarantees or any material restrictive covenants. We currently do not have any finance leases. See Note 16 for information on related disclosures regarding leases.

Restructuring and other charges. We continually perform strategic reviews and assess the return on our businesses. This sometimes results in a plan to restructure the operations of our business. We record an accrual for severance and other exit costs under the provisions of the relevant accounting guidance.

Additionally, as part of these restructuring plans, write-downs of long-lived assets may occur. Two types of assets are impacted: assets to be disposed of by sale and assets to be abandoned. Assets to be disposed of by sale are measured at the lower of carrying amount or estimated net proceeds from the sale. Assets to be abandoned with no remaining future service potential are written down to amounts expected to be recovered. The useful life of assets to be abandoned that have a remaining future service potential are adjusted and depreciation is recorded over the adjusted useful life.

Finite-lived intangible assets. Finite-lived intangible assets consist of a patent, which is being amortized over a period of 15 years.

Revenue recognition. Revenue from product sales is recognized when we satisfy a performance obligation by transferring the promised goods to a customer, that is, when control of the good transfers to the customer. The customer is then invoiced at the agreed-upon price with payment terms generally ranging from 30 to 180 days. See Note 4 for further details regarding revenue recognition.

Research and Development. Research and development costs are expensed as incurred.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Income and other taxes. We provide current income taxes on income reported for financial statement purposes adjusted for transactions that do not enter into the computation of income taxes payable and recognize deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities. Prior to separation, pursuant to the tax matters agreement with FMC, in jurisdictions where we file consolidated returns with FMC, we have recorded our allocated share of the consolidated liability as part of the income tax payable in our consolidated balance sheets. In taxing jurisdictions where we file as a standalone entity we have recorded the tax liability/benefit to income tax payable/receivable. We do not provide income taxes on the equity in undistributed earnings of consolidated foreign subsidiaries as it is our intention that such earnings will remain invested in those companies.

Segment information. We operate as one reportable segment based on the commonalities among our products and services and the manner in which we review and evaluate operating performance.

Stock-based compensation. Stock-based compensation expense for the three years ended December 31, 2021 has been recognized for all share options and other equity-based arrangements. Stock-based compensation cost is measured at the date of grant, based on the fair value of the award, and is recognized over the employee’s requisite service period. We made a policy election to recognize forfeitures in stock-based compensation expense as they occur. See Note 12 for more information.

As of December 31, 2021, there were 10,683,837 shares of Livent common stock authorized and registered for issuance under the Livent Plan.

Environmental obligations. We provide for environmental-related obligations when they are probable and amounts can be reasonably estimated. Where the available information is sufficient to estimate the amount of liability, that estimate has been used.

Included in our environmental liabilities are costs for the operation, maintenance and monitoring of site remediation plans (“OM&M”). Such reserves are based on our best estimates for these OM&M plans. Over time we may incur OM&M costs in excess of these reserves. However, we are unable to reasonably estimate an amount in excess of our recorded reserves because we cannot reasonably estimate the period for which such OM&M plans will need to be in place or the future annual cost of such remediation, as conditions at these environmental sites change over time. Such additional OM&M costs could be significant in total but would be incurred over an extended period of years.

Environmental remediation charges represent the costs for the continuing charges associated with environmental remediation at operating sites from previous years and from products that are no longer manufactured. Livent has one environmental remediation site located in Bessemer City, North Carolina. The (income)/charge associated with the cost of remediation for the years ended December 31, 2021, 2020 and 2019 are $(0.3) million, $0.1 million and $0.9 million, respectively. These amounts are recorded as a component within “Restructuring and other charges” on the consolidated statements of operations. The total environmental remediation liability as of December 31, 2021 and 2020 was $6.1 million and $6.7 million, respectively.

Foreign currency. We translate the assets and liabilities of our foreign operations at exchange rates in effect at the balance sheet date. For foreign operations for which the functional currency is not the U.S. dollar, we record translation gains and losses as a component of accumulated other comprehensive loss in equity. The foreign operations’ statements of operations are translated at the monthly exchange rates for the period. Transactions denominated in foreign currency other than our functional currency of the operation are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are remeasured at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences are recognized as foreign currency transaction gain or loss recorded as a component of Costs of sales in our consolidated statements of operations. We recorded transaction and remeasurement losses of $10.3 million, $14.2 million and $14.8 million for the years ended December 31, 2021, 2020 and 2019, respectively.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 3: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items

New Accounting guidance and regulatory items

In April 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848). The amendments in this ASU provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. An entity may optionally elect to apply the amendments effective in the first interim period that includes or is subsequent to March 12, 2020 through December 31, 2022. The FASB also issued ASU No. 2021-01, Reference Rate Reform (Topic 848). The amendments in this ASU provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective for all entities as of March 12, 2020 through December 31, 2022. We do not expect the adoption to have a material impact on our consolidated financial statements.

Recently adopted accounting guidance

As of January 1, 2021, Livent early adopted Accounting Standards Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06"). ASU 2020-06 reduces the number of accounting models for convertible debt instruments by eliminating the cash conversion model. As compared with current U.S. GAAP, when following ASU 2020-06, more convertible debt instruments will be reported as a single liability instrument and the interest rate of more convertible debt instruments will be closer to the coupon interest rate. ASU 2020-06 also aligns the consistency of diluted Earnings Per Share ("EPS") calculations for convertible instruments by requiring that (1) an entity use the if-converted method and (2) share settlement be included in the diluted EPS calculation for both convertible instruments and equity contracts when those contracts include an option of cash settlement or share settlement. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Livent elected to early adopt ASU 2020-06 on January 1, 2021, using the full retrospective method.

Prior to adoption, under Accounting Standards Codification 470-20, Debt with Conversion and Other Options ("ASC 470-20"), the Company had separately accounted for the liability and equity components of its 4.125% Convertible Senior Notes Due 2025 (the "2025 Notes"), which may be settled entirely or partially in cash upon conversion, in a manner that reflected the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the 2025 Notes was that the equity component was required to be included in the additional paid-in capital section of stockholders’ equity on the consolidated balance sheet, and the value of the equity component was treated as original issue discount for purposes of accounting for the debt component of the 2025 Notes. As a result, prior to the adoption of ASU 2020-06, the Company was required to record a greater amount of non-cash interest expense as a result of the amortization of the discounted carrying value of the 2025 Notes to their face amount over the term of the 2025 Notes. Because the Company intends to settle in cash the principal outstanding under its 2025 Notes, the Company previously could elect to use the treasury stock method when calculating their potential dilutive effect, if any. ASU 2020-06 now requires the Company to use the if-converted method for EPS. For the full retrospective method of adoption, the accounting change was recognized as an adjustment to the balance of retained earnings, additional paid-in capital, long-term debt and deferred income taxes in the consolidated balance sheet as of December 31, 2020, the year in which the 2025 Notes were issued. Interest expense, loss from operations before income taxes, income tax benefit, net loss and loss per share were also adjusted in the consolidated statement of operations for the year ended December 31, 2020. Non-cash adjustments to reconcile net loss to cash provided by operating activities, including deferred income taxes and deferred financing fee amortization were also adjusted in the consolidated statement of cash flows for the year ended December 31, 2020. See Note 11 and Note 14 for further details.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The amendments in this ASU simplified the accounting for income taxes by removing certain exceptions to the general principle in Topic 740. The amendments also contain improvements and clarifications of certain guidance in Topic 740. The new amendments are effective for fiscal years beginning after December 15, 2020 (i.e. a January 1, 2021 effective date), with early adoption permitted. The adoption did not have a material impact on our consolidated financial statements.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 4: Revenue Recognition

Disaggregation of revenue

We disaggregate revenue from contracts with customers by geographical areas (based on product destination) and by product categories. The following table provides information about disaggregated revenue by major geographical region:


	Year Ended December 31,
(in Millions)	2021		2020		2019
North America (1) (2)	$	61.4	$	53.3	$	76.2
Latin America	—		0.2		1.0
Europe, Middle East & Africa	62.2		49.2		59.0
Asia Pacific (1) (2)	296.8		185.5		252.2
Total Revenue	$	420.4	$	288.2	$	388.4

____________________

1.In 2021, countries with sales in excess of 10% of combined revenue consisted of Japan, the U.S., South Korea and China. Sales for the year ended December 31, 2021 for Japan, the U.S., South Korea and China totaled $75.1 million, $59.9 million, $43.6 million and $160 million, respectively. Sales for the year ended December 31, 2020 for Japan, the U.S. and China totaled $97.7 million, $52.6 million and $55.3 million, respectively, and sales for the year ended December 31, 2019 totaled $160.4 million, $75.2 million and $53.2 million, respectively.

2.In the fourth quarter of 2021, we reclassified certain revenue from the nine months ended September 30, 2021 from North America to Asia Pacific to present revenue based on product destination.

For the years ended December 31, 2021, 2020 and 2019, one customer accounted for approximately 31%, 26% and 28% of total revenue, respectively and our 10 largest customers accounted in aggregate for approximately 69%, 64% and 60% of our revenue, respectively. A loss of any material customer could have a material adverse effect on our business, financial condition and results of operations.

The following table provides information about disaggregated revenue by major product category:


	Year Ended December 31,
(in Millions)	2021		2020		2019
Lithium Hydroxide	$	208.0	$	157.5	$	213.8
Butyllithium	105.4		87.1		99.9
High Purity Lithium Metal and Other Specialty Compounds	36.9		31.7		52.4
Lithium Carbonate and Lithium Chloride	70.1		11.9		22.3
Total Revenue	$	420.4	$	288.2	$	388.4

Our lithium products are developed and sold to global and regional customers in the EV, electronics, agrochemicals, pharmaceuticals, polymer and specialty alloy metals market among others. Lithium hydroxide products are used in advanced batteries for all-electric vehicles as well as other products that require portable energy storage such as power tools and military devices. Lithium hydroxide is also sold into grease applications for use in automobiles, aircraft, railcars, agricultural and other types of equipment. Butyllithium products are primarily used as polymer initiators, and in the synthesis of agrochemicals and pharmaceuticals. High purity lithium metal and other specialty compounds include lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride and specialty organics. Additionally, we sell whatever lithium carbonate and lithium chloride we do not use internally to our customers for various applications.

Sale of Goods

Revenue from product sales is recognized when we satisfy a performance obligation by transferring the promised goods to a customer, that is, when control of the good transfers to the customer. The customer is then invoiced at the agreed-upon price with payment terms generally ranging from 30 to 180 days.

In determining when the control of goods is transferred, we typically assess, among other things, the transfer of title and risk and the shipping terms of the contract. When we perform shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to delivery), they are considered fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. For FOB shipping point terms, revenue is recognized at the time of shipment since the customer gains control at this point in time.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

We record amounts billed for shipping and handling fees as revenue. Costs incurred for shipping and handling are recorded as distribution costs. Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from revenue in the consolidated statements of operations. We record a liability until remitted to the respective taxing authority.

Variable Consideration

As a part of our customary business practice, we may offer sales incentives to our customers, such as volume discounts or rebates. Variable consideration given can differ by product. For all such contracts that include any variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining the transaction price requires significant judgment, we have significant historical experience with incentives provided to customers and estimating the expected consideration considering historical patterns of incentive payouts. These estimates are re-assessed each reporting period as required.

In addition to the variable consideration described above, in certain instances, we may require our customers to meet certain volume thresholds within their contract term. We estimate what amount of variable consideration should be included in the transaction price at contract inception and continually reassesses this estimation each reporting period to determine situations when the minimum volume thresholds will not be met. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. In those circumstances, we apply the guidance on breakage and estimate the amount of the shortfall and recognize it over the remaining performance obligations in the contract.

Right of Return

Contract asset and contract liability balances

We satisfy our obligations by transferring goods and services in exchange for consideration from customers. The timing of performance sometimes differs from the timing the associated consideration is received from the customer, thus resulting in the recognition of a contract liability. We recognize a contract liability if the customer’s payment of consideration is received prior to completion of our related performance obligation. As of December 31, 2021 and 2020 there were no significant contract liabilities recorded in the consolidated balance sheets.

The following table presents the opening and closing balances of our receivables, net of allowances from contracts with customers.


	Balance as of
(in Millions)	December 31, 2021		December 31, 2020		Increase
Receivables from contracts with customers, net of allowances	$	96.4	$	76.3	$	20.1

The balance of receivables listed in the table above represents the current trade receivables (including buy/sell arrangements), net of allowance for doubtful accounts. The allowance for receivables represents our best estimate of the probable losses associated with potential customer defaults. We determine the allowance based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors.

Performance obligations

Revenue is recognized when the performance obligation is satisfied, which is when the customer obtains control of the good or service. Periodically, we may enter into contracts with customers which require them to submit a forecast of non-binding purchase obligations to us. These forecasts are typically provided by the customer to us in good faith, and there are no penalties or obligations if the forecasts are not met. Accordingly, we have determined that these are optional purchases and do not represent material rights and are not considered as unsatisfied (or partially unsatisfied) performance obligations for the purposes of this disclosure.

Occasionally, we may enter into multi-year take or pay supply agreements with customers. The aggregate amount of revenue expected to be recognized related to these contracts’ performance obligations that are unsatisfied or partially unsatisfied is approximately $589 million in the next four years. These approximate revenues do not include amounts of variable consideration attributable to contract renewals or contract contingencies. Based on our past experience with the customers under these arrangements, we expect to continue recognizing revenue in accordance with the contracts as we transfer control of the

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

product to the customer (refer to the sales of goods section for our determination of transfer of control). However, in the case a shortfall of volume purchases occurs, we will recognize the amount payable by the customer over the remaining performance obligations in the contract.

Practical Expedients and Exemptions

We have elected the following practical expedients following the adoption of ASC 606:


a.			Costs of obtaining a contract: We incur certain costs such as sales commissions which are incremental to obtaining the contract. We have taken the practical expedient of expensing such costs to obtain a contract, as and when they are incurred, when the expected amortization period is one year or less.


b.			Remaining performance obligations: We elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for our contracts that are one year or less, as the revenue is expected to be recognized within one year. Additionally, we have elected not to disclose information about variable considerations for remaining, wholly unsatisfied performance obligations for which the criteria in paragraph 606-10-32-40 have been met.


c.			Shipping and handling costs: We elected to account for shipping and handling activities that occur after the customer has obtained control of a good as fulfillment activities (i.e., an expense) rather than as a promised service.


d.			Measurement of transaction price: We have elected to exclude from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by us from a customer.

Note 5: Inventories, Net

Inventories consisted of the following:


	December 31,
(in Millions)	2021		2020
Finished goods	$	52.2	$	36.1
Semi-finished goods	43.6		46.2
Raw materials, supplies, and other	38.8		23.3
FIFO inventory, net	$	134.6	$	105.6

Note 6: Investments

In the fourth quarter of 2020, Livent entered into an agreement with The Pallinghurst Group relating to Québec Lithium Partners ("QLP"), a joint venture owned equally by The Pallinghurst Group and Livent, and the conduct of certain business operations and oversight, previously conducted solely by Nemaska Lithium Inc. for the development of a fully integrated lithium chemical asset located in Québec, Canada that is not yet in commercial production. QLP owns a 50% equity interest in the Nemaska Project. The Company accounts for the investment in QLP as an equity method investment on a one-quarter lag basis and is included in Investments in our condensed consolidated balance sheets. For the year ended December 31, 2021 we recorded a $5.5 million loss related to our 50% equity interest in QLP to Equity in net loss of unconsolidated affiliates in our consolidated statement of operations. The carrying amount of our 50% equity interest in QLP was $23.8 million and $21.2 million as of December 31, 2021 and December 31, 2020, respectively.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 7: Property, Plant and Equipment, Net

Property, plant and equipment consisted of the following:


	December 31,
(in Millions)	2021		2020
Land and land improvements	$	85.8	$	85.8

Buildings	84.4		83.0
Machinery and equipment	330.2		314.9
Construction in progress	420.5		284.0
Total cost	$	920.9	$	767.7
Accumulated depreciation	(243.0)		(222.4)
Property, plant and equipment, net	$	677.9	$	545.3

Depreciation expense was $22.9 million, $22.0 million, and $19.1 million in 2021, 2020 and 2019, respectively.

Note 8: Restructuring and Other Charges

The following table shows total restructuring and other charges included in the consolidated statements of operations:


	Year Ended December 31,
(in Millions)	2021		2020		2019
Restructuring charges:

Severance-related and exit costs (1)	$	0.2	$	6.2	$	—

Other charges:
Corporate severance-related costs (2)	—		—		3.5
Environmental remediation (3)	(0.3)		0.1		0.9
Other (4)	3.9		4.4		1.8
Total restructuring and other charges	$	3.8	$	10.7	$	6.2

___________________

1.The years ended December 31, 2021 and 2020 include severance costs for management changes at certain operating and administrative facilities. Additionally, December 31, 2020 includes exit costs of $1.6 million for the closing of leased office space.

2.The year ended December 31, 2019 represents severance costs and stock-based compensation expense for accelerated vesting related to corporate management changes.

3.Represents costs associated with environmental remediation with respect to certain discontinued products. There is one environmental remediation site in Bessemer City, North Carolina. See Note 9 for more details.

4.The year ended December 31, 2021 consists primarily of transaction-related legal fees and miscellaneous nonrecurring transactions. The years ended December 31, 2020 and 2019 include legal fees related to IPO securities litigation, including $2.0 million accrued as of December 31, 2020, for the IPO securities litigation settlement, net of insurance reimbursement. See Note 16 for more details.

Note 9: Environmental Obligations

We are subject to various federal, state, local and foreign environmental laws and regulations that govern emissions of air pollutants, discharges of water pollutants, and the manufacture, storage, handling and disposal of hazardous substances, hazardous wastes and other toxic materials and remediation of contaminated sites. We are also subject to liabilities arising under the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) and similar state laws that impose responsibility on persons who arranged for the disposal of hazardous substances, and on current and previous owners and operators of a facility for the clean-up of hazardous substances released from the facility into the environment. We are also subject to liabilities under the Resource Conservation and Recovery Act (“RCRA”) and analogous state laws that require owners and operators of facilities that have treated, stored or disposed of hazardous waste pursuant to a RCRA permit to follow certain waste management practices and to clean up releases of hazardous substances into the environment associated with past or present practices. In addition, when deemed appropriate, we enter certain sites with potential liability into voluntary remediation compliance programs, which are also subject to guidelines that require owners and operators, current and previous, to clean up releases of hazardous substances into the environment associated with past or present practices.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Environmental liabilities consist of obligations relating to waste handling and the remediation and/or study of sites at which we are alleged to have released or disposed of hazardous substances. As of the periods presented, the Bessemer City site located in North Carolina is the only site for which we have a reserve. We have provided reserves for potential environmental obligations that we consider probable and for which a reasonable estimate of the obligation can be made. Accordingly, total reserves of $6.1 million and $6.7 million existed for the years ended December 31, 2021 and 2020, respectively.

The estimated reasonably possible environmental loss contingencies exceed amount accrued by approximately $3 million at December 31, 2021. This reasonably possible estimate is based upon information available as of the date of the filing and the actual future losses may be higher given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of potentially responsible parties, technology and information related to the site.

Although potential environmental remediation expenditures in excess of the reserves and estimated loss contingencies could be significant, the impact on our future consolidated financial results is not subject to reasonable estimation due to numerous uncertainties concerning the nature and scope of possible contamination, identification of remediation alternatives under constantly changing requirements, selection of new and diverse clean-up technologies to meet compliance standards, and the timing of potential expenditures. The liabilities arising from potential environmental obligations that have not been reserved for at this time may be material to results of operations in the future. However, we believe any liability arising from such potential environmental obligations is not likely to have a material adverse effect on our liquidity or financial condition as it may be satisfied over many years.

The table below is a roll forward of our total environmental reserves.


(in Millions)	Environmental Reserves Total








Balance December 31, 2020	$	6.7
Change in reserves	(0.3)
Cash payments	(0.3)

Balance December 31, 2021	$	6.1

The table below provides detail of current and long-term environmental reserves.


	December 31,
(in Millions)	2021		2020
Environmental reserves, current (1)	$	0.5	$	0.6
Environmental reserves, long-term (2)	5.6		6.1
Total environmental reserves	$	6.1	$	6.7

______________

1.These amounts are included within “Accrued and other liabilities” on the consolidated balance sheets.

2.These amounts are included in "Environmental liabilities" on the consolidated balance sheets.

Note 10: Income Taxes

Domestic and foreign components of income/(loss) from operations before income taxes are shown below:


	Year Ended December 31,
(in Millions)	2021		2020 (1)		2019
Domestic	$	(15.2)	$	(19.7)	$	9.9
Foreign	39.1		(2.3)		47.9
Total	$	23.9	$	(22.0)	$	57.8

__________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The provision for income taxes attributable to income/(loss) from operations consisted of:


	Year Ended December 31,
(in Millions)	2021		2020 (1)		2019
Current:
Federal (2)	$	1.7	$	(1.9)	$	3.5
Foreign	2.6		4.6		7.4
State	—		—		0.1
Total current	$	4.3	$	2.7	$	11.0
Deferred:
Federal	$	1.3	$	(0.9)	$	1.2
Foreign	17.7		(7.4)		(4.8)
State	—		(0.1)		0.2
Total deferred	19.0		(8.4)		(3.4)
Total	$	23.3	$	(5.7)	$	7.6

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

The effective income tax rate applicable to income/(loss) from operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:


	Year Ended December 31,
(in Millions)	2021		2020 (1)		2019
U.S. Federal statutory rate	$	5.1	$	(4.6)	$	12.1

Foreign earnings subject to different tax rates	(1.2)		0.6		(3.6)
Foreign derived intangible income	(0.7)		—		(1.1)

State and local income taxes, less federal income tax benefit	—		(0.1)		0.3

Tax on intercompany dividends and deemed dividends for tax purposes	3.8		0.1		4.4
Changes to unrecognized tax benefits	(0.9)		2.1		0.6

Other permanent items	(0.9)		(0.2)		(0.8)
Change in valuation allowance	4.4		0.3		0.3
Exchange gains and losses (2)	12.7		(5.9)		(1.8)
Withholding taxes net of credits	0.8		1.1		—
Other(3)	0.2		0.9		(2.8)
Total tax provision/(benefit)	$	23.3	$	(5.7)	$	7.6

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

2.Includes the impact of transaction gains or losses on net monetary assets for which no corresponding tax expense or benefit is realized and the tax provision for statutory taxable gains or losses in foreign jurisdictions for which there is no corresponding amount in income before taxes. Additionally, the year ended December 31, 2021 includes an adjustment relating to inflation of $22.1 million.

3.The year ended December 31, 2019 includes a $3.2 million tax benefit due to revisions to our tax liabilities upon completion of prior year tax returns.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Significant components of our deferred tax assets and liabilities were attributable to:


	December 31,
(in Millions)	2021		2020 (1)
Environmental and restructuring	$	0.4	$	1.4



Net operating loss carry-forwards and credits	5.7		15.3

Other assets and reserves	7.9		5.1
Deferred tax assets	$	14.0	$	21.8
Valuation allowance, net	(6.4)		(3.6)
Deferred tax assets, net of valuation allowance	$	7.6	$	18.2
Property, plant and equipment, net	(19.0)		(10.2)

Other liabilities	(0.4)		(0.2)
Deferred tax liabilities	(19.4)		(10.4)
Net deferred tax (liabilities)/assets	$	(11.8)	$	7.8

____________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

We evaluate our deferred income taxes quarterly to determine if valuation allowances are required or should be adjusted. U.S. GAAP requires companies to assess whether valuation allowances should be established against deferred tax assets based on all available evidence, both positive and negative, using a “more likely than not” standard. In assessing the need for a valuation allowance, appropriate consideration is given to all positive and negative evidence related to the realization of deferred tax assets. This assessment considers, among other matters, the nature and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, and tax planning alternatives.

As of December 31, 2021, we had total foreign net operating loss carry-forwards of $3.5 million (tax effected) primarily related to the Netherlands and United Kingdom expiring over various tax years.

Income taxes are not provided for any additional outside basis differences inherent in our investments in subsidiaries because the investments and related unremitted earnings are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings is not practicable due to the complexity of the hypothetical calculation.

Uncertain Income Tax Positions

U.S. GAAP accounting guidance for uncertainty in income taxes prescribes a model for the recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides guidance on derecognition, classification, interest and penalties, disclosure and transition.

We file tax returns in various jurisdictions. Pursuant to the TMA with FMC we have recorded amounts in uncertain tax positions at December 31, 2018 for tax positions that relate to our legacy business before IPO. In jurisdictions where we filed consolidated returns with FMC, and did not maintain the entity at IPO, our uncertain tax positions have been reduced as of December 31, 2021. We have recorded a $0.9 million indemnification asset from FMC regarding uncertain tax positions that are related to our legacy business before IPO and for which we are indemnified by FMC. Our significant foreign jurisdictions, which total 3, are open for examination and adjustment during varying periods from 2016 - 2020.

As of December 31, 2021, we had total unrecognized tax benefits of $2.9 million, of which $1.0 million would unfavorably impact the effective tax rate from operations if recognized. As of December 31, 2020, we had total unrecognized tax benefits of $2.7 million, of which $1.3 million would unfavorably impact the effective tax rate if recognized. As of December 31, 2019, we had total unrecognized tax benefits of $2.4 million, of which $0.2 million would unfavorably impact the effective tax rate if recognized. Interest and penalties related to unrecognized tax benefits are reported as a component of income tax expense. For the years ended December 31, 2021, 2020 and 2019, we recognized interest and penalties of $(0.1) million, $0.7 million, and $0.2 million, respectively, in the consolidated statement of operations. As of December 31, 2021 and 2020, we have accrued interest and penalties in the consolidated balance sheets of $0.6 million and $1.1 million, respectively.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Due to the potential for resolution of federal, state, or foreign examinations, and the expiration of various jurisdictional statutes of limitation, it is reasonably possible that our liability for unrecognized tax benefits will decrease within the next 12 months by a range of zero to $1.0 million.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:


(in Millions)	2021		2020		2019
Balance at beginning of year	$	2.7	$	2.4	$	2.6
Increases related to positions taken in the current year	—		0.7		0.9

Decreases related to positions taken in prior years	(1.6)		—		—
Increases related to positions taken in prior years	1.9		—		—
Decreases related to lapse of statutes of limitations	(0.1)		(0.4)		(1.1)



Balance at end of year	$	2.9	$	2.7	$	2.4

Note 11: Debt

Long-term debt

Long-term debt consists of the following:


	Interest Rate Percentage			Maturity Date	December 31, 2021		December 31, 2020 (1)
(in Millions)	LIBOR borrowings	Base rate borrowings
Revolving Credit Facility (2)	2.35%	4.5%		2023	$	—	$	35.6
4.125% Convertible Senior Notes due 2025			4.125%	2025	245.8		245.8

Transaction costs - 2025 Notes					(5.4)		(6.8)
Total long-term debt (3)					$	240.4	$	274.6

______________________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

2.As of December 31, 2021 and December 31, 2020, there were $14.5 million and $14.4 million, respectively, in letters of credit outstanding under our Revolving Credit Facility and $385.5 million and $275.0 million available funds as of December 31, 2021 and December 31, 2020, respectively. Fund availability is subject to the Company meeting its debt covenants.

3.As of December 31, 2021 and December 31, 2020, the Company had no debt maturing within one year.

On January 1, 2021, the Company elected to early adopt ASU 2020-06 under the full retrospective method, that is, the accounting change was recognized as an adjustment to the balance of retained earnings, additional paid-in capital, long-term debt and deferred income taxes in our consolidated balance sheet as of December 31, 2020, the year in which the 2025 Notes were issued. The ASU reduces the number of accounting models for convertible debt instruments by eliminating the cash conversion model. Our 2025 Notes are now reported as a single liability instrument net of transaction costs with an interest rate closer to the coupon interest rate.

The comparative financial statements of prior years have been adjusted to apply the adopted guidance retrospectively.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


Statement of operations
(in Millions, except per share amounts)
Year ended December 31, 2021	As computed under ASC 470-20		As reported under ASU 2020-06		Effect of change
Interest expense/(income)	$	7.3	$	0.3	$	(7.0)

Income from operations before income taxes	16.9		23.9		7.0
Income tax expense	21.7		23.3		1.6
Net (loss)/income	$	(4.8)	$	0.6	$	5.4
Net (loss)/income per weighted average share - basic	$	(0.03)	$	—	$	0.03
Net (loss)/income per weighted average share - diluted	$	(0.03)	$	—	$	0.03

Year ended December 31, 2020	As originally reported		As adjusted		Effect of change
Interest expense/(income)	$	3.7	$	0.3	$	(3.4)

(Loss)/income from operations before income taxes	(25.4)		(22.0)		3.4
Income tax (benefit)/expense	(6.5)		(5.7)		0.8
Net (loss)/income	$	(18.9)	$	(16.3)	$	2.6
Net (loss)/income per weighted average share - basic and diluted	$	(0.13)	$	(0.11)	$	0.02


Balance Sheet
(in Millions, except per share amounts)
December 31, 2021	As computed under ASC 470-20		As reported under ASU 2020-06		Effect of change




Deferred income taxes	$	19.3	12.7		$	(6.6)
Long-term debt	209.6		240.4		30.8
Total liabilities	$	228.9	$	253.1	$	24.2
Common stock, $0.001 per share par value	0.1		0.1		—
Capital in excess of par value of common stock	810.3		778.1		(32.2)
Retained earnings	52.9		60.9		8.0
Accumulated other comprehensive loss	(42.9)		(42.9)		—
Treasury stock	(0.8)		(0.8)		—
Total equity	819.6		795.4		(24.2)
Total liabilities and equity	$	1,048.5	$	1,048.5	$	—

December 31, 2020	As originally reported		As adjusted		Effect of change





Deferred income taxes	$	13.9	$	5.6	$	(8.3)
Long-term debt	236.7		274.6		37.9
Total liabilities	$	250.6	$	280.2	$	29.6
Common stock, $0.001 per share par value	0.1		0.1		—
Capital in excess of par value of common stock	553.1		520.9		(32.2)
Retained earnings	57.7		60.3		2.6
Accumulated other comprehensive loss	(44.4)		(44.4)		—
Treasury stock, common, at cost	(0.7)		(0.7)		—
Total equity	565.8		536.2		(29.6)
Total liabilities and equity	$	816.4	$	816.4	$	—

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


Statement of cash flows
(in Millions)
Year ended December 31, 2021	As computed under ASC 470-20		As reported under ASU 2020-06		Effect of change
Net (loss)/income	$	(4.8)	$	0.6	$	5.4
Adjustments to reconcile net (loss)/income to cash provided by operating activities:
Deferred income taxes	10.9		12.5		1.6
Deferred financing fee amortization	7.3		0.3		(7.0)
Net cash provided by operating activities	13.4		13.4		—
Net increase in cash and cash equivalents	101.4		101.4		—
Cash and cash equivalents, beginning of period	11.6		11.6		—
Cash and cash equivalents, end of period	$	113.0	$	113.0	$	—

Year ended December 31, 2020	As originally reported		As adjusted		Effect of change
Net (loss)/income	$	(18.9)	$	(16.3)	$	2.6
Adjustments to reconcile net (loss)/income to cash used in operating activities:
Deferred income taxes	(7.1)		(6.3)		0.8
Deferred financing fee amortization	4.1		0.7		(3.4)
Net cash used in operating activities	(21.9)		(21.9)		—
Net decrease in cash and cash equivalents	(5.2)		(5.2)		—
Cash and cash equivalents, beginning of period	16.8		16.8		—
Cash and cash equivalents, end of period	$	11.6	$	11.6	$	—

4.125% Convertible Senior Notes due 2025

In the second and third quarters of 2020, the Company issued $245.8 million in aggregate principal amount of 4.125% Convertible Senior Notes due in July 2025 (the "2025 Notes"). Total net cash proceeds received were $238.2 million net of $7.6 million of third-party transaction costs, including initial purchasers' discounts and commissions. The Company used or will use the net proceeds received to finance or refinance eligible green projects designed to align with the provisions of the International Capital Market Association Green Bond Principles 2018, including repaying amounts outstanding under its Revolving Credit Facility.

Each $1,000 of principal of the 2025 Notes is initially convertible into 114.4885 shares of our common stock, which is equivalent to an initial conversion price of $8.73 per share, subject to adjustment upon the occurrence of specified events. We may not redeem the 2025 Notes prior to July 20, 2023. We may redeem for cash all or any portion of the 2025 Notes, at our option, on or after July 20, 2023 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the 2025 Notes to be redeemed, plus accrued and unpaid interest.

Holders of the 2025 Notes may convert their notes at any time, at their option, on or after January 15, 2025. Further, holders of the 2025 Notes may convert their notes at any time, at their option, prior to January 15, 2025 only under the following circumstances: (1) during any calendar quarter commencing after September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each trading day; (2) during the five-business day period after any five-consecutive trading day period in which the trading price per $1,000 principal amount of the 2025 Notes for each trading day of such period is less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day, (3) if we call any or all of the 2020 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date or (4) if specified corporate events occur. Upon conversion, the 2025 Notes will be settled in cash, shares of our common stock or a combination thereof, at our election. If a fundamental change occurs prior to the maturity date, holders of the 2025 Notes may require us to repurchase all or a portion of their 2025 Notes for cash at a repurchase price equal to 100% of the principal amount plus any accrued and unpaid interest. In

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

addition, if specific corporate events occur prior to the maturity date or if we deliver a notice of redemption, we will increase the conversion rate for a holder who elects to convert its 2025 Notes in connection with such an event or notice of redemption in certain circumstances.

In the first quarter of 2022, the holders of the 2025 Notes were notified that the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, December 31, 2021 was greater than or equal to 130% of the conversion price on each trading day, and as a result, the holders have the option to convert all or any portion of their 2025 Notes through March 31, 2022. The 2025 Notes are classified as long-term debt.

The Company recorded interest expense related to the amortization of transaction costs of $1.5 million and $0.8 million for the years ended December 31, 2021 and 2020, respectively; $1.2 million and $0.5 million of which was capitalized for years ended December 31, 2021 and 2020, respectively. The Company recorded $10.2 million and $5.2 million of accrued interest expense related to the principal amount for the years ended December 31, 2021 and 2020, respectively.

Revolving Credit Facility

On September 28, 2018, we entered into a credit agreement among us, our subsidiary, Livent USA Corp., as borrowers (the “Borrowers”), certain of our wholly owned subsidiaries as guarantors (the "Guarantors"), the lenders party thereto (the “Lenders”), Citibank, N.A., as administrative agent (the "Agent"), and certain other financial institutions party thereto, as joint lead arrangers (the “Original Credit Agreement”, and as amended the "Credit Agreement"). The Credit Agreement provides for a $400 million senior secured revolving credit facility, $50 million of which is available for the issuance of letters of credit for the account of the Borrowers, with an option, subject to certain conditions and limitations, to increase the aggregate amount of the revolving credit commitments to $600 million (the “Revolving Credit Facility”). The issuance of letters of credit and the proceeds of revolving credit loans made pursuant to the Revolving Credit Facility are available, and will be used, for general corporate purposes, including capital expenditures and permitted acquisitions, of the Borrowers and their subsidiaries.

Amounts under the Revolving Credit Facility may be borrowed, repaid and re-borrowed from time to time until the final maturity date of the Revolving Credit Facility, which will be the fifth anniversary of the Revolving Credit Facility’s effective date. Voluntary prepayments and commitment reductions under the Revolving Credit Facility are permitted at any time without any prepayment premium upon proper notice and subject to minimum dollar amounts.

Revolving loans under the Credit Agreement will bear interest at a floating rate, which will be a base rate or a Eurodollar rate equal to the London interbank offered rate for the relevant interest period, plus, in each case, an applicable margin based on our leverage ratio, as determined in accordance with the provisions of the Credit Agreement. The base rate will be the greatest of: the rate of interest announced publicly by Citibank, N.A. in New York City from time to time as its “base rate”; the federal funds effective rate plus 0.5%; and a Eurodollar rate for a one-month interest period plus 1%. Each Borrower on a joint and several basis is required to pay a commitment fee quarterly in arrears on the average daily unused amount of each Lender’s revolving credit commitment at a rate equal to an applicable percentage based on the leverage ratio, as determined in accordance with the provisions of the Credit Agreement. The applicable margin and the commitment fee are subject to adjustment as provided in the Credit Agreement.

The Borrowers’ domestic material subsidiaries (the “Guarantors”) will guarantee the obligations of the Borrowers under the Revolving Credit Facility. The obligations of the Borrowers and the Guarantors are secured by all of the present and future assets of the Borrowers and the Guarantors, including the Borrowers’ facility and real estate in Bessemer City, North Carolina, subject to certain exceptions and exclusions as set forth in the Credit Agreement and other security and collateral documents.

Fees incurred to secure the Revolving Credit Facility have been deferred and will be amortized over the term of the arrangement. The carrying value of our deferred financing costs was $1.5 million as of December 31, 2021.

Covenants

The Credit Agreement contains certain affirmative and negative covenants that are binding on the Borrowers and their subsidiaries, including, among others, restrictions (subject to exceptions and qualifications) on the ability of the Borrowers and their subsidiaries to create liens, to undertake fundamental changes, to incur debt, to sell or dispose of assets, to make investments, to make restricted payments such as dividends, distributions or equity repurchases, to change the nature of their businesses, to enter into transactions with affiliates and to enter into certain burdensome agreements. Furthermore, the Borrowers are subject to financial covenants regarding leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our maximum allowable first lien leverage ratio is 3.5 as of December 31, 2021. Our minimum allowable interest coverage ratio is 3.5. We were in compliance with all requirements of the covenants at December 31, 2021.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 12: Stock-based Compensation

Livent Corporation Incentive Compensation and Stock Plan

As of December 31, 2021, the total shares of Livent common stock authorized for issuance under the Livent Corporation Incentive Compensation and Stock Plan (the "Livent Plan") is 10,683,837 shares. The Livent Plan provides for the grant of a variety of cash and equity awards to officers, directors, employees and consultants, including stock options, restricted stock, restricted stock units (including performance units), stock appreciation rights, and management incentive awards. The Compensation and Organization Committee of the Livent Board of Directors (the “Livent Committee”) has the authority to amend the Livent Plan at any time, approve financial targets, award grants, establish performance objectives and conditions and the times and conditions for payment of awards.

Stock options granted under the Livent Plan may be incentive or non-qualified stock options. The exercise price for stock options may not be less than the fair market value of the stock at the date of grant. Awards granted under the Livent Plan vest or become exercisable or payable at the time designated by the Livent Committee. The options granted in 2021 will vest on the third anniversary of the date of grant, subject generally to continued employment, and cost is recognized over the vesting period. Incentive and non-qualified options granted under the Livent Plan expire not later than 10 years from the grant date.

Under the Livent Plan, awards of restricted stock units ("RSUs") vest over periods designated by the Livent Committee. The RSUs granted in 2021 to employees vest on the same schedule as the stock options granted in 2021. The RSUs granted to non-employee directors in 2021 vest at the Company's next annual meeting of stockholders following the grant date. Compensation cost is recognized over the vesting periods based on the market value of Livent common stock on the grant date of the award.

Stock Compensation

We recognized the following stock compensation expense for awards under the Livent Plan:


	Year Ended December 31,
(in Millions)	2021		2020		2019
Stock Option Expense, net of taxes of $0.3, $0.2 and $0.4	$	1.6	$	1.1	$	1.7
Restricted Stock Expense, net of taxes of $0.6, $0.5 and $0.8	2.9		2.6		2.8

Total Stock Compensation Expense, net of taxes of $0.9, $0.7 and $1.2 (1)	$	4.5	$	3.7	$	4.5

____________________

1.Gross stock compensation charges of $5.3 million was recorded to "Selling, general and administrative expenses" in our consolidated statement of operations for the year ended December 31, 2021. Gross stock compensation charges of $4.1 million, $0.2 million and $0.1 million were recorded to "Selling, general and administrative expenses", "Restructuring and other charges", and "Separation-related costs", respectively, in our consolidated statement of operations for the year ended December 31, 2020. Gross stock compensation charges of $4.3 million, $1.2 million and $0.2 million were recorded to "Selling, general and administrative expenses", "Restructuring and other charges", and "Separation-related costs", respectively, in our consolidated statement of operations for the year ended December 31, 2019.

Stock Options

The grant date fair values of the stock options granted in the year ended December 31, 2021, were estimated using the Black-Scholes option valuation model, the key assumptions for which are listed in the table below. The expected volatility assumption is based on the historical volatility of a group of twelve of our publicly traded peers that operate in the specialty chemical sector and five companies that have recently been spun off from larger publicly traded companies. The expected life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on U.S. Treasury securities with terms equal to the expected timing of stock option exercises as of the grant date. The dividend yield assumption reflects anticipated dividends on Livent's common stock. Livent stock options granted in 2021 cliff vest on the third anniversary following the grant date and expire ten years from the date of grant.

The following table contains Black Scholes valuation assumptions for stock option granted for the years ended December 31, 2021, 2020 and 2019:

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



	2021	2020	2019
Expected dividend yield	—%	—%	—%
Expected volatility	27.0%	20.2% - 20.7%	20.1% - 21.0%
Expected life (in years)	6.5	6.5	6.5
Risk-free interest rate	0.81%	1.20% - 1.73%	1.86% - 2.55%

The weighted-average grant date fair value of options granted during the years ended December 31, 2021, 2020 and 2019 was $5.86 per share, $2.29 and $3.26 per share, respectively.

The following table shows stock option activity, for the year ended December 31, 2021:


	Number of Options Granted But Not Exercised	Weighted-Average Remaining Contractual Life (in Years)	Weighted-Average Exercise Price Per Share		Aggregate Intrinsic Value (in Millions)




Outstanding as of December 31, 2020	1,725,494	6.2 years	$	12.45	$	11.0
Granted	542,760		$	20.35
Exercised	(109,578)		$	13.56	$	1.2
Forfeited	(24,245)		$	15.09

Outstanding as of December 31, 2021	2,134,431	6.4 years	$	14.37	$	21.4
Exercisable as of December 31, 2021	930,390	4.6 years	$	11.64	$	11.9

As of December 31, 2021 and December, 31, 2020, we had total remaining unrecognized compensation cost related to unvested stock options of $3.0 million and $1.7 million, which will be amortized over the weighted-average remaining requisite service period of approximately 1.9 years. The aggregate intrinsic value of stock options exercised for the year ended December 31, 2020 was $0.4 million. No stock options were exercised during the year ended December 31, 2019.

Restricted Stock Unit Awards

The grant date fair value of RSUs under the Livent Plan is based on the market price per share of Livent's common stock on the date of grant, and the related compensation cost is amortized to expense on a straight-line basis over the vesting period during which the employees perform related services, which for the RSUs granted in 2021 is cliff vesting on the third anniversary following the grant date.

The following table shows RSU activity for the year ended December 31, 2021:


	Restricted Stock Units
	Number of awards	Weighted-Average Grant Date Fair Value		Aggregate Intrinsic Value (in Millions)








Nonvested as of December 31, 2020	687,006	$	11.50	$	12.9
Granted	274,408	$	20.12
Vested	(233,130)	$	13.70
Forfeited	(11,846)	$	14.78
Nonvested as of December 31, 2021	716,438	$	14.03	$	17.5

The weighted-average grant date fair value of RSUs granted during the years ended December 31, 2021, 2020 and 2019 was $20.12 per share, $7.31 per share and $11.50 per share, respectively. The intrinsic value of RSUs vested during the years ended December 31, 2021, 2020, and 2019 was $5.0 million, $1.6 million, and $0.7 million, respectively. The total fair value of RSUs vested during the years ended December 31, 2021, 2020 and 2019 was $3.2 million, $1.7 million, and $1.3 million, respectively.

As of December 31, 2021, there was total remaining unrecognized compensation cost related to unvested RSUs of $4.5 million which will be amortized over the weighted-average remaining requisite service period of approximately 1.8 years.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 13: Equity

For the period from December 31, 2018 to December 31, 2021, the Company had 2 billion shares of common stock authorized. The following table reflects the changes in Livent's common shares issued and outstanding for each period presented:


	Issued	Treasury	Outstanding







Balance as of December 31, 2019	146,085,696	(104,012)	145,981,684
RSU awards	256,161	—	256,161
Stock option awards	119,392	—	119,392
Net sales of treasury stock - deferred compensation plan	—	4,744	4,744
Balance as of December 31, 2020	146,461,249	(99,268)	146,361,981
RSU awards	270,775	—	270,775
Stock option awards	109,578	—	109,578
Net purchases of treasury stock - deferred compensation plan	—	(2,350)	(2,350)
Issuance of common stock	14,950,000	—	14,950,000
Balance as of December 31, 2021	161,791,602	(101,618)	161,689,984

On June 15, 2021, the Company closed on the issuance of 14,950,000 shares of its common stock, par value $0.001 per share, at a public offering price of $17.50 per share, in an underwritten public offering (the "Offering"), including 1,950,000 shares purchased under a 30-day underwriters' option exercised in full by the underwriters on June 11, 2021. Total net proceeds from the Offering, including from the exercise of the underwriters’ option, were $252.2 million, after deducting the underwriters’ fees and offering expenses payable by the Company of $9.4 million. The total net proceeds were recorded to paid-in capital in the consolidated balance sheet.

Accumulated other comprehensive loss

Summarized below is the roll forward of accumulated other comprehensive loss, net of tax.


(in Millions)	Foreign currency adjustments		Derivative Instruments (1)		Total



Accumulated other comprehensive loss, net of tax as of December 31, 2019	$	(48.3)	$	—	$	(48.3)
Other comprehensive income before reclassifications	3.9		—		3.9

Accumulated other comprehensive loss, net of tax as of December 31, 2020	$	(44.4)	$	—	$	(44.4)
Other comprehensive income before reclassifications	1.3		0.3		1.6
Amounts reclassified from accumulated other comprehensive loss	—		(0.1)		(0.1)
Accumulated other comprehensive loss, net of tax as of December 31, 2021	$	(43.1)	$	0.2	$	(42.9)

______________

1.See Note 15 for more information.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Reclassifications of accumulated other comprehensive loss

The table below provides details about the reclassifications from accumulated other comprehensive loss and the affected line items in the consolidated statement of operations for each of the periods presented.


Details about Accumulated Other Comprehensive Loss Components	Amounts Reclassified from Accumulated Other Comprehensive Loss (1)		Affected Line Item in the Consolidated Statements of Income
(in Millions)	Year ended December 31, 2021			Year ended December 31, 2019


Derivative instruments
Foreign currency contracts	$	(0.1)		$	1.3	Costs of sales



Total before tax	(0.1)			1.3
	—			(0.1)		Provision for income taxes
Amount included in net income	$	(0.1)		$	1.2







Total reclassifications for the period	$	(0.1)		$	1.2	Amount included in net income

____________________

1.Amounts in parentheses indicate charges to the consolidated statement of operations. No amounts were reclassified for the year ended December 31, 2020. Provision for income taxes was less than $0.1 million for the year ended December 31, 2021.

Dividends

For the years ended December 31, 2021, 2020 and 2019, we paid no dividends. We do not expect to pay any dividends in the foreseeable future.

Note 14: Earnings/(Loss) Per Share

Earnings/(loss) per common share ("EPS") is computed by dividing net (loss)/income by the weighted average number of common shares outstanding during the period on a basic and diluted basis.

Our potentially dilutive securities include potential common shares related to our stock options, restricted stock units and 2025 Notes. Diluted earnings/(loss) per share (“Diluted EPS”) considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. Diluted EPS excludes the impact of potential common shares related to our stock options in periods in which the option exercise price is greater than the average market price of our common stock for the period. We use the if-converted method when calculating the potential dilutive effect of our 2025 Notes.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Earnings/(loss) applicable to common stock and common stock shares used in the calculation of basic and diluted (loss)/earnings per share are as follows:


(in Millions, Except Per Share Data)	Year Ended December 31,
	2021		2020 (1)		2019
Numerator:
Net income/(loss)	$	0.6	$	(16.3)	$	50.2
Adjustment for interest on 2025 Notes, net of tax (2)	0.2		—		—
Net income/(loss) after assumed conversion of 2025 Notes	$	0.8	$	(16.3)	$	50.2

Denominator:
Weighted average common shares outstanding - basic	154.7		146.2		146.0
Dilutive share equivalents from share-based plans	1.5		—		0.4
Dilutive share equivalents from 2025 Notes	28.1		—		—
Weighted average common shares outstanding - diluted	184.3		146.2		146.4

Basic earnings/(loss) per common share:


Net income/(loss) per weighted average share - basic	$	—	$	(0.11)	$	0.34
Diluted earnings/(loss) per common share:
Net income/(loss) per weighted average share - diluted	$	—	$	(0.11)	$	0.34

_______________________________

1.As adjusted for the adoption of ASU 2020-06 using the full retrospective method.

2.For the years ended December 31, 2021 and 2020, $11.4 million and $5.7 million of interest for the 2025 Notes was capitalized, respectively.

The following table presents weighted average share equivalents associated with share-based plans and the 2025 Notes that were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The 2025 Notes are further discussed in Note 11.


(in Millions)	Year Ended December 31,
	2021	2020	2019
Share equivalents from share-based plans	—	0.7	—
Share equivalents from 2025 Notes	—	14.6	—
Total antidilutive weighted average share equivalents	—	15.3	—

Anti-dilutive stock options

For the year ended December 31, 2021, none of the outstanding options to purchase shares of our common stock were anti-dilutive. For the years ended December 31, 2020 and 2019, options to purchase 1,684,731 shares of our common stock at an average exercise price of $13.13 per share and 1,127,253 shares of our common stock at an average exercise price of $14.43 per share, respectively, were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average market price of the common stock for the full year.

Note 15: Financial Instruments, Risk Management and Fair Value Measurements

Our financial instruments include cash and cash equivalents, trade receivables, other current assets, investments held in trust fund, trade payables, derivatives and amounts included in accruals meeting the definition of financial instruments. Investments in the Livent NQSP deferred compensation plan trust fund are considered Level 1 investments based on readily available quoted prices in active markets for identical assets. The carrying value of cash and cash equivalents, trade receivables, other current assets, and accounts payable approximates their fair value and are considered Level 1 investments. Our other financial instruments include the following:

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


Financial Instrument						Valuation Method

Foreign exchange forward contracts						Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.

The estimated fair value of our foreign exchange forward contracts have been determined using standard pricing models which take into account the present value of expected future cash flows discounted to the balance sheet date. These standard pricing models utilize inputs derived from, or corroborated by, observable market data such as interest rate yield curves and currency and commodity spot and forward rates.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The inputs used to measure fair value are classified into the following hierarchy:

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 - Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.

Level 3 - Unobservable inputs for the asset or liability.

The estimated fair value and the carrying amount of debt was $796.0 million and $240.4 million, respectively, as of December 31, 2021. Our 2025 Notes are classified as Level 2 in the fair value hierarchy.

Use of Derivative Financial Instruments to Manage Risk

We mitigate certain financial exposures connected to currency risk through a program of risk management that includes the use of derivative financial instruments. We enter into foreign exchange forward contracts to reduce the effects of fluctuating foreign currency exchange rates.

We formally document all relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also assess both at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If we determine that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we discontinue hedge accounting with respect to that derivative prospectively.

Foreign Currency Exchange Risk Management

We conduct business in many foreign countries, exposing earnings, cash flows, and our financial position to foreign currency risks. The majority of these risks arise as a result of foreign currency transactions. The primary currencies for which we have exchange rate exposure are the Euro, the British pound, the Chinese yuan, the Argentine peso, and the Japanese yen. We currently do not hedge foreign currency risks associated with the Argentine peso due to the limited availability and the high cost of suitable derivative instruments. Our policy is to minimize exposure to adverse changes in currency exchange rates. This is accomplished through a controlled program of risk management that could include the use of foreign currency debt and forward foreign exchange contracts. We also use forward foreign exchange contracts to hedge firm and highly anticipated foreign currency cash flows, with an objective of balancing currency risk to provide adequate protection from significant fluctuations in the currency markets.

Concentration of Credit Risk

Our counterparties to derivative contracts are primarily major financial institutions. We limit the dollar amount of contracts entered into with any one financial institution and monitor counterparties’ credit ratings. We also enter into master netting agreements with each financial institution, where possible, which helps mitigate the credit risk associated with our financial instruments. While we may be exposed to credit losses due to the nonperformance of counterparties, we consider this risk remote.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Accounting for Derivative Instruments and Hedging Activities

Cash Flow Hedges

We recognize all derivatives on the balance sheet at fair value. On the date we enter into the derivative instrument, we designate the derivative as a hedge of the variability of cash flows to be received or paid related to a forecasted transaction (cash flow hedge). We record in Accumulated Other Comprehensive Loss ("AOCL") changes in the fair value of derivatives that are designated as and meet all the required criteria for, a cash flow hedge. We then reclassify these amounts into earnings as the underlying hedged item affects earnings. In contrast we immediately record in earnings changes in the fair value of derivatives that are not designated as cash flow hedges. As of December 31, 2021, we had open foreign currency forward contracts in AOCL in a net after-tax gain position of $0.2 million designated as cash flow hedges of underlying forecasted sales and purchases. As of December 31, 2021 we had open forward contracts with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $18.1 million.

Less than $0.2 million of net after-tax gain, representing open foreign currency exchange contracts, will be realized in earnings during the twelve months ending December 31, 2022 if spot rates in the future are consistent with market rates as of December 31, 2021. The actual effect on earnings will be dependent on the actual spot rates when the forecasted transactions occur. We recognize derivative gains and losses in the “Costs of sales and services” line in the consolidated statements of operations.

Derivatives Not Designated As Cash Flow Hedging Instruments

We hold certain forward contracts that have not been designated as cash flow hedging instruments for accounting purposes. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as cash flow hedging instruments and changes in the fair value of these items are recorded in earnings.

We had open forward contracts not designated as cash flow hedging instruments for accounting purposes with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $102.8 million as of December 31, 2021.

Fair Value of Derivative Instruments

The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments. The Company had no open derivative cash flow hedge contracts as of December 31, 2020.


	December 31, 2021
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges
Derivatives
Foreign exchange contracts	$	0.2
Total derivative assets	0.2
Net derivative assets	$	0.2

______________________

1.Balance is included in “Prepaid and other current assets” in the consolidated balance sheets.

The following tables summarize the gains or losses related to our cash flow hedges and derivatives not designated as cash flow hedging instruments. The Company had no open derivative cash flow hedge contracts as of December 31, 2020 and 2019.

Derivatives in Cash Flow Hedging Relationships


(in Millions)	Total Foreign Exchange Contracts














Accumulated other comprehensive loss, net of tax at December 31, 2020	$	—
Unrealized hedging gains, net of tax	$	0.3
Reclassification of deferred hedging gains, net of tax (1)	(0.1)


Total derivative instrument impact on comprehensive loss, net of tax	0.2
Accumulated other comprehensive loss, net of tax at December 31, 2021	$	0.2

____________________

1.Amounts are included in “Cost of sales” on the consolidated statement of operations.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Derivatives Not Designated as Cash Flow Hedging Instruments


	Location of Gain or (Loss) Recognized in Income on Derivatives	Amount of Pre-tax Gain or (Loss) Recognized in Income on Derivatives (1)
		Year Ended December 31,
(in Millions)		2021		2020		2019
Foreign Exchange contracts	Cost of sales (2)	$	(2.4)	$	(1.7)	$	(1.2)

Total		$	(2.4)	$	(1.7)	$	(1.2)

____________________

1.Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

2.A loss of $0.4 million, loss of $0.1 million, and gain of $0.1 million related to intercompany loan hedges is included in Restructuring and other charges in the consolidated statement of operations for the years ended December 31, 2021, 2020 and 2019, respectively.

Fair-Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are defined as buyers or sellers in the principle or most advantageous market for the asset or liability that are independent of the reporting entity, knowledgeable and able and willing to transact for the asset or liability.

Fair-Value Hierarchy

We have categorized our assets and liabilities that are recorded at fair value, based on the priority of the inputs to the valuation technique, into a three-level fair-value hierarchy. The fair-value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets and liabilities fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair-value measurement of the instrument.

Recurring Fair Value Measurements

The following tables present our fair-value hierarchy for those assets and liabilities measured at fair-value on a recurring basis in our consolidated balance sheets as of December 31, 2021 and 2020.


(in Millions)	December 31, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets




Investments in deferred compensation plan (1)	$	3.4	$	3.4	$	—	$	—
Total Assets	$	3.4	$	3.4	$	—	$	—

Liabilities



Deferred compensation plan obligation (2)	$	5.9	$	5.9	$	—	$	—
Total Liabilities	$	5.9	$	5.9	$	—	$	—


(in Millions)	December 31, 2020		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets




Investments in deferred compensation plan(1)	$	2.6	$	2.6	$	—	$	—
Total Assets	$	2.6	$	2.6	$	—	$	—

Liabilities


Deferred compensation plan obligation (2)	$	4.5	$	4.5	$	—	$	—

Total Liabilities	$	4.5	$	4.5	$	—	$	—

____________________

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

1.Balance is included in “Other assets” in the consolidated balance sheets. Livent NQSP investments in Livent common stock are recorded as "Treasury stock" in the consolidated balance sheets and carried at historical cost. A mark-to-market loss of $0.6 million and $1.0 million related to the Livent common stock was recorded in "Selling, general and administrative expense" in the consolidated statements of operations for the years ended December 31, 2021 and December 31, 2020, respectively, with a corresponding offset to the deferred compensation plan obligation in the consolidated balance sheets.

2.Balance is included in “Other long-term liabilities” in the consolidated balance sheets.

3.See the Fair Value of Derivative Instruments table within this Note for classifications on our consolidated balance sheets.

Note 16: Commitments and Contingencies

Commitments

Leases

All of our leases are operating leases as of December 31, 2021. We have operating leases for corporate offices, manufacturing facilities, and land. Our leases have remaining lease terms of 2 years to 15 years. Disclosures about our leases under ASC 842 are summarized in the table below.


	Year ended December 31,
(in Millions)	2021		2020		2019
Lease Cost
Operating lease cost (1)	$	1.2	$	2.2	$	2.2
Short-term lease cost (2)	0.9		0.5		—
Variable lease cost (1)	0.1		0.2		0.2
Sublease income	—		—		(0.3)
Total lease cost (1)	$	2.2	$	2.9	$	2.1
Other information
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases	$	1.8	$	2.1	$	1.6

____________________________

1.Lease expense is classified as "Selling, general and administrative expenses" in our consolidated statements of operations.

2.The year ended December 31, 2021 includes $0.6 million for our corporate headquarters office space sublease with FMC, which terminated in the first quarter of 2021.

As of December 31, 2021, our operating leases had a weighted average remaining lease term of 8.3 years and a weighted average discount rate of 4.9%.

The table below presents a maturity analysis of our operating lease liabilities for each of the next five years and a total of the amounts for the remaining years.

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


(in Millions)	Undiscounted cash flows
2022	$	1.4
2023	1.2
2024	1.1
2025	1.1
2026	0.2
Thereafter	2.9
Total future minimum lease payments	7.9
Less: Imputed interest	(1.4)
Total	$	6.5

In the first quarter of 2021, we notified FMC of the termination of, effective July 31, 2021, our existing sublease with FMC for approximately twenty-five thousand square feet of office space used for our corporate headquarters in Philadelphia, Pennsylvania and removed the related right-of-use ("ROU") asset and lease liability of approximately $10.9 million from our consolidated balance sheets. On April 13, 2021 we executed a new five-year sublease agreement with a different counterparty for approximately thirteen thousand square feet of office space for our new corporate headquarters in Philadelphia, Pennsylvania and recorded a $2.1 million ROU asset and lease liability in the second quarter of 2021 related thereto.

Contingencies

We are a party to various legal proceedings, including those noted in this section. Livent records reserves for estimated losses from contingencies when information available indicates that a loss is probable and the amount of the loss, or range of loss, can be reasonably estimated. As additional information becomes available, management adjusts its assessments and estimates. Legal costs are expensed as incurred.

In addition to the legal proceedings noted below, we have certain contingent liabilities arising in the ordinary course of business. Some of these contingencies are known but are so preliminary that the merits cannot be determined, or if more advanced, are not deemed material based on current knowledge; and some are unknown - for example, claims with respect to which we have no notice or claims which may arise in the future from products sold, guarantees or warranties made, or indemnities provided. Therefore, we are unable to develop a reasonable estimate of our potential exposure of loss for these contingencies, either individually or in the aggregate, at this time. There can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on the consolidated financial position, results of operations in any one reporting period, or liquidity.

IPO Securities Litigation

As previously reported, in May 2019, purported stockholders of the Company (the "plaintiffs") filed putative class action complaints against the Company and certain other parties (the "defendants") in federal and state courts arising out of the Company's October 2018 IPO. The Company agreed to defend and indemnify FMC with regard to these cases.

On October 28, 2020, defendants entered into a stipulation of settlement with the state court plaintiffs in which the Company, on behalf of defendants, paid $7.4 million to resolve all claims related to the IPO. On October 29, 2020, the state court plaintiffs filed a motion seeking preliminary approval of the settlement. The court approved the settlement following a hearing on April 15, 2021 and a final order was issued on April 26, 2021. The settlement resolved all pending litigation relating to the IPO, including the claims in both the state and federal actions. The plaintiffs dismissed their appeal in the federal court on April 30, 2021 with prejudice in light of the settlement.

Nemaska arrangement

As previously reported, in October 2016, we entered into a long-term supply agreement (the “Agreement”) with Nemaska. To enforce our right to supply under the Agreement, in July 2018, we filed for arbitration before the International Chamber of Commerce (in accordance with the Agreement’s terms).

On December 22, 2019, Nemaska, Nemaska Lithium Inc. and certain affiliates filed for creditor protection in Canada under the Companies’ Creditors Arrangement Act (the "CCAA") in the Superior Court of Québec (the “CCAA Court”).

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

On May 29, 2020, we filed the Application with the CCAA Court to obtain remittance of U.S. $20 million held in escrow by a third party for the benefit of Livent (the “Escrow Funds”), composed of: (i) U.S. $10 million corresponding to the reimbursement of a payment made by Livent under the Agreement and (ii) U.S. $10 million corresponding to a termination penalty under the Agreement.

On June 22, 2020, we acknowledged the termination of the Agreement, withdrew our arbitration claims with prejudice, and requested the remittance of the Escrow Funds.

On August 24, 2020, Nemaska Lithium Inc. announced that it had accepted a sale proposal structured as a credit bid under the CCAA from a group made up of Orion Mine Finance, Investissement Québec and The Pallinghurst Group (The Pallinghurst Group acting through a new entity named Québec Lithium Partners; the "Nemaska Transaction"). In connection with the consummation of the Nemaska Transaction, Livent agreed to settle its claims against Nemaska Lithium Inc. and agreed to withdraw the Application before the CCAA Court in exchange for payment of an agreed upon portion of the Escrow Funds (subject to the final determination of any appeals).

On October 15, 2020, the Nemaska Transaction was approved by the CCAA Court pursuant to an approval and vesting order. The Supreme Court of Canada dismissed two appeals of this order by judgments dated April 29, 2021. The approval of the Nemaska Transaction is now final and executory.

Livent has entered into an agreement with The Pallinghurst Group relating to Québec Lithium Partners (a joint venture owned equally by The Pallinghurst Group and Livent) and the conduct of certain business operations previously conducted solely by Nemaska Lithium Inc. for the development a fully integrated lithium chemical asset located in Québec, Canada that is not yet in commercial production (the "Nemaska Project"). Livent indirectly owns a 25% equity interest in the Nemaska Project through its investment in Québec Lithium Partners.

Argentine Customs Authority

On July 31, 2020, we received notice from the Argentine Customs Authority that it was conducting an audit of Minera del Altiplano SA, our subsidiary in Argentina (“MdA”). The audit relates to the export of Lithium Carbonate from Argentina for the period January 10, 2015 through December 31, 2017. Although this relates to a period of time when MdA was a subsidiary of FMC, the Company agreed to bear any possible liability for this matter under the terms of the Tax Matters Agreement that it entered into with FMC at the Separation Date. A range of reasonably possible liabilities, if any, cannot be currently estimated by the Company.

Note 17: Supplemental Information

The following tables present details of prepaid and other current assets, other assets, accrued and other liabilities and other long-term liabilities as presented on the consolidated balance sheets:


(in Millions)	December 31,
	2021		2020
Prepaid and other current assets
Tax related items	$	17.7	$	15.7
Argentina government receivable (1)	13.3		10.8
Prepaid expenses	12.2		8.2
Other receivables	2.3		8.6

Derivative assets (Note 15)	0.2		—


Bank Acceptance Drafts (2)	—		0.2
Other current assets (3)	9.6		12.8
Total	$	55.3	$	56.3

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


(in Millions)	December 31,
	2021		2020
Other assets
Argentina government receivable (1)	$	55.8	$	55.8
Advance to contract manufacturers (4)	16.0		16.3
Long-term raw materials inventory	4.9		—
Capitalized software, net	1.5		1.8
Tax related items	1.3		2.7




Other long-term assets	11.4		11.8
Total	$	90.9	$	88.4

____________________

1.We have various subsidiaries that conduct business within Argentina. At December 31, 2021 and 2020, $38.4 million and $39.5 million of outstanding receivables due from the Argentina government, which primarily represent export tax and export rebate receivables, were denominated in U.S. dollars. As with all outstanding receivable balances we continually review recoverability by analyzing historical experience, current collection trends and regional business and political factors among other factors.

2.Bank Acceptance Drafts are a common Chinese finance note used to settle trade transactions. Livent accepts these notes from Chinese customers based on criteria intended to ensure collectability and limit working capital usage.

3.December 31, 2020 balance includes a $5.4 million receivable for insurance reimbursement related to the IPO litigation settlement which was netted with the IPO litigation settlement accrual in "Restructuring and other" in the consolidated statement of operations (see Note 8 and Note 16 for details).

4.We record deferred charges related to certain contract manufacturing agreements which we amortize over the term of the underlying contract.


(in Millions)	December 31,
	2021		2020
Accrued and other current liabilities
Accrued payroll	$	17.1	$	12.5
Accrued investment in unconsolidated affiliate	6.2		—
Restructuring reserves	3.2		3.2
Retirement liability - 401K	2.5		2.6

Environmental reserves, current	0.5		0.6

Severance	—		2.5
Other accrued and other current liabilities (1)	32.3		15.3
Total	$	61.8	$	36.7


(in Millions)	December 31,
	2021		2020
Other long-term liabilities
Deferred compensation plan obligation	$	5.9	$	4.5
Contingencies related to uncertain tax positions (2)	2.3		3.4
Self insurance reserves	1.5		1.5
Asset retirement obligations	0.3		0.3
Accrued investment in unconsolidated affiliate	—		6.2
Other long-term liabilities	1.7		1.3
Total	$	11.7	$	17.2

Table of Contents

LIVENT CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

____________________

1.December 31, 2020 includes a $7.4 million settlement accrual related to IPO litigation. See Note 16 for details about IPO litigation settlement. 2021 and 2020 amounts include accrued capital expenditures related to our expansion projects.

2.As of December 31, 2021, we have recorded a liability for uncertain tax positions of $1.9 million and a $0.4 million indemnification liability to FMC for assets where the offsetting uncertain tax position is with FMC.

Note 18: Quarterly Financial Information (Unaudited)

On January 1, 2021, the Company elected to early adopt new accounting guidance ASU 2020-06 which simplifies the accounting for convertible debt instruments. The Company elected the full retrospective method of adoption; that is, the accounting change was recognized as an adjustment to the balance of retained earnings, additional paid-in capital, long-term debt and deferred income taxes in our consolidated balance sheet as of December 31, 2020, the year in which the 2025 Notes were issued. Our 2025 Notes are now reported as a single liability instrument net of transaction costs with an interest rate closer to the coupon interest rate. The amounts below in the comparative quarterly financial information of the prior year have been adjusted to apply the new method retrospectively. See Note 11 for more information.


(in Millions, Except Per Share Data)	2021								2020
	1Q		2Q		3Q		4Q		1Q		2Q		3Q		4Q
Revenue	$	91.7	$	102.2	$	103.6	$	122.9	$	68.5	$	64.9	$	72.6	$	82.2
Gross margin	$	13.3	$	20.4	$	18.3	$	36.4	$	14.6	$	10.2	$	2.8	$	9.2
Income/(loss) from operations before loss on debt extinguishment, equity in net loss of unconsolidated affiliates, and interest expense, net	$	1.7	$	5.4	$	3.8	$	18.8	$	(2.1)	$	(1.9)	$	(13.2)	$	(3.9)
Interest expense, net	$	0.3	$	—	$	—	$	—	$	—	$	—	$	0.3	$	—
Income tax expense/(benefit)	$	0.9	$	(2.5)	$	15.4	$	9.5	$	(0.3)	$	(2.0)	$	(3.1)	$	(0.3)
Net (loss)/income	$	(0.8)	$	6.5	$	(12.6)	$	7.5	$	(1.9)	$	(0.2)	$	(10.5)	$	(3.7)
Net loss/(income) per weighted average share - basic (1)	$	(0.01)	$	0.04	$	(0.08)	$	0.05	$	(0.01)	$	—	$	(0.07)	$	(0.03)
Net loss/(income) per weighted average share - diluted (1)	$	(0.01)	$	0.03	$	(0.08)	$	0.04	$	(0.01)	$	—	$	(0.07)	$	(0.03)
Weighted average common shares outstanding:
Basic	146.5		148.7		161.6		161.7		146.1		146.2		146.3		146.3
Diluted	146.5		178.0		161.6		191.6		146.1		146.2		146.3		146.3

____________________

1.The sum of quarterly earnings per common share may differ from the full-year amount.

Table of Co ntents

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Livent Corporation:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Livent Corporation and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income/(loss), equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 28, 2022 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Change in Accounting Principle

As discussed in Note 2 and 3 to the consolidated financial statements, the Company has changed its method of accounting for convertible debt instruments as of January 1, 2021 due to the adoption of Accounting Standards Update (ASU) 2020-06, Det - Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Topic 815).

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Assessment of uncertain tax positions

As discussed in Note 10 to the consolidated financial statements, the Company has recorded unrecognized tax benefits of $2.9 million as of December 31, 2021. This balance primarily relates to tax positions from periods prior to the Company’s initial public offering in 2018 and for which the Company is indemnified for by its former parent, FMC Corporation.

We identified the assessment of the Company’s unrecognized tax benefits, other than those that are indemnified by the Company’s former parent, as a critical audit matter. This is due to the complex auditor judgment that was required in evaluating the Company’s interpretation of tax laws in the international jurisdictions in which the Company operates, its

Table of Co ntents

intercompany charges and cross-jurisdictional transfer pricing (collectively “intercompany pricing”) policies, and its estimate of the ultimate resolution of the tax positions.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the critical audit matter. This included certain controls related to the interpretation of tax law and related to intercompany pricing policies. We also tested certain controls related to the application of tax law and intercompany pricing policies in the liability estimation process. Since tax laws, as well as intercompany pricing, are complex and often subject to interpretations, we involved tax and transfer pricing professionals with specialized skills and knowledge, who assisted in:

–evaluating the Company’s interpretation of tax law and the potential impact of intercompany pricing policies on the unrecognized tax benefits

–assessing intercompany pricing studies for compliance with applicable laws and regulations

–assessing the reliability of the data used in the intercompany pricing studies

–inspecting settlement documents with applicable taxing authorities, and assessing the expiration of statutes of limitations

–assessing the amounts recognized in the financial statements to check that they are consistent with the amounts determined for the related uncertain tax positions.

In addition, we evaluated the Company’s ability to accurately estimate its unrecognized tax benefits by comparing unrecognized tax benefits to actual results upon conclusion of tax examinations or expiration of the statute of limitations.

/s/ KPMG LLP

We have served as the Company’s auditor since 2017.

Philadelphia, Pennsylvania

February 28, 2022

Table of Co ntents

MANAGEMENT’S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rule 13a-15(f). Livent’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Internal control over financial reporting includes those written policies and procedures that:


•			pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of Livent;


•			provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles;


•			provide reasonable assurance that receipts and expenditures of Livent are being made only in accordance with authorization of management and directors of Livent; and


•			provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.

Internal control over financial reporting includes the controls themselves, monitoring and internal auditing practices and actions taken to correct deficiencies as identified.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

We assessed the effectiveness of our internal control over financial reporting as of December 31, 2021. We based this assessment on criteria for effective internal control over financial reporting described in “Internal Control—Integrated Framework (COSO 2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of our internal control over financial reporting. We reviewed the results of our assessment with the Audit Committee of our Board of Directors.

Based on this assessment, we determined that, as of December 31, 2021, Livent has effective internal control over financial reporting.

KPMG LLP, our independent registered public accounting firm, has issued an attestation report on the effectiveness of internal control over financial reporting as of December 31, 2021, which appears on the following page.

Table of Co ntents

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Livent Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited Livent Corporation and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income/(loss), equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements), and our report dated February 28, 2022 expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying "Management's Annual Report on Internal Control over Financial Reporting". Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

/s/ KPMG LLP

Philadelphia, Pennsylvania

February 28, 2022

Table of Co ntents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Management’s Annual Report on Internal Control over Financial Reporting. Refer to Management’s Report on Internal Control Over Financial Reporting which is included in Item 8 of Part II of this Annual Report on Form 10-K and is incorporated by reference to this Item 9A.

(c) Attestation Report of the Independent Registered Public Accounting Firm. Refer to Report of Independent Registered Public Accounting Firm which is included in Item 8 of Part II of this Annual Report on Form 10-K and is incorporated by reference to this Item 9A.

(d) Change in Internal Controls over Financial Reporting. There have been no changes in internal controls over financial reporting that occurred during the quarter ended December 31, 2021 that materially affected or are reasonably likely to materially affect our internal control over financing reporting.

ITEM 9B. OTHER INFORMATION

Not applicable.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

Table of Co ntents

PART III

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information concerning directors, appearing under the caption “III. Board of Directors” in our Proxy Statement to be filed with the SEC in connection with the Annual Meeting of Stockholders scheduled to be held on April 26, 2022 (the “Proxy Statement”), information concerning executive officers, appearing under the caption “Item 4A. Executive Officers of the Registrant” in Part I of this Form 10-K, information concerning the Audit Committee, appearing under the caption “IV. Information About the Board of Directors and Corporate Governance - Committees and Independence of Directors - Audit Committee” in the Proxy Statement, and information concerning the Code of Ethics, appearing under the caption “IV. Information About the Board of Directors and Corporate Governance - Corporate Governance - Code of Ethics and Business Conduct Policy” in the Proxy Statement, and is incorporated herein by reference in response to this Item 10.

ITEM 11. EXECUTIVE COMPENSATION

The information contained in the Proxy Statement in the section titled “VI. Executive Compensation” with respect to executive compensation, in the section titled “IV. Information About the Board of Directors and Corporate Governance—Director Compensation” and “—Corporate Governance—Compensation and Organization Committee Interlocks and Insider Participation” is incorporated herein by reference in response to this Item 11.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information contained in the section titled “V. Security Ownership of Livent Corporation” in the Proxy Statement, with respect to security ownership of certain beneficial owners and management, is incorporated herein by reference in response to this Item 12.

Equity Compensation Plan Information

The table below sets forth information with respect to compensation plans under which equity securities of Livent are authorized for issuance as of December 31, 2021. All of the equity compensation plans pursuant to which we are currently granting equity awards have been approved by stockholders.


Plan Category	Number of Securities to be issued upon exercise of outstanding options and restricted stock units (A) (1)	Weighted-average exercise price of outstanding options awards (B) (2)		Number of Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A)) (C) (3)
Equity Compensation Plans approved by stockholders	4,360,918	$	14.37	6,322,919

(1)Includes 2,490,593 stock options and 667,919 Restricted Stock Units granted to Livent employees, 283,784 Restricted Stock Units held by Livent non-employee directors and 918,622 Restricted Stock Units held by FMC personnel but subject to settlement in Livent common stock as a result of the bifurcation of certain FMC equity awards in connection with the Distribution.

(2)Taking into account all outstanding awards included in this table, the weighted-average exercise price of such stock options is $14.37 and the weighted-average term-to-expiration is 6.4 years.

(3)The Livent Plan contains an “evergreen” provision, pursuant to which the number of shares of Livent common stock available for issuance under the Livent Plan will be increased by an amount equal to the lesser of (a) 3% of the number of issued and outstanding shares of common stock as of January 1 of each year or (b) such other number of shares of common stock as determined by the Board of Directors in its discretion. The Board of Directors determined not to authorize any increase in the shares available for issuance under the Livent Plan pursuant to the "evergreen" provision as of January 1, 2022.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information contained in the Proxy Statement concerning our independent directors and related party transactions under the caption “IV. Information About the Board of Directors and Corporate Governance—Committees and Independence of Directors” and the information contained in the Proxy Statement concerning our related party transactions policy, appearing under the caption “IV. Information About the Board of Directors and Corporate Governance—Corporate Governance—Related Party Transactions Policy,” is incorporated herein by reference in response to this Item 13.

Table of Co ntents

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information contained in the Proxy Statement in the section titled “II. The Proposals to be Voted On—Ratification of Appointment of Independent Registered Public Accounting Firm” is incorporated herein by reference in response to this Item 14.

Auditor Information

Auditor Name: KPMG LLP

Auditor Location: Philadelphia, PA (U.S. firm)

Auditor Firm ID: PCAOB ID 185

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)Documents filed with this Report

1. Consolidated financial statements of Livent Corporation and its subsidiaries are incorporated under Item 8 of this Form 10-K.

The schedules not included herein are omitted because they are not applicable or the required information is presented in the financial statements or related notes.

2. Exhibits: See attached Index of Exhibits

(b)Exhibits


Exhibit No.			Exhibit Description
*3.1			Certificate of Incorporation of Livent Corporation (Exhibit 3.1 to Amendment No. 1 to the Registrant's Registration Statement on Form S-1/A filed on October 1, 2018 (the "2018 Form S-1/A"))
*3.2			By-Laws of Livent Corporation (Exhibit 3.2 to the 2018 Form S-1/A)
*4.1			Form of Common Stock Certificate (Exhibit 4.1 to the 2018 Form S-1/A)
*4.2			Description of Common Stock (Exhibit 4.2 to the Registrant's Annual Report on Form 10-K filed on February 26, 2021 (the "2020 Form 10-K"))
*4.3			Indenture, dated as of June 25, 2020, between Livent Corporation and U.S. Bank National Association. (Exhibit 4.1 to Current Report on Form 8-K filed on June 25, 2020)
*4.4.			Form of 4.125% Convertible Senior Notes due 2025 (Exhibit 4.2 to Current Report on Form 8-K filed on June 25, 2020)
*10.1			Tax Matters Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.4 to the October 15, 2018 Form 8-K)
*10.2			Agreement dated as of February 21, 1991, as amended among the Province of Catamarca, Argentina, FMC Corporation and Minera del Altiplano S.A. (Exhibit 10.9 to the Registrant's Registration Statement on Form S-1 filed on August 27, 2018)
*10.3			Credit Agreement, dated as of September 28, 2018, among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein (Exhibit 10.10 to the 2018 Form S-1/A)
†*10.4			Livent Corporation Incentive Compensation and Stock Plan, as of October 10, 2018 (Exhibit 99 to the Registrant's Registration Statement on Form S-8 filed on October 11, 2018)
†*10.5			Form of IPO RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Exhibit 10.11 to the 2018 Form S-1/A)
†*10.6			Form of IPO Option Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Exhibit 10.12 to the 2018 Form S-1/A)
†*10.7			Form of Employee RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Exhibit 10.13 to the 2020 Form 10-K)
†10.8			Form of Employee Option Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan
†*10.9			Form of Non-Employee Director RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Annual Equity Grant) (Exhibit 10.13 to the 2018 Form S-1/A)

Table of Co ntents


Exhibit No.			Exhibit Description
†*10.10			Form of Non-Employee Director RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Retainer Grant) (Exhibit 10.14 to the 2018 Form S-1/A)
†*10.11			Livent Corporation Compensation Policy for Non-Employee Directors, as of December 11, 2018 (Exhibit 10.17 to the 2018 Form 10-K)
†*10.12			Livent Corporation Executive Severance Guidelines for Corporate Officers, as of October 10, 2018 (Exhibit 10.18 to the 2018 Form 10-K)
†*10.13			Livent Corporation Executive Severance Plan, dated as of February 22, 2021, with Form of Agreement (Exhibit 10.19 to the 2020 Form 10-K)
†*10.14			Executive Severance Agreement, dated as of February 23, 2021, by and between Livent Corporation and Paul Graves (Exhibit 10.20 to the 2020 Form 10-K). Pursuant to Instruction 2 to Item 601 of Regulation S-K, an Executive Severance Agreement that is substantially identical in all material respects, except as to the parties thereto, between Livent Corporation and Gilberto Antoniazzi was not filed.
†*10.15			Livent Non-qualified Savings Plan Adoption Agreement, as of January 1, 2019 (Exhibit 10.21 to the 2018 Form 10-K)
†*10.16			Livent Non-qualified Savings Plan, as of January 1, 2019 (Exhibit 10.22 to the 2018 Form 10-K)
†*10.17			Executive Severance Agreement, dated as of February 24, 2021, by and between Livent Corporation and Sara Ponessa (Exhibit 10.23 to the 2020 Form 10-K)
*10.18			First Amendment to the Credit Agreement, dated May 6, 2020, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein (Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020)
*10.19			Second Amendment to the Credit Agreement, dated August 3, 2020, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein (Exhibit 10.2 to the Registrants Quarterly Report on Form 10-Q for the three months ended June 30, 2020)
*10.20			First Amendment to Trademark License Agreement, dated as of May 11, 2020, by and among FMC Corporation and Livent Corporation (Exhibit 10.26 to the 2020 Form 10-K)
10.21			Third Amendment to the Credit Agreement, dated November 5, 2021, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein
10.22			Fourth Amendment to the Credit Agreement, dated December 28, 2021, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein
21.1			Subsidiaries of the Registrant
23.1			Consent of KPMG LLP
23.2			Consent of Bloomberg NEF
23.3			Consent of Wood Mackenzie
23.4			Consent of EV-Volumes
31.1			Certifying Statement of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2			Certifying Statement of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1			Certifying Statement of the Chief Executive Officer pursuant to Section 1350 of Title 18 of the United States Code
32.2			Certifying Statement of the Chief Financial Officer pursuant to Section 1350 of Title 18 of the United States Code
101			Interactive Data File
104			Cover Page Interactive Data File

* Incorporated by reference

† Management contract or compensatory plan or arrangement

ITEM 16. FORM 10-K SUMMARY

Optional disclosure, not included in this Report.

Table of Co ntents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LIVENT CORPORATION

(Registrant)


By:			/S/ PAUL W. GRAVES
			Paul W. Graves President, Chief Executive Officer and Director

Date: February 28, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.


Signature	Title	Date
/S/ PAUL W. GRAVES Paul W. Graves	President, Chief Executive Officer and Director	February 28, 2022
/S/ GILBERTO ANTONIAZZI Gilberto Antoniazzi	Vice President and Chief Financial Officer	February 28, 2022
/S/ RONALD STARK Ronald Stark	Chief Accounting Officer	February 28, 2022
/S/ PIERRE R. BRONDEAU Pierre R. Brondeau	Chairman and Director	February 28, 2022
/S/ ROBERT C. PALLASH Robert C. Pallash	Director	February 28, 2022
/S/ G. PETER D'ALOIA G. Peter D’Aloia	Director	February 28, 2022
/S/ MICHAEL F. BARRY Michael F. Barry	Director	February 28, 2022
/S/ STEVEN T. MERKT Steven T. Merkt	Director	February 28, 2022
/S/ ANDREA E. UTECHT Andrea E. Utecht	Director	February 28, 2022
/S/ CHRISTINA LAMPE-ÖNNERUD Christina Lampe-Önnerud	Director	February 28, 2022
/S/ PABLO MARCET Pablo Marcet	Director	February 28, 2022

#113565746 v2 NONQUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This NONQUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”) is made by and between Livent Corporation (the “Company”) and [Participant Name] (the “Participant”). WHEREAS, the Company maintains the Livent Corporation Incentive Compensation and Stock Plan (as it may be amended from time to time, the “Plan”); WHEREAS, Article 8 of the Plan authorizes the grant of Awards in the form of Nonqualified Stock Options; and WHEREAS, in recognition of the Participant’s past and anticipated future contributions to the Company, and to further align the Participant’s personal financial interests with those of the Company’s stockholders, the Committee has approved this grant of an award of Nonqualified Stock Options to the Participant on the terms described herein, effective as of [Grant Date] (the “Grant Date”); and WHEREAS, the terms of the Plan are incorporated herein by reference and made a part of this Agreement and will control the rights and obligations of the Company and the Participant under this Agreement. In the event of a conflict among the provisions of the Plan, this Agreement and any descriptive materials provided in connection herewith, the provisions of the Plan will prevail. Capitalized terms not otherwise defined herein will have the same meanings as in the Plan. NOW, THEREFORE, in consideration of the mutual covenants herein contained and other good and valuable consideration, receipt of which is hereby acknowledged, the parties hereto agree as follows: 1. Grant of Option. Pursuant to the Plan, effective as of the Grant Date, the Committee hereby grants the Participant a Nonqualified Stock Option (“Option”) to purchase an aggregate of [Number of Shares Granted] shares of Common Stock (“Shares”), at an exercise price of [Exercise Price] per Share (“Exercise Price”), subject to the terms and conditions set forth in this Agreement. 2. Vesting. (a) [Vesting Terms] (b) Upon the Participant’s Termination of Employment for any reason, any Unvested Option (as defined below) will be forfeited immediately and automatically and the Participant will have no further rights with respect thereto. (c) For purposes of this Agreement, (i) “Vested Option” means any portion of the Option which has vested and become exercisable in accordance with the terms of this Exhibit 10.8

-2- #113565746 v2 Agreement (including pursuant to Sections 2(a)[ ]) and (ii) “Unvested Option” means any portion of the Option that is not a Vested Option. 3. Termination of Option. The Option and all rights hereunder, to the extent such rights will not have been exercised, will terminate and become null and void on the earliest to occur of (a) [Expiration Date], (b) [Period] after the date of the Participant’s Termination of Employment for any reason other than due to the Participant’s death or Disability, (c) [Period] after the Participant’s Termination of Employment due to the Participant’s Disability or death, (d) the date of the Participant’s Termination for Cause, (d) the date the Option is terminated in accordance with the Plan and this Agreement or (e) if so determined by the Committee, the date of a Change in Control, provided the Participant is afforded the opportunity to exercise any Vested Option immediately prior to such Change in Control (such earliest date being referred to herein as the “Option Expiration Date”). 4. Right to Exercise. Subject to the terms of this Agreement and the Plan, any Vested Option will remain exercisable from time to time, in whole or in part, until the Option Expiration Date. In no event may the Option (or any portion thereof) be exercised to any extent by the Participant (a) before it becomes a Vested Option or (b) after the Option Expiration Date. 5. Method of Exercise; Settlement. (a) The Participant may exercise a Vested Option with respect to all or any portion of the Shares underlying such Vested Option at any time prior to the Option Expiration Date by (i) delivering to the Company, in accordance with such procedures as determined by the Company, a written notice specifying the Grant Date, the number of such Shares as to which the Vested Option is being exercised (the “Exercise Notice”), (ii) paying the Company an amount equal to the sum of (1) the aggregate Exercise Price applicable to such Shares being exercised and (2) the amount of any taxes required to be withheld by the Company (collectively, the “Option Payment”) in accordance with Section 5(b) and (iii) making such representations and assurances as the Company deems necessary or appropriate to comply with applicable securities laws. The date on which the Participant delivers the Exercise Notice in accordance with this Section 5(a) shall be referred to herein as the “Exercise Date”. The Company may from time to time make available alternative methods of exercise upon notice to the Participant. (b) The Participant may pay the Option Payment by any of the following means (or by a combination thereof): (i) cash or check, certified bank draft or postal or express money order payable to the order of the Company in lawful money of the United States; or (ii) if permitted by the Committee, in its sole discretion, pursuant to such procedures as the Committee may require, by the Participant’s (A) transferring to the Company, effective as of the Exercise Date, a number of vested Shares owned and designated by the Participant having an aggregate Fair Market Value as of the Exercise Date equal to the Option Payment, (B) electing a “net cashless exercise” procedure in accordance with Section 8.04 of the Plan, or (C) delivering irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the Option Payment; or (iii) by any other method acceptable to the Committee.

-3- #113565746 v2 (c) As soon as practicable after receipt of the Exercise Notice and the Option Payment, the Company will, without transfer or issue tax or other incidental expense to the Participant, issue the Shares deliverable upon such exercise by causing its transfer agent to make an appropriate book entry in the name of the Participant. 6. Adjustments. The Committee shall make equitable substitutions or adjustments to the Option (including, without limitation, the Exercise Price) and/or Shares issuable upon the exercise of the Option as it determines to be necessary or appropriate in the event of any stock dividend, stock split, merger, consolidation, separation or other change in capitalization, spin-off, extraordinary dividend or distribution, reorganization (whether or not such reorganization comes within the definition of such term in Section 368 of the Code), reclassification, recapitalization, partial or complete liquidation of the Company or other similar event or transaction; provided, however, that no such substitution or adjustment will be made if such substitution or adjustment would give rise to any tax under Section 409A of the Code, and provided further, that the number of Shares subject to the Option will always be a whole number. 7. Non-Transferability. During the Participant’s lifetime, the Option will only be exercisable by the Participant, and neither the Option nor any right with respect thereto may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance will be void and unenforceable against the Company and may result in the Company terminating the Option. 8. Stockholder Rights. The Participant will not have any stockholder rights or privileges, including voting or dividend rights, with respect to the Shares subject to the Option until such Shares are actually issued and registered in the Participant’s name in the Company’s books and records. 9. No Limitation on Rights of the Company. For the avoidance of doubt, the grant of the Option will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure or to merge, consolidate, reincorporate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 10. Clawback Policy. Without limiting the generality of Article 14 of the Plan, to the extent the Participant is a current or former executive officer of the Company, the Option, any Shares or other securities or property issued in respect of the Option or upon exercise of the Option, and the rights of the Participant hereunder, are subject to any policy (whether currently in existence or later adopted) established by the Company providing for clawback or recovery of amounts paid or credited to current or former executive officers of the Company. The Committee will make any determination for clawback or recovery under any such policy in its sole discretion and in accordance with any applicable law or regulation, and the Participant agrees to be bound by any such determination. 11. No Continuation of Service. Nothing in this Agreement or in the Plan will confer on the Participant any right to continue in employment or service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or Affiliate

-4- #113565746 v2 employing or retaining the Participant) to terminate the Participant’s employment or service at any time for any reason, with or without cause. 12. Tax Treatment and Withholding. (a) The Participant has had the opportunity to review with his or her own tax advisors the federal, state and local tax consequences of the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. (b) The Company may withhold any tax (or other governmental obligation) arising in connection with the Option, and it is a condition to the Company’s obligation to issue Shares upon the exercise of the Option hereunder that the Participant pay to the Company such amount as may be required to satisfy all tax withholding obligations (or other governmental obligations) arising in connection with the Option (or otherwise make arrangements acceptable to the Company for the satisfaction of such tax withholding obligations). If the required withholding amount required is not timely paid or satisfied, the Participant’s right to receive such Shares upon exercise of the Option will be permanently forfeited. Notwithstanding the foregoing, and in accordance with Section 17.03 of the Plan, the Participant may satisfy any such withholding requirement by transferring to the Company pursuant to such procedures as the Committee may require, effective as of the date on which such requirement arises, a number of vested Shares owned and designated by the Participant having an aggregate Fair Market Value as of such date that is at least equal to the minimum, and not more than the maximum, amount required to be withheld. If the Committee permits the Participant to satisfy any such withholding requirement pursuant to the preceding sentence, the Company shall remit to the Internal Revenue Service and appropriate state and local revenue agencies, for the credit of the Participant, an amount of cash withholding equal to the Fair Market Value of the Shares transferred to the Company as provided above. 13. Government Regulation. The Company’s obligation to deliver Shares upon exercise of the Option will be subject to all applicable laws, rules and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required. 14. Notices. (a) Any notice required to be given or delivered to the Company under the terms of this Agreement will be addressed to it in care of its Secretary, Livent Corporation, 1818 Market Street, Philadelphia, PA 19103, and any notice to the Participant will be addressed to the Participant’s address now on file with the Company, or to such other address as either may designate to the other in writing. Except as otherwise provided below in Section 14(b), any notice will be deemed to be duly given when enclosed in a properly sealed envelope addressed as stated above and deposited, postage paid, in a post office or branch post office regularly maintained by the United States government. (b) The Participant hereby authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option, the Plan and any other compensation or benefit plan or arrangement in effect from time to time (including, without

-5- #113565746 v2 limitation, reports, proxy statements or other documents that are required to be delivered to participants in such plans or arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by means of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to the Participant a paper copy of any document also delivered to the Participant electronically. The authorization described in this Section 14(b) may be revoked by the Participant at any time by written notice to the Company. 15. Administration. By entering into this Agreement, the Participant agrees and acknowledges that (a) the Company has provided or made available to the Participant a copy of the Plan, (b) he or she has read the Plan, (c) the Option is subject to the Plan and (d) pursuant to the Plan, the Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee with respect to questions arising under the Plan or this Agreement. 16. References. References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant’s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Agreement. 17. Binding Effect. This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and permitted assigns. 18. Entire Agreement; Amendment. This Agreement, together with the Plan, represents the entire agreement between the parties with respect to the subject matter hereof and supersedes any prior agreement, written or otherwise, relating to the subject matter hereof. This Agreement may only be amended by a writing signed by each of the parties hereto, except that the Company may amend or modify this Agreement without the Participant’s consent in accordance with the provisions of the Plan. 19. Governing Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware, without reference to the principles of conflict of laws. 20. Privacy. By signing this Agreement, the Participant hereby acknowledges and agrees to the Company’s transfer of certain personal data of such Participant to the Company and its agents for purposes of implementing, performing or administering the Plan, this Award or any related benefit. Participant expressly gives his or her consent to the Company to process such personal data. 21. Discretionary Nature. The Participant acknowledges and agrees that this award is discretionary, and any future awards will be made in the Committee’s discretion; and that the Plan may be terminated, amended or canceled by the Company at any time in accordance with its terms.

-6- #113565746 v2 22. Section Headings. The headings of sections and paragraphs of this Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement. 23. Counterparts. This Agreement may be executed in multiple counterparts (including by facsimile or .pdf signature), each of which will be deemed to be an original, but all of which together will constitute but one and the same instrument. 24. Section 409A of the Code. To the extent applicable, this Agreement is intended to be exempt from the requirements of Section 409A of the Code and the regulations thereunder, and the provisions of this Agreement shall be interpreted accordingly. If any provision of this Agreement or any term or condition of the Option would otherwise frustrate or conflict with this intent, the provision, term or condition shall be interpreted and deemed amended so as to avoid this conflict. Notwithstanding the foregoing, in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A of the Code. [Signature Page Follows]

#113565746 v2 IN WITNESS WHEREOF, the Company’s duly authorized representative and the Participant have each executed this Agreement on the respective date below indicated. LIVENT CORPORATION By: Name: Title: Date: PARTICIPANT Signature:

EXECUTION VERSION WEIL:\98229966\5\35899.0596 THIRD AMENDMENT TO CREDIT AGREEMENT THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of November 5, 2021, by and among LIVENT CORPORATION, a Delaware corporation (“Livent”), FMC LITHIUM USA CORP., a Delaware corporation (together with Livent, collectively, the “Borrowers” and, each, a “Borrower”), the Guarantors (as defined below), the lenders and issuing banks listed on the signature pages hereof under the heading “Lenders” (the “Lenders”) and CITIBANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders. W I T N E S S E T H: WHEREAS, the Borrowers, the guarantors party thereto from time to time (the “Guarantors”), the lenders from time to time party thereto and the Administrative Agent are party to that certain Credit Agreement, dated as of September 28, 2018 (as amended by the First Amendment to Credit Agreement, dated as of May 6, 2020, and the Second Amendment to Credit Agreement, dated as of August 3, 2020, the “Existing Credit Agreement”; the Existing Credit Agreement, as amended by this Amendment, the “Amended Credit Agreement”). WHEREAS, the Borrowers and the Administrative Agent wish to amend Section 6.04(a)(xviii) of the Existing Credit Agreement as detailed herein, subject to the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the covenants and agreements contained herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: SECTION 1. Defined Terms. Capitalized terms used but not otherwise defined herein shall have the respective meanings assigned to such terms in the Amended Credit Agreement. SECTION 2. Amendments. Effective as of the Third Amendment Effective Date, Section 6.04(a)(xviii) of the Existing Credit Agreement is hereby amended and restated in its entirety as follows: “(xviii) other Indebtedness of Livent or its Restricted Subsidiaries (other than any Mine OpCo Group Member) in an aggregate principal amount (i) not to exceed $25 million at any time outstanding prior to the Covenant Conversion Date, and (ii) not to exceed $50 million at any time outstanding on and following the Covenant Conversion Date; and” SECTION 3. Representations and Warranties. Each Loan Parties hereby represent and warrant to the Lenders on the Third Amendment Effective Date that: (a) The execution, delivery and performance by each Loan Party of this Amendment and the consummation of the transactions contemplated hereby: (i) are within such Loan Party’s corporate, limited liability company, partnership or other powers; (ii) have been duly authorized by all necessary action, including the consent of shareholders, partners and members where required; Exhibit 10.21

- 2 - WEIL:\98229966\5\35899.0596 (iii) do not and will not contravene such Loan Party’s or any other Restricted Subsidiaries’ respective Constituent Documents, violate any other Requirement of Law applicable to such Loan Party or any other Restricted Subsidiary (including the Margin Regulations), or any order or decree of any Governmental Authority or arbitrator applicable to such Loan Party or any other Restricted Subsidiary, conflict with or result in the breach of, or constitute a default under, or result in or permit the termination or acceleration of, any Contractual Obligation of such Loan Party or any other Restricted Subsidiary, or result in the creation or imposition of any Lien upon any property of such Loan Party or any other Restricted Subsidiary; and (iv) do not require the consent of, authorization by, approval of, notice to, permit from or filing or registration with, any Governmental Authority or any other Person, other than those that have been or will be, prior to the Third Amendment Effective Date, obtained or made, and each of which on the Third Amendment Effective Date will be in full force and effect. (b) This Agreement has been duly executed and delivered by each Loan Party. This Agreement is the legal, valid and binding obligation of each Loan Party, enforceable against such Loan Party in accordance with its terms. (c) Immediately prior to and after giving effect to the terms, conditions, and provisions of this Amendment, no Default or Event of Default exists. (d) The representations and warranties contained in the Loan Documents are correct in all material respects (except any representations and warranties that are qualified by materiality, which shall be true and correct in all respects) with the same effect as though made on and as of such date, other than any such representations or warranties that, by their terms, refer to an earlier date, such representations and warranties are true and correct as of such earlier date. SECTION 4. Conditions to Effectiveness of this Amendment. The effectiveness of this Amendment is subject to the satisfaction (or waiver in writing by the Administrative Agent (at the direction of the Required Lenders)) of the following conditions precedent (the date on which such conditions are satisfied or waived being referred to herein as the “Third Amendment Effective Date”): (a) This Amendment, duly executed and delivered by each of the Borrowers, the Guarantors and the Lenders (which together constitute the Required Lenders). (b) Immediately prior to and after giving effect to the terms, conditions, and provisions of this Amendment, no Default or Event of Default exists. (c) The representations and warranties contained in this Amendment and the other Loan Documents are correct in all material respects (except any representations and warranties that are qualified by materiality, which shall be true and correct in all respects) with the same effect as though made on and as of such date, other than any such representations or warranties that, by their terms, refer to an earlier date, such representations and warranties are true and correct as of such earlier date.

- 3 - WEIL:\98229966\5\35899.0596 SECTION 5. Effect on Loan Documents. (a) On and after the effectiveness of this Amendment, each reference in the Existing Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import shall mean and be a reference to the Amended Credit Agreement and each reference in any other Loan Document to “the Credit Agreement” shall mean and be a reference to the Amended Credit Agreement. (b) Except as specifically amended hereby, all Loan Documents shall continue to be in full force and effect and are hereby in all respects ratified and confirmed. (c) The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents or in any way limit, impair or otherwise affect the rights and remedies of the Administrative Agent or the Lenders under the Loan Documents, except as provided herein. (d) The Borrowers and the other parties hereto acknowledge and agree that, on and after the effective date of this Amendment, this Amendment shall constitute a Loan Document for all purposes of the Amended Credit Agreement. SECTION 6. Applicable Law; Waiver of Right; Trial by Jury; Jurisdiction. THIS AMENDMENT, AND ALL CLAIMS OR CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) THAT MAY BE BASED UPON, ARISE OUT OF OR RELATE IN ANY WAY TO THIS AMENDMENT, THE EXECUTION OR PERFORMANCE OF THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO ANY PRINCIPLE OF CONFLICTS OF LAW THAT COULD REQUIRE THE APPLICATION OF ANY OTHER LAW. The jurisdiction and waiver of right to trial by jury provisions in Sections 9.12 and 9.13 of the Existing Credit Agreement are incorporated herein by reference, mutatis mutandis. SECTION 7. Miscellaneous. (a) This Amendment shall be binding upon and inure to the benefit of the Loan Parties and their respective successors and permitted assigns, and upon the Administrative Agent and the Lenders and their respective successors and permitted assigns. (b) The illegality or unenforceability of any provision of this Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment or any instrument or agreement required hereunder. (c) This Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic imaging (including in .pdf format) means shall be effective as delivery of a manually executed counterpart of this Amendment. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby or thereby shall be deemed to include Electronic Signatures (as defined below), deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery

- 4 - WEIL:\98229966\5\35899.0596 thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. For the purposes of the foregoing, “Electronic Signature” means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record. (d) Section headings herein are included for convenience of reference only and shall not affect the interpretation of this Amendment. SECTION 8. Reaffirmation. Each of the Loan Parties signatory hereto as debtor, grantor, pledgor, guarantor, assignor, or in any other similar capacity in which such Loan Party grants liens or security interests in its property or otherwise acts as accommodation party or guarantor, as the case may be, hereby (a) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Loan Documents to which it is a party (after giving effect hereto) and (b) to the extent such Loan Party granted liens on or security interests in any of its property pursuant to any such Loan Document as security for or otherwise guaranteed the Obligations under or with respect to the Loan Documents, ratifies and reaffirms such guarantee and grant of security interests and liens and confirms and agrees that such security interests and liens hereafter secure all of the Obligations as amended hereby. Each of the Loan Parties signatory hereto hereby consents to this Amendment and acknowledges that each of the Loan Documents (as amended herby) remains in full force and effect and is hereby ratified and reaffirmed. The execution of this Amendment shall not operate as a waiver of any right, power or remedy of the Administrative Agent or Lenders, constitute a waiver of any provision of any of the Loan Documents or serve to effect a novation of the Obligations. [Remainder of page intentionally left blank.]

[SIGNATURE PAGE TO THIRD AMENDMENT TO CREDIT AGREEMENT] Credit Suisse AG Cayman Islands Branch, as Lender By: Name: Nupur Kumar Title: Authorized Signatory By: Name: Cassandra Droogan Title: Authorized Signatory

[SIGNATURE PAGE TO THIRD AMENDMENT TO CREDIT AGREEMENT] Goldman Sachs Bank USA, as Lender By: Name: Dan Martis Title: Authorized Signatory

[SIGNATURE PAGE TO THIRD AMENDMENT TO CREDIT AGREEMENT] Industrial and Commercial Bank of China Limited, New York Branch, as Lender By: Name: Christine Cai Title: Vice President Industrial and Commercial Bank of China Limited, New York Branch, as Lender By: Name: Pinyen Shih Title: Executive Director Digitally signed by: Christine Cai Date: 2021.11.03 17:26:59 -05'00' Pinyen Shih 2021.11.03 17: 41:38 -05'00'

[SIGNATURE PAGE TO THIRD AMENDMENT TO CREDIT AGREEMENT] JPMORGAN CHASE BANK, N.A., as Lender By: Name: James A. Knight Title: Executive Director

[SIGNATURE PAGE TO THIRD AMENDMENT TO CREDIT AGREEMENT] Sumitomo Mitsui Banking Corporation, as Lender By: Name: Jun Ashley Title: Director

EXECUTION VERSION WEIL:\98229966\5\35899.0596 FOURTH AMENDMENT TO CREDIT AGREEMENT FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of December 28, 2021, by and among LIVENT CORPORATION, a Delaware corporation (“Livent”), LIVENT USA CORP. (f/k/a FMC LITHIUM USA CORP., a Delaware corporation (together with Livent, collectively, the “Borrowers” and, each, a “Borrower”), the Guarantors (as defined below), the lenders and issuing banks listed on the signature pages hereof under the heading “Lenders” (the “Lenders”) and CITIBANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders. W I T N E S S E T H: WHEREAS, the Borrowers, the guarantors party thereto from time to time (the “Guarantors”), the lenders from time to time party thereto and the Administrative Agent are party to that certain Credit Agreement, dated as of September 28, 2018 (as amended by the First Amendment to Credit Agreement, dated as of May 6, 2020, the Second Amendment to Credit Agreement, dated as of August 3, 2020, and the Third Amendment to Credit Agreement, dated as of November 5, 2021, the “Existing Credit Agreement”; the Existing Credit Agreement, as amended by this Amendment, the “Amended Credit Agreement”). WHEREAS, the Borrowers wish to amend Sections 6.04(d) and 6.04(e) of the Existing Credit Agreement, subject to the terms and conditions set forth herein, to permit certain corporate reorganizations pursuant to which (i) the Stock of Livent Switzerland GmbH (f/k/a FMC Switzerland IV GmbH) (“Livent SUI”) currently held by Livent will be transferred, directly or indirectly, to Livent’s wholly-owned direct subsidiary, Livent Lithium Foreign HoldCo B.V. (f/k/a FMC Lithium Foreign HoldCo B.V.) (“Lithium BV”) and (ii) the Stock of Livent Singapore Pte. Ltd. (f/k/a FMC Singapore PTE Limited) (“LL Singapore”) currently held by Livent and by Lithium BV will be transferred to a newly created UK limited company that will be, and, through a series of subsequent transfers of the Stock of such UK limited company, become, a wholly- owned indirect subsidiary of Livent that is 99.99% indirectly owned by Lithium BV (the transactions set forth in clauses (i) and (ii), the “Specified Reorganization”). WHEREAS, the Lien on the issued and outstanding Stock of Livent SUI and LL Singapore held by Livent immediately prior to the consummation of the Specified Reorganization will be released as a result of the Specified Reorganization. NOW, THEREFORE, in consideration of the covenants and agreements contained herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: SECTION 1. Defined Terms. Capitalized terms used but not otherwise defined herein shall have the respective meanings assigned to such terms in the Amended Credit Agreement. SECTION 2. Amendments. Effective as of the Fourth Amendment Effective Date, the Existing Credit Agreement is hereby amended and restated in its entirety as follows: (a) Section 1.01 is hereby amended by adding the following defined terms in the appropriate alphabetical order therein: “Fourth Amendment” means that certain Fourth Amendment to Credit Agreement, dated as of December 28, 2021, by and among the Borrowers, the Guarantors, the Lenders party thereto and the Administrative Agent. Exhibit 10.22

- 2 - WEIL:\98229966\5\35899.0596 “Fourth Amendment Effective Date” means the date on which the conditions to effectiveness of the Fourth Amendment were first satisfied or waived in accordance with the Fourth Amendment. The Fourth Amendment Effective Date occurred on December 28, 2021. “Specified Reorganization” means, collectively, those certain transactions identified to the Administrative Agent and the Lenders on or prior to the Fourth Amendment Effective Date pursuant to which (i) the issued and outstanding Stock of Livent Switzerland GmbH (f/k/a FMC Switzerland IV GmbH) currently held by Livent will be transferred, directly or indirectly, to Livent’s wholly-owned direct subsidiary, Livent Lithium Foreign HoldCo B.V. (f/k/a FMC Lithium Foreign HoldCo BV) (“Lithium BV”) and (ii) the issued and outstanding Stock of Livent Singapore Pte. Ltd. (f/k/a FMC Singapore PTE Limited) currently held by Livent and by Lithium BV will be, and, through a series of subsequent transfers of the Stock of such UK limited company, become, transferred, directly or indirectly, to a newly created UK limited company that will be a wholly- owned indirect subsidiary of Livent that is 99.99% indirectly owned by Lithium BV. (b) Section 6.04(d)(xvii) of the Credit Agreement is hereby amended by deleting the word “and” at the end thereof. (c) Section 6.04(d)(xviii) of the Credit Agreement is hereby amended by deleting the period at the end thereof and replacing it with “; and”. (d) Section 6.04(d) of the Credit Agreement is hereby amended by inserting the following as a new paragraph (xix) thereof: “(xix) to the extent constituting Investments, the transactions in respect of the Specified Reorganization.” (e) Section 6.04(e)(xi) of the Credit Agreement is hereby amended by deleting the word “and” at the end thereof. (f) Section 6.04(e)(xii) of the Credit Agreement is hereby amended by deleting the period at the end thereof and replacing it with “; and”. (g) Section 6.04(e) of the Credit Agreement is hereby amended by inserting the following as a new paragraph (xiii) thereof: “(xiii) to the extent constituting Dispositions, the transactions in respect of the Specified Reorganization.” SECTION 3. Representations and Warranties. Each Loan Parties hereby represent and warrant to the Lenders on the Fourth Amendment Effective Date that: (a) The execution, delivery and performance by each Loan Party of this Amendment and the consummation of the transactions contemplated hereby: (i) are within such Loan Party’s corporate, limited liability company, partnership or other powers;

- 3 - WEIL:\98229966\5\35899.0596 (ii) have been duly authorized by all necessary action, including the consent of shareholders, partners and members where required; (iii) do not and will not contravene such Loan Party’s or any other Restricted Subsidiaries’ respective Constituent Documents, violate any other Requirement of Law applicable to such Loan Party or any other Restricted Subsidiary (including the Margin Regulations), or any order or decree of any Governmental Authority or arbitrator applicable to such Loan Party or any other Restricted Subsidiary, conflict with or result in the breach of, or constitute a default under, or result in or permit the termination or acceleration of, any Contractual Obligation of such Loan Party or any other Restricted Subsidiary, or result in the creation or imposition of any Lien upon any property of such Loan Party or any other Restricted Subsidiary; and (iv) do not require the consent of, authorization by, approval of, notice to, permit from or filing or registration with, any Governmental Authority or any other Person, other than those that have been or will be, prior to the Fourth Amendment Effective Date, obtained or made, and each of which on the Fourth Amendment Effective Date will be in full force and effect. (b) This Amendment has been duly executed and delivered by each Loan Party. This Amendment is the legal, valid and binding obligation of each Loan Party, enforceable against such Loan Party in accordance with its terms. (c) Immediately prior to and after giving effect to the terms, conditions, and provisions of this Amendment, no Default or Event of Default exists. (d) The representations and warranties contained in the Loan Documents are correct in all material respects (except any representations and warranties that are qualified by materiality, which shall be true and correct in all respects) with the same effect as though made on and as of such date, other than any such representations or warranties that, by their terms, refer to an earlier date, such representations and warranties are true and correct as of such earlier date. SECTION 4. Conditions to Effectiveness of this Amendment. The effectiveness of this Amendment is subject to the satisfaction (or waiver in writing by the Administrative Agent (at the direction of the Required Lenders)) of the following conditions precedent (the date on which such conditions are satisfied or waived being referred to herein as the “Fourth Amendment Effective Date”): (a) This Amendment, duly executed and delivered by each of the Borrowers, the Guarantors and the Lenders (which together constitute the Required Lenders). (b) Immediately prior to and after giving effect to the terms, conditions, and provisions of this Amendment, no Default or Event of Default exists. (c) The representations and warranties contained in this Amendment and the other Loan Documents are correct in all material respects (except any representations and warranties that are qualified by materiality, which shall be true and correct in all respects) with the same effect as though made on and as of such date, other than any such representations or warranties that, by their terms, refer to an earlier date, such representations and warranties are true and correct as of such earlier date.

- 4 - WEIL:\98229966\5\35899.0596 SECTION 5. Effect on Loan Documents. (a) On and after the effectiveness of this Amendment, each reference in the Existing Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import shall mean and be a reference to the Amended Credit Agreement and each reference in any other Loan Document to “the Credit Agreement” shall mean and be a reference to the Amended Credit Agreement. (b) Except as specifically amended hereby, all Loan Documents shall continue to be in full force and effect and are hereby in all respects ratified and confirmed. (c) The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents or in any way limit, impair or otherwise affect the rights and remedies of the Administrative Agent or the Lenders under the Loan Documents, except as provided herein. (d) The Borrowers and the other parties hereto acknowledge and agree that, on and after the effective date of this Amendment, this Amendment shall constitute a Loan Document for all purposes of the Amended Credit Agreement. SECTION 6. Applicable Law; Waiver of Right; Trial by Jury; Jurisdiction. THIS AMENDMENT, AND ALL CLAIMS OR CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) THAT MAY BE BASED UPON, ARISE OUT OF OR RELATE IN ANY WAY TO THIS AMENDMENT, THE EXECUTION OR PERFORMANCE OF THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO ANY PRINCIPLE OF CONFLICTS OF LAW THAT COULD REQUIRE THE APPLICATION OF ANY OTHER LAW. The jurisdiction and waiver of right to trial by jury provisions in Sections 9.12 and 9.13 of the Existing Credit Agreement are incorporated herein by reference, mutatis mutandis. SECTION 7. Miscellaneous. (a) This Amendment shall be binding upon and inure to the benefit of the Loan Parties and their respective successors and permitted assigns, and upon the Administrative Agent and the Lenders and their respective successors and permitted assigns. (b) The illegality or unenforceability of any provision of this Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment or any instrument or agreement required hereunder. (c) This Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic imaging (including in .pdf format) means shall be effective as delivery of a manually executed counterpart of this Amendment. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby or thereby shall be deemed to include Electronic Signatures (as defined below), deliveries or the keeping of records in electronic form, each of

- 5 - WEIL:\98229966\5\35899.0596 which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. For the purposes of the foregoing, “Electronic Signature” means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record. (d) Section headings herein are included for convenience of reference only and shall not affect the interpretation of this Amendment. SECTION 8. Reaffirmation. Each of the Loan Parties signatory hereto as debtor, grantor, pledgor, guarantor, assignor, or in any other similar capacity in which such Loan Party grants liens or security interests in its property or otherwise acts as accommodation party or guarantor, as the case may be, hereby (a) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Loan Documents to which it is a party (after giving effect hereto) and (b) to the extent such Loan Party granted liens on or security interests in any of its property pursuant to any such Loan Document as security for or otherwise guaranteed the Obligations under or with respect to the Loan Documents, ratifies and reaffirms such guarantee and grant of security interests and liens and confirms and agrees that such security interests and liens hereafter secure all of the Obligations as amended hereby. Each of the Loan Parties signatory hereto hereby consents to this Amendment and acknowledges that each of the Loan Documents (as amended herby) remains in full force and effect and is hereby ratified and reaffirmed. The execution of this Amendment shall not operate as a waiver of any right, power or remedy of the Administrative Agent or Lenders, constitute a waiver of any provision of any of the Loan Documents or serve to effect a novation of the Obligations. [Remainder of page intentionally left blank.]

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] CITIBANK, N.A., as Administrative Agent By: ___________________________________ Name: Michael Vondriska Title: Vice President

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] CITIBANK, N.A., as Lender By: Name: Michael Vondriska Title: Vice President

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as Lender By: Name: Lingzi Huang Title: Authorized Signatory By: Name: Cassandra Droogan Title: Authorized Signatory

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] CITIZENS BANK, N.A., as Lender By: Name: Kolby D. Baker Title: Vice President

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH By: Name: Christine Cai Title: Vice President INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH By: Name: Pinyen Shih Title: Executive Directors Digitally signed by: Christine Cai Date: 2021.12.23 14:58:29 -05'00' Pinyen Shih 2021.12.27 10: 32:30 -05'00'

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] JPMORGAN CHASE BANK, N.A., as Lender By: Name: James A. Knight Title: Executive Director

[SIGNATURE PAGE TO FOURTH AMENDMENT TO CREDIT AGREEMENT] SUMITOMO MITSUI BANKING CORPORATION, as Lender By: Name: Jane Pedreira Title: Director

Exhibit 21

LIVENT CORPORATION

SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT

The following is a list of the Company’s consolidating subsidiaries, as of December 31, 2021, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934. This list does not include equity affiliate investments and cost investments.


Name of Subsidiary						State or Country of Incorporation
Livent Corporation (the Registrant)						Delaware
Livent USA Corp.						Delaware
Livent Lithium LLC						Delaware
Livent Lithium (Zhangjiagang) Co. Ltd.						China
Minera del Altiplano S.A.						Argentina

Exhibit 23.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements (No. 333-227776, 333-230044, 333- 230076, 333-232043, and 333-251997) on Form S-8 and (No. 333-256939) on Form S-3ASR of our reports dated February 28, 2022, with respect to the consolidated financial statements of Livent Corporation and subsidiaries and the effectiveness of internal control over financial reporting. Our report refers to a change in the accounting principle for convertible debt instruments. /s/ KPMG LLP Philadelphia, Pennsylvania February 28, 2022

Exhibit 23.2

1 CLIENT CONSENT AGREEMENT Livent Lithium LLC 2801 Yorkmont Rd., Suite 300 Charlotte, NC 28208 USA Attention: Ashish Patki Tuesday, 11 February 2022 Dear Ashish, You have requested that permission be given by Wood Mackenzie Limited ("Wood Mackenzie") for the inclusion by you of certain proprietary data and information of Wood Mackenzie contained in Roskill’s 2021 Lithium Outlook to 2031 18th edition (the "Report"), published in August 2021, and all information derived from the Report that is contained in the annual report on Form 10-K of Livent Corporation (the "Document") for the year ended December 31, 2021, which Document is to be made publicly available. Wood Mackenzie is prepared to agree to the publication of the Information in the Document and to the distribution of the Document to persons outside your organisation on condition that you agree to the following terms and conditions: 1. Wood Mackenzie does not warrant or represent that the Information is appropriate or sufficient for your purposes and has not taken into account the purposes for which you are preparing the Document or using the Information and you acknowledge and agree that if you use or rely upon the Information for any purpose then you shall do so entirely at your own risk. 2. Any information disclosed pursuant to this agreement shall include the following disclaimer: "The data and information provided by Wood Mackenzie should not be interpreted as advice and you should not rely on it for any purpose. You may not copy or use this data and information except as expressly permitted by Wood Mackenzie in writing. To the fullest extent permitted by law, Wood Mackenzie accepts no responsibility for your use of this data and information". 3. Wood Mackenzie does not undertake any duty of care to any third party in respect of the Information and disclaims all liability to the fullest extent permitted by law for any consequence whatsoever should any third- party use or rely on the Information. 4. You shall pay, protect, indemnify and hold harmless Wood Mackenzie and its parent, subsidiary and affiliated undertakings and their respective officers, employees and representatives from and against any and all claims, demands, damages, losses, costs, expenses or liabilities of whatever nature (including legal fees and expenses), brought or threatened against or incurred by Wood Mackenzie or any of its parent, subsidiary or affiliated undertakings or any of their respective officers, employees or representatives on account of or arising in connection with or otherwise relating to the use of or reliance on any of the Information by any third party. 5. The final proof of the Document shall not be published or distributed without the prior approval by Wood Mackenzie of any reference to the Information in the final proof of the Document. 6. This letter agreement sets out the entire agreement as between Wood Mackenzie and you in relation to the conditions upon which publication of the Information in the Document is approved by Wood Mackenzie and, shall not modify or affect, or be deemed to modify or affect, the terms of the Agreement entered into between you and Wood Mackenzie dated 21st July 2021. 7. This letter agreement shall be governed by and construed in accordance with the laws of England and the Courts of England shall have exclusive jurisdiction in respect of any dispute arising out of or in connection with this letter agreement. We should be grateful if you would acknowledge your acceptance and agreement of the terms and conditions of this Exhibit 23.3

2 letter agreement by signing and dating a copy of this letter where indicated below and returning it to us. Yours sincerely, Michel Rosier Title SVP Sales, EMEARC Date 11th February 2022 For and on behalf of Wood Mackenzie Limited We hereby acknowledge receipt of this letter and agree to and accept its terms. ___________________________ Authorised signatory, for and on behalf of Livent Lithium, LLC ___________________________ Title ___________________________ Date February 14, 2022 Secretary

CONSENT OF EV-VOLUMES We hereby consent to references to our firm, our Global Plug-in Passenger Cars and Light Commercial Vehicles Forecast published in August 2021 (the “Forecast”), as the Forecast may be amended and supplemented from time to time, and all information derived from the Reports that is contained in the annual report on Form 10-K of Livent Corporation for the year ended December 31, 2021. Date: February 2, 2022 EV-VOLUMES By: Name: Viktor Irle Title: Market Analyst Exhibit 23.4

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, Paul W. Graves, certify that:

1.I have reviewed this Annual Report on Form 10-K of Livent Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 28, 2022


/s/ Paul W. Graves

Paul W. Graves
President and Chief Executive Officer

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Gilberto Antoniazzi, certify that:

1.I have reviewed this Annual Report on Form 10-K of Livent Corporation;

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 28, 2022


/s/ Gilberto Antoniazzi

Gilberto Antoniazzi
Vice President and Chief Financial Officer

Exhibit 32.1

CEO CERTIFICATION OF ANNUAL REPORT

I, Paul W. Graves, President and Chief Executive Officer of Livent Corporation (the "Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(1)the Annual Report on Form 10-K of the Company for the year ended December 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 28, 2022


/s/ Paul W. Graves

Paul W. Graves
President and Chief Executive Officer

Exhibit 32.2

CFO CERTIFICATION OF ANNUAL REPORT

I, Gilberto Antoniazzi, Vice President and Chief Financial Officer of Livent Corporation (the "Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 28, 2022


/s/ Gilberto Antoniazzi

Gilberto Antoniazzi
Vice President and Chief Financial Officer